Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" A1BG ENSG00000121410 "Alpha-1-B glycoprotein" P04217 19 58345178-58353499 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 180 "liver: 299.6" "Cell type enriched" "Detected in many" 11 "Hepatocytes: 1227.5" "Cancer enriched" "Detected in single" 85 "liver cancer: 22.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEK 293: 5.1;Hep G2: 4.9;REH: 6.6;U-266/70: 4.9" "Not detected" "Not detected" "CAB016673, HPA044252" Supported "Secreted to blood" NA NA 200000000000 49000000000 "CAB016673: AB_1611892, HPA044252: AB_2678876" "unprognostic (9.95e-2)" "unprognostic (5.31e-2)" "unprognostic (3.67e-2)" "unprognostic (3.44e-2)" "unprognostic (1.18e-1)" "unprognostic (1.66e-2)" "prognostic favorable (3.97e-4)" "unprognostic (1.09e-1)" "unprognostic (2.59e-1)" "unprognostic (2.10e-1)" "unprognostic (1.47e-2)" "unprognostic (1.37e-2)" "unprognostic (4.19e-5)" "unprognostic (2.37e-2)" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (6.72e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 299.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.6 0.0 0.1 0.0 1.0 0.7 0.0 0.7 0.1 1.3 0.0 0.3 0.6 2.0 0.0 0.0 0.0 0.2 0.0 1.8 0.9 0.0 0.5 0.0 0.0 0.0 0.0 0.9 5.1 2.6 0.0 4.9 0.0 1.0 0.4 0.2 0.4 0.0 0.0 1.2 0.0 1.5 0.8 0.0 0.0 1.8 0.9 1.7 0.3 0.2 0.4 6.6 3.2 1.3 0.0 0.0 0.0 0.4 0.7 0.2 0.8 0.0 1.1 1.1 0.0 1.8 0.3 0.0 0.0 4.9 2.2 1.6 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.1 0.4 0.5 0.5 0.6 0.0 0.3 0.0 0.0 0.0 1.6 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 13.1 48.0 2.3 7.8 2.9 0.4 17.8 14.7 14.8 21.0 2.0 0.9 6.6 0.8 0.5 9.8 0.0 0.0 7.9 7.4 27.9 11.0 16.3 1227.5 26.2 7.9 1.2 36.8 96.4 1.9 1.1 50.1 109.6 47.7 0.0 2.2 8.5 0.0 1.1 1.3 5.2 25.8 52.4 1.4 5.1 3.1 1.6 34.8 0.1 0.6 ABO "A3GALNT, A3GALT1" ENSG00000175164 "ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase" 9 133250401-133275219 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 28.2" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 56.2;Collecting duct cells: 45.4;Enterocytes: 68.1;Mucus-secreting cells: 54.8;Paneth cells: 49.5;Undifferentiated cells: 61.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 8 "basophil: 2.1;eosinophil: 3.0;naive B-cell: 2.2" "Group enriched" "Detected in many" 8 "B-cells: 2.2;granulocytes: 3.0" "Group enriched" "Detected in some" 6 "K-562: 20.4;RT4: 8.0" "Not detected" "Not detected" "Secreted to blood" NA NA "unprognostic (2.78e-3)" "unprognostic (2.56e-3)" "unprognostic (1.38e-1)" "unprognostic (1.87e-3)" "unprognostic (1.39e-1)" "unprognostic (3.10e-2)" "unprognostic (1.84e-3)" "unprognostic (1.30e-1)" "unprognostic (1.69e-2)" "unprognostic (8.51e-2)" "unprognostic (9.30e-3)" "unprognostic (7.23e-2)" "unprognostic (2.67e-2)" "unprognostic (4.57e-3)" "unprognostic (1.50e-1)" "unprognostic (2.34e-1)" "unprognostic (9.04e-2)" 1.6 1.0 0.1 5.8 0.1 0.3 0.4 0.0 0.6 1.0 15.0 0.0 2.3 1.7 1.6 0.8 3.0 0.3 7.6 0.3 0.0 10.7 0.3 3.6 0.3 0.0 0.0 3.2 2.6 0.3 0.0 0.3 0.2 1.5 2.4 1.0 2.2 0.3 1.4 0.3 28.2 0.6 0.0 0.3 0.3 2.0 0.0 0.0 10.1 4.2 5.8 1.0 1.4 2.2 0.1 3.0 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 3.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 2.2 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.2 29.8 22.2 0.5 3.6 0.0 0.0 2.8 17.8 56.2 27.3 45.4 0.0 0.7 0.0 3.7 3.3 6.8 68.1 0.0 0.3 0.2 0.8 6.5 0.0 0.0 0.2 0.0 24.6 3.1 0.6 6.7 14.1 0.3 0.0 1.0 54.8 0.0 8.2 49.5 6.3 19.5 0.1 6.5 0.6 0.5 1.5 0.0 0.6 0.0 61.3 15.2 AFP "FETA, HPAFP" ENSG00000081051 "Alpha fetoprotein" P02771 4 73431138-73456174 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "heart muscle: 4.3;liver: 9.6;lung: 2.9" "Group enriched" "Detected in some" 10 "Hepatocytes: 99.9;Proximal tubular cells: 38.7" "Group enriched" "Detected in some" 14 "liver cancer: 208.8;testis cancer: 49.4" "Region enhanced" "Detected in single" "basal ganglia: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 190 "Hep G2: 219.7" "Region enhanced" "Detected in single" "cerebellum: 0.8" "Not detected" "Not detected" "HPA010607, HPA023600, CAB024283, CAB025339" Approved Approved "Golgi apparatus,Cytosol" "Secreted to blood" NA NA 3010000 930000 "Golgi apparatus" Cytosol "CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769" "unprognostic (4.69e-1)" "unprognostic (1.87e-1)" "unprognostic (3.34e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-3)" "unprognostic (2.95e-2)" "unprognostic (3.35e-1)" "unprognostic (1.54e-1)" "unprognostic (3.81e-2)" "unprognostic (1.01e-1)" "unprognostic (1.25e-1)" "unprognostic (1.63e-6)" "unprognostic (1.98e-2)" "unprognostic (5.80e-2)" "unprognostic (1.14e-1)" 0.0 0.4 0.1 0.0 1.0 0.0 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 4.3 0.3 0.0 0.0 9.6 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 219.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 6.6 0.0 0.0 0.0 0.3 0.0 2.4 0.7 0.3 0.0 0.0 99.9 2.1 0.0 0.0 1.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 38.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 ANGPTL1 "ANG3, ANGPT3, AngY, ARP1" ENSG00000116194 "Angiopoietin like 1" O95841 1 178849705-178871052 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Leydig cells: 394.4;Peritubular cells: 199.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 2.3;naive B-cell: 2.9" "Lineage enhanced" "Detected in single" "B-cells: 2.9" "Group enriched" "Detected in some" 18 "ASC diff: 48.7;ASC TERT1: 19.6;HHSteC: 21.1;HSkMC: 48.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA009976 Approved "Secreted to blood" NA NA 100000 "HPA009976: AB_1844822" "unprognostic (2.59e-2)" "unprognostic (1.31e-1)" "unprognostic (5.80e-3)" "unprognostic (2.63e-2)" "unprognostic (3.60e-1)" "unprognostic (1.71e-2)" "prognostic favorable (8.73e-4)" "unprognostic (3.81e-2)" "unprognostic (5.78e-3)" "unprognostic (1.47e-1)" "unprognostic (1.39e-1)" "unprognostic (5.31e-2)" "prognostic favorable (5.11e-4)" "unprognostic (1.49e-2)" "unprognostic (1.30e-1)" "unprognostic (2.85e-2)" "unprognostic (3.61e-3)" 17.7 16.3 1.2 8.5 1.1 0.0 14.4 0.7 1.4 26.3 36.2 0.9 9.6 2.6 34.6 46.5 33.6 29.7 16.6 12.9 1.0 0.6 15.9 7.1 12.4 15.8 0.6 2.5 35.7 6.4 0.0 2.2 42.0 1.6 16.7 8.7 0.9 14.2 4.2 20.0 4.5 28.2 22.7 1.8 7.0 13.1 24.7 0.4 0.9 19.3 57.5 2.8 25.5 13.7 2.9 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 48.7 19.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 21.1 0.0 0.0 48.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 2.9 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.2 1.1 0.7 1.4 1.0 0.6 0.6 2.5 1.6 0.4 0.0 0.0 0.5 0.0 3.3 2.2 3.1 30.6 1.4 0.0 1.8 5.9 0.5 1.7 0.7 0.8 2.9 0.0 0.0 0.4 0.6 51.8 0.1 0.0 0.9 1.3 0.0 0.0 11.6 0.0 1.9 394.4 0.0 3.3 0.0 0.0 36.6 0.0 0.0 199.4 0.0 12.4 38.8 35.0 0.7 0.7 3.1 1.1 0.0 0.0 0.1 ANGPTL2 "ARP2, HARP" ENSG00000136859 "Angiopoietin like 2" Q9UKU9 9 127087332-127122883 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 15 "Fibroblasts: 66.4;Leydig cells: 19.2;Smooth muscle cells: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 41.4;ASC TERT1: 28.2;BJ hTERT+: 58.2;HSkMC: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040933, HPA041299" Approved Approved "Golgi apparatus" "Secreted to blood" NA NA 2510000 770000 "Golgi apparatus" "HPA040933: AB_10795530, HPA041299: AB_10794552" "unprognostic (5.46e-2)" "unprognostic (4.96e-3)" "unprognostic (1.11e-2)" "unprognostic (2.07e-2)" "unprognostic (8.79e-2)" "unprognostic (3.13e-2)" "unprognostic (1.79e-2)" "unprognostic (2.04e-2)" "unprognostic (3.31e-1)" "unprognostic (1.17e-3)" "unprognostic (2.34e-2)" "unprognostic (1.80e-2)" "prognostic unfavorable (3.32e-5)" "unprognostic (1.97e-3)" "unprognostic (1.72e-1)" "unprognostic (2.45e-2)" "unprognostic (4.15e-2)" 56.6 4.9 3.3 13.5 4.7 0.0 29.0 8.2 16.5 34.9 26.8 19.5 4.4 6.2 29.9 19.8 12.6 13.1 34.9 28.4 4.6 3.4 4.3 6.1 8.3 3.8 9.3 2.9 38.4 2.2 1.6 1.5 8.7 9.6 22.9 7.8 3.4 7.1 12.1 41.9 11.4 10.0 37.4 6.3 26.6 12.7 8.7 8.5 1.7 6.4 27.0 6.4 38.7 20.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 4.9 0.0 41.4 28.2 2.5 2.1 58.2 2.6 2.4 0.0 0.0 0.0 1.9 5.8 0.5 0.0 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.1 8.9 0.0 0.0 28.4 0.0 5.3 0.0 8.3 7.5 0.6 0.0 0.0 1.8 0.0 0.0 1.1 5.2 0.0 0.2 4.3 7.6 0.4 0.6 0.0 2.5 2.8 0.0 0.0 0.0 1.0 0.0 0.0 2.3 9.6 1.2 13.6 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 4.7 8.2 9.0 4.6 3.4 9.3 2.9 9.6 8.5 8.9 3.7 0.0 6.6 12.7 14.5 12.9 0.0 2.7 0.0 0.0 2.0 0.8 0.0 0.2 0.7 11.7 0.0 0.0 0.0 0.7 66.4 1.3 0.0 0.0 1.2 0.0 0.0 2.5 0.0 1.3 19.2 0.3 6.8 0.0 0.0 1.6 1.0 0.0 6.0 1.4 0.3 0.0 25.2 0.2 0.0 9.7 2.2 0.0 0.0 0.6 APCS "MGC88159, PTX2, SAP" ENSG00000132703 "Amyloid P component, serum" P02743 1 159587825-159588865 "Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 81 "liver: 316.6" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 3479.3" "Cancer enriched" "Detected in some" 25 "liver cancer: 826.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 3.3;RH-30: 4.3;SiHa: 2.2;U-937: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB007817, HPA053294" Supported "Secreted to blood" NA NA 27700000000 76000000000 "CAB007817: AB_598185, HPA053294: AB_2682104" "unprognostic (3.19e-3)" "unprognostic (2.30e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.8 0.0 0.0 0.0 0.7 316.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.0 0.0 3.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.7 4.3 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.7 0.2 1.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 451.0 0.0 0.0 0.0 0.0 0.0 0.0 77.6 0.0 0.0 0.0 70.0 5.1 0.0 0.0 0.0 0.0 3479.3 0.0 0.0 0.0 63.8 73.6 0.0 0.0 0.0 0.0 5.4 0.0 0.0 16.5 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASIP "AGTIL, ASP" ENSG00000101440 "Agouti signaling protein" P42127 20 34194569-34269344 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.7;epididymis: 18.4;ovary: 24.8" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 25.4;Hofbauer cells: 12.3;Leydig cells: 11.5;Peritubular cells: 9.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 6 "hippocampal formation: 5.4" "Cell type enriched" "Detected in single" 321 "plasmacytoid DC: 43.7" "Lineage enriched" "Detected in single" 321 "dendritic cells: 43.7" "Cell line enhanced" "Detected in some" "CACO-2: 6.6;HSkMC: 5.4;SK-MEL-30: 3.9;U-698: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA048636 Uncertain Supported Vesicles "Secreted to blood" NA NA Vesicles "HPA048636: AB_2680471" "unprognostic (4.81e-2)" "unprognostic (7.46e-2)" "unprognostic (1.97e-3)" "unprognostic (3.26e-2)" "unprognostic (2.24e-1)" "unprognostic (3.07e-2)" "unprognostic (5.13e-2)" "unprognostic (4.57e-2)" "unprognostic (4.52e-2)" "unprognostic (1.61e-1)" "unprognostic (1.62e-1)" "unprognostic (1.48e-1)" "unprognostic (5.53e-6)" "unprognostic (1.02e-1)" "unprognostic (3.09e-1)" "unprognostic (1.27e-1)" "unprognostic (1.33e-1)" 0.5 0.1 0.3 0.3 0.3 0.2 1.9 0.3 0.8 2.0 1.0 0.3 0.3 0.0 2.0 18.4 0.3 2.1 0.3 10.3 5.4 0.0 0.3 0.5 0.3 0.4 0.3 0.3 24.8 0.3 0.0 0.3 0.3 0.7 2.5 0.0 0.3 0.3 0.3 0.3 5.4 0.3 0.3 1.3 0.3 0.1 7.1 0.3 0.3 0.3 0.3 0.8 0.5 0.4 0.1 43.7 0.0 0.0 0.0 0.0 0.2 0.1 2.4 0.9 0.8 0.5 1.6 0.2 0.2 0.0 0.0 0.0 6.6 0.1 2.4 0.5 0.7 0.0 0.4 0.0 0.0 0.0 0.2 1.6 3.4 0.7 1.1 0.0 0.0 0.9 5.4 0.0 0.0 0.0 0.3 0.0 1.6 1.2 2.0 0.0 0.7 0.5 3.5 0.0 0.3 1.4 0.7 0.6 3.0 0.0 0.2 0.6 0.6 0.0 0.4 3.9 1.1 0.7 0.4 0.8 1.2 1.2 0.2 0.6 0.8 0.8 4.0 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 43.7 0.0 0.2 0.3 0.3 0.3 0.8 5.4 0.0 0.3 0.3 0.7 0.3 0.0 1.1 0.0 0.0 2.3 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 1.0 1.3 0.0 0.0 0.0 0.1 2.3 0.0 0.0 4.0 12.3 0.0 0.0 4.3 0.3 0.2 11.5 1.7 1.7 0.0 0.0 0.0 0.1 0.0 9.9 4.4 0.0 6.5 1.0 1.6 1.3 2.8 0.7 0.0 0.0 0.0 AZGP1 "ZA2G, ZAG" ENSG00000160862 "Alpha-2-glycoprotein 1, zinc-binding" P25311 7 99966720-99976157 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 158.8;salivary gland: 270.5" "Group enriched" "Detected in many" 6 "Glandular cells: 2272.6;Hepatocytes: 3981.0" "Group enriched" "Detected in many" 12 "breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 16.8;Karpas-707: 9.6;OE19: 49.6;RPMI-8226: 38.9;T-47d: 13.0" "Region enriched" "Detected in single" 4 "olfactory region: 0.9" "HPA012582, HPA012876, CAB016087, CAB032276" Enhanced Approved Nucleoplasm,Vesicles "Secreted to blood" NA NA 55200000000 160000000000 Vesicles Nucleoplasm "CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226, HPA012876: " "unprognostic (8.14e-2)" "unprognostic (1.50e-1)" "unprognostic (3.41e-1)" "unprognostic (5.42e-3)" "unprognostic (4.98e-2)" "unprognostic (5.74e-3)" "prognostic favorable (2.90e-4)" "unprognostic (1.50e-1)" "unprognostic (1.85e-1)" "unprognostic (2.19e-1)" "unprognostic (2.35e-2)" "unprognostic (1.79e-1)" "prognostic favorable (1.53e-4)" "unprognostic (2.18e-1)" "unprognostic (2.08e-2)" "unprognostic (9.80e-2)" "unprognostic (3.51e-3)" 6.4 0.0 1.1 1.3 1.7 0.0 64.1 1.1 1.4 1.1 1.4 1.5 0.9 1.4 0.9 1.2 1.3 0.0 2.2 9.0 1.2 0.4 18.0 158.8 3.0 0.9 2.7 1.2 1.0 55.3 0.0 0.9 1.0 1.3 62.4 0.0 1.6 270.5 2.5 1.0 11.5 1.5 0.9 1.1 0.9 14.4 1.2 1.7 0.9 1.0 3.0 3.2 1.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.2 4.3 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 1.6 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 1.4 0.0 49.6 0.0 0.0 0.5 38.9 0.0 0.0 0.0 0.6 0.2 7.9 3.8 0.0 13.0 0.0 0.0 0.1 0.0 0.6 0.3 0.6 0.2 0.1 0.0 0.1 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 1.7 1.1 1.4 1.2 0.4 2.7 1.2 1.3 1.7 20.8 187.7 32.0 321.8 3.8 0.0 94.8 420.4 5.3 50.0 5.2 2.0 0.0 39.7 11.0 1.3 0.4 8.5 46.7 221.1 0.0 0.2 2272.6 3.5 3981.0 0.0 0.0 11.9 58.3 79.1 3.1 0.9 0.3 59.1 3.6 5.4 22.6 173.5 5.8 0.0 512.3 0.2 0.0 1.1 4.3 0.4 8.4 0.0 15.2 6.3 497.4 BX248415.1 ENSG00000276911 1 196819745-196959210 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 938 "liver: 93.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RH-30: 2.6" "HPA038915, HPA040726, HPA049813" Supported "Secreted to blood" NA NA "HPA038915: AB_2676269, HPA040726: AB_2677101, HPA049813: AB_2680895" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 93.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C16orf89 MGC45438 ENSG00000153446 "Chromosome 16 open reading frame 89" Q6UX73 16 5044122-5066110 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 35.8;thyroid gland: 79.3" "Cell type enhanced" "Detected in many" 18 "Alveolar cells type 2: 191.8;Club cells: 122.8;Distal tubular cells: 96.2" "Group enriched" "Detected in many" 14 "lung cancer: 64.7;thyroid cancer: 145.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 4.9;Hep G2: 5.9;HHSteC: 3.1;NTERA-2: 3.6;U-2197: 5.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013613, HPA016934" Enhanced "Secreted to blood" NA NA 1200000 "HPA013613: AB_1845584, HPA016934: AB_2732417" "unprognostic (1.92e-2)" "unprognostic (1.53e-1)" "unprognostic (2.97e-1)" "unprognostic (6.29e-2)" "unprognostic (3.79e-2)" "unprognostic (1.48e-1)" "unprognostic (2.67e-2)" "unprognostic (1.01e-2)" "unprognostic (9.23e-2)" "unprognostic (2.65e-1)" "unprognostic (6.39e-2)" "unprognostic (3.25e-2)" "unprognostic (6.64e-3)" "unprognostic (3.53e-2)" "unprognostic (1.25e-1)" "unprognostic (5.54e-2)" "unprognostic (8.48e-3)" 6.0 1.7 7.7 4.4 9.3 0.3 4.7 5.1 8.6 7.3 2.3 5.2 0.3 5.9 1.4 30.3 2.5 4.6 15.3 7.1 6.1 3.0 5.6 0.3 35.8 0.5 6.2 7.4 1.9 8.2 0.3 1.9 0.5 5.3 4.0 1.9 5.0 11.5 0.6 0.2 0.4 2.8 6.2 7.4 0.4 28.0 1.4 2.9 0.0 79.3 2.7 1.4 4.3 1.8 1.1 0.9 3.3 0.5 1.3 0.6 0.2 0.1 0.2 0.0 0.4 4.9 0.1 0.8 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.4 0.6 1.4 5.9 3.1 0.2 0.5 1.4 0.0 0.0 0.0 0.5 0.0 0.4 0.3 0.3 0.0 0.3 1.6 0.7 3.6 0.0 0.1 0.5 0.1 0.3 0.0 0.5 0.6 0.4 0.3 0.7 1.1 0.7 0.4 0.0 0.2 0.6 0.3 5.0 0.3 0.4 0.2 0.1 0.4 0.2 0.1 3.3 0.5 0.7 0.4 0.4 0.3 0.7 0.4 0.4 0.2 1.1 0.5 0.6 1.9 1.3 0.2 0.9 0.3 0.2 7.7 9.3 5.1 8.6 6.1 3.0 6.2 7.4 5.3 2.9 41.7 191.8 0.0 1.8 0.3 0.2 2.6 0.0 29.4 122.8 0.0 0.0 0.1 96.2 0.0 1.4 0.0 0.0 0.0 7.2 0.1 7.0 3.7 4.7 0.0 4.6 0.0 0.0 0.0 0.0 1.2 8.6 0.6 0.0 0.0 0.3 0.1 0.7 0.0 13.8 0.3 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 1.8 C1orf54 FLJ23221 ENSG00000118292 "Chromosome 1 open reading frame 54" Q8WWF1 1 150268200-150280916 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 98.9;Leydig cells: 88.1;Macrophages: 71.5;Peritubular cells: 97.9;Smooth muscle cells: 69.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "myeloid DC: 36.2" "Lineage enriched" "Detected in many" 5 "dendritic cells: 36.2" "Cell line enhanced" "Detected in many" "AF22: 20.9;AN3-CA: 31.6;ASC diff: 22.4;ASC TERT1: 37.5;HSkMC: 30.3;HUVEC TERT2: 29.2" "Low region specificity" "Detected in all" "HPA026518, HPA043874" Approved Approved "Plasma membrane" "Secreted to blood" NA NA "Plasma membrane" "HPA026518: AB_1845647, HPA043874: AB_2732511" "unprognostic (4.64e-3)" "unprognostic (6.81e-3)" "unprognostic (4.01e-3)" "unprognostic (5.69e-3)" "unprognostic (2.22e-1)" "unprognostic (1.72e-1)" "unprognostic (1.51e-2)" "unprognostic (1.88e-1)" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "unprognostic (3.45e-1)" "unprognostic (3.21e-1)" "prognostic unfavorable (2.43e-4)" "unprognostic (3.16e-2)" "unprognostic (8.06e-2)" "unprognostic (1.33e-2)" "unprognostic (4.48e-2)" 16.0 8.8 16.4 19.0 19.3 4.5 13.8 5.8 10.5 11.9 14.0 4.5 19.1 5.8 19.8 21.1 11.0 17.1 21.6 13.8 13.7 13.7 12.7 12.0 11.8 21.5 21.8 8.3 8.3 6.8 2.0 6.7 24.4 14.0 15.3 11.1 10.9 9.8 30.4 13.4 4.5 8.1 24.1 20.4 27.3 8.3 5.7 14.8 4.9 8.3 17.1 11.2 22.0 14.3 0.3 36.2 0.4 7.7 0.2 1.5 2.2 0.5 0.1 20.9 31.6 22.4 37.5 0.6 3.4 5.0 0.9 3.0 0.2 0.6 0.2 1.1 3.0 0.4 0.9 0.0 0.1 1.1 0.3 3.7 0.6 0.5 0.3 4.6 1.1 0.8 30.3 1.5 6.3 0.5 3.7 29.2 0.5 0.4 4.1 3.2 1.2 0.2 7.2 1.7 0.0 1.1 5.2 0.5 0.4 0.3 1.6 0.4 0.4 0.4 0.2 2.3 4.2 0.4 15.8 0.2 7.5 0.6 0.2 0.3 1.7 1.4 0.3 16.6 0.9 0.2 0.0 7.7 0.3 0.2 6.8 0.9 0.3 1.5 0.6 36.2 0.3 1.5 0.8 0.4 0.2 1.9 0.7 0.6 2.2 16.4 19.3 5.8 10.5 13.7 13.7 21.8 8.3 14.0 14.8 3.0 5.0 2.4 2.0 5.7 0.8 6.2 2.5 0.0 2.3 21.0 0.0 1.0 64.6 0.5 7.4 64.6 2.1 0.0 2.0 0.7 22.1 1.8 1.1 0.8 45.5 0.0 1.2 49.1 98.9 15.7 88.1 71.5 11.8 20.8 1.1 11.1 1.5 0.8 97.9 2.6 1.3 32.3 69.0 16.6 1.3 4.4 3.0 2.5 1.2 5.5 C1orf56 "FLJ20519, MENT" ENSG00000143443 "Chromosome 1 open reading frame 56" Q9BUN1 1 151047740-151051986 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "blood: 54.8;testis: 67.7" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 336.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA037429, HPA037430" Enhanced "Secreted to blood" NA NA 90000000 "HPA037429: AB_10671755, HPA037430: AB_2675473" "unprognostic (7.60e-2)" "unprognostic (8.26e-2)" "unprognostic (1.09e-2)" "unprognostic (3.83e-1)" "unprognostic (4.31e-2)" "unprognostic (2.83e-2)" "unprognostic (1.11e-2)" "unprognostic (3.81e-3)" "unprognostic (1.59e-2)" "unprognostic (2.70e-3)" "unprognostic (3.28e-3)" "unprognostic (5.29e-2)" "unprognostic (3.61e-2)" "unprognostic (3.61e-2)" "unprognostic (6.16e-2)" "unprognostic (2.26e-1)" "unprognostic (4.79e-2)" 3.3 6.4 2.9 2.0 3.6 0.9 3.1 3.8 3.5 3.7 2.7 5.2 5.1 2.9 3.4 5.6 3.1 4.3 4.6 5.6 3.1 2.1 4.0 6.4 2.6 2.8 3.3 2.0 4.8 7.0 3.9 6.3 3.0 3.4 4.7 1.2 4.3 6.5 6.4 4.0 3.3 2.0 3.8 2.3 2.7 3.1 67.7 3.8 0.7 7.1 1.2 1.7 3.3 3.0 16.3 7.8 54.8 15.4 15.5 28.4 1.0 4.0 8.1 2.8 1.3 4.8 4.7 2.6 2.3 3.4 1.5 1.2 3.5 5.8 0.9 3.7 2.5 3.2 5.5 1.6 0.3 0.8 5.2 1.8 1.0 6.4 4.3 3.3 1.1 0.8 3.4 1.8 2.3 0.8 2.9 2.2 1.8 2.1 2.1 1.3 15.8 1.5 2.8 4.7 3.2 4.6 1.3 2.8 2.9 1.2 2.3 3.8 7.4 7.4 3.8 5.3 5.6 7.5 3.0 2.3 2.0 3.6 5.3 2.0 5.0 3.9 12.7 3.8 0.6 2.5 54.8 7.3 13.7 27.8 15.4 20.8 14.2 24.2 24.2 5.5 16.3 20.6 28.4 20.2 15.5 12.7 7.8 13.7 1.0 2.9 3.6 3.8 3.5 3.1 2.1 3.3 2.0 3.4 3.8 6.0 8.5 68.1 31.4 57.5 18.6 7.0 48.4 6.7 10.3 40.1 19.6 38.8 33.2 18.8 336.7 30.8 8.0 46.7 12.8 26.9 47.4 29.5 39.1 34.7 28.3 17.5 14.3 63.3 73.4 44.3 26.4 65.6 84.4 83.0 12.5 13.8 26.2 17.5 24.1 24.8 24.2 25.8 37.6 148.7 13.6 72.8 74.8 126.9 12.0 45.1 C2orf40 "augurin, ECRG4" ENSG00000119147 "Chromosome 2 open reading frame 40" Q9H1Z8 2 106063246-106078159 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Ciliated cells: 481.8;Early spermatids: 894.2" "Cancer enriched" "Detected in many" 11 "thyroid cancer: 72.8" "Region enriched" "Detected in all" 7 "pons and medulla: 44.8" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 10.0;naive CD8 T-cell: 8.2" "Lineage enriched" "Detected in single" 77 "T-cells: 10.0" "Cell line enhanced" "Detected in some" "BEWO: 2.2;HSkMC: 1.0;NB-4: 1.3" "Group enriched" "Detected in many" 5 "basal ganglia: 44.8;cerebellum: 37.1;hippocampal formation: 85.7;pons and medulla: 114.2;thalamus: 69.1" "Low region specificity" "Detected in many" HPA008546 Uncertain "Secreted to blood" NA NA "HPA008546: AB_2066524" "prognostic favorable (4.58e-4)" "unprognostic (3.91e-1)" "unprognostic (2.44e-2)" "unprognostic (1.34e-2)" "unprognostic (1.09e-1)" "unprognostic (2.32e-1)" "unprognostic (1.61e-3)" "unprognostic (6.56e-3)" "unprognostic (1.82e-2)" "unprognostic (1.25e-1)" "unprognostic (2.35e-3)" "unprognostic (1.36e-2)" "unprognostic (1.06e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (9.11e-3)" "unprognostic (1.30e-4)" 27.5 14.0 1.6 7.6 3.2 0.4 12.7 4.1 4.1 21.8 11.0 18.7 19.9 2.9 19.5 25.8 16.5 15.9 10.3 6.5 3.2 5.1 14.7 1.4 8.4 1.0 6.2 3.7 7.9 3.4 1.0 27.6 4.2 44.8 37.1 3.0 33.9 10.2 50.7 4.1 3.2 6.4 66.8 9.6 12.0 50.6 11.0 1.9 0.1 44.2 8.2 2.5 46.6 26.8 0.1 0.0 0.0 0.0 0.1 10.0 1.7 0.0 0.0 0.7 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.1 2.4 1.6 0.0 0.0 10.0 8.2 0.0 0.1 0.0 0.0 0.7 1.7 1.6 3.2 4.1 4.1 3.2 5.1 6.2 3.7 44.8 1.9 0.0 1.4 0.0 1.8 7.1 0.1 6.3 0.0 481.8 40.9 19.2 0.0 1.4 0.0 0.6 894.2 5.8 0.0 0.0 0.0 0.7 22.3 1.6 1.1 0.0 2.3 3.2 10.2 11.1 0.3 110.5 19.0 2.7 1.7 0.0 0.0 0.2 0.0 0.0 59.4 0.0 0.2 38.8 97.8 9.7 3.6 0.9 2.6 0.5 0.0 1.8 C4orf48 ENSG00000243449 "Chromosome 4 open reading frame 48" Q5BLP8 4 2041993-2043970 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 78.4;brain: 37.2" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 378.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 38.6;NB-4: 27.7;PC-3: 83.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052447 Uncertain Approved Cytosol "Secreted to blood" NA NA 32000 Cytosol "HPA052447: AB_2681837" "unprognostic (7.96e-2)" "unprognostic (2.57e-3)" "unprognostic (2.08e-1)" "unprognostic (3.20e-2)" "unprognostic (4.01e-2)" "unprognostic (8.26e-2)" "unprognostic (4.85e-3)" "unprognostic (2.51e-3)" "unprognostic (2.28e-3)" "unprognostic (1.80e-1)" "unprognostic (1.95e-2)" "unprognostic (5.55e-2)" "unprognostic (3.42e-2)" "unprognostic (5.38e-3)" "unprognostic (2.68e-1)" "unprognostic (5.55e-2)" "unprognostic (3.17e-3)" 11.4 7.8 25.5 9.7 22.2 5.6 4.8 7.7 37.2 3.4 19.7 18.2 3.2 6.5 4.1 3.0 1.2 3.2 3.1 3.8 26.4 26.2 5.2 2.5 4.7 8.7 24.8 15.6 2.9 16.8 5.6 19.8 5.3 14.9 3.9 3.1 4.3 5.1 4.3 3.3 3.7 16.6 2.4 30.7 9.6 9.8 13.9 15.7 1.2 2.2 0.7 2.4 2.6 2.6 29.8 49.4 67.5 78.4 4.5 31.0 28.4 7.8 6.5 1.3 6.1 0.6 0.9 8.7 7.5 1.5 1.4 1.3 4.4 4.7 1.0 7.3 0.2 2.5 2.2 0.1 0.8 0.4 4.7 38.6 2.5 3.5 2.5 1.3 5.1 17.3 0.7 1.4 0.3 0.0 0.4 1.4 4.3 8.1 0.0 0.9 4.8 5.7 27.7 3.9 0.4 83.8 13.2 2.0 2.5 1.2 2.9 10.5 14.8 3.7 0.1 10.1 0.1 2.0 2.4 6.4 3.6 7.8 2.7 8.4 5.9 5.1 0.0 3.6 3.1 5.0 11.5 78.4 67.5 21.5 50.6 22.0 29.8 27.8 23.9 44.2 22.6 16.0 16.7 59.0 4.5 44.0 49.4 31.0 28.4 25.5 22.2 7.7 37.2 26.4 26.2 24.8 15.6 14.9 15.7 0.0 3.4 61.1 5.3 19.5 14.6 6.1 17.8 6.7 3.4 190.1 0.0 7.5 59.7 304.2 76.9 29.1 185.6 23.3 194.2 111.5 25.9 12.6 109.2 8.9 199.3 17.5 225.6 114.2 260.9 247.7 17.8 117.6 310.4 64.9 97.5 43.9 199.3 378.7 26.5 6.8 11.5 12.9 12.8 61.7 167.2 8.8 11.0 64.3 73.8 9.2 CAMP "CAP18, FALL-39, FALL39, LL37" ENSG00000164047 "Cathelicidin antimicrobial peptide" 3 48223347-48225491 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 63.7;bone marrow: 201.8;epididymis: 275.0" "Cell type enhanced" "Detected in some" 14 "Early spermatids: 14.1;Glandular cells: 10.4;Late spermatids: 6.8;Spermatogonia: 4.9" "Cancer enhanced" "Detected in many" "testis cancer: 10.1" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 4 "neutrophil: 63.7" "Lineage enriched" "Detected in many" 12 "granulocytes: 63.7" "Cell line enhanced" "Detected in some" "Daudi: 13.6;hTCEpi: 9.5;U-698: 39.4" "Low region specificity" "Detected in single" "CAB015949, CAB016522, HPA029874" Enhanced "Secreted to blood" NA NA 617000000 "CAB015949: , CAB016522: , HPA029874: AB_10600859" "unprognostic (2.14e-2)" "prognostic favorable (5.73e-4)" "unprognostic (4.59e-2)" "unprognostic (2.62e-1)" "unprognostic (9.41e-2)" "unprognostic (4.57e-5)" "unprognostic (3.09e-1)" "unprognostic (5.71e-2)" "unprognostic (4.89e-2)" "unprognostic (7.65e-2)" "unprognostic (1.32e-1)" "unprognostic (8.08e-4)" "unprognostic (1.23e-2)" "unprognostic (2.55e-1)" "unprognostic (1.71e-1)" "unprognostic (1.80e-2)" "unprognostic (1.03e-2)" 0.2 0.1 0.1 0.1 0.2 201.8 0.2 0.1 0.1 0.1 0.1 0.0 14.7 0.0 0.0 275.0 0.1 0.2 0.0 0.5 0.1 0.1 0.1 0.2 1.5 0.5 0.1 0.0 0.1 0.1 0.0 0.1 0.4 0.0 0.2 0.0 0.1 1.1 0.1 0.1 0.1 2.6 0.0 0.1 10.1 0.1 4.0 0.0 0.4 0.4 0.1 0.2 0.4 0.1 0.5 1.5 63.7 5.2 0.5 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 39.4 0.0 1.5 0.0 5.5 1.1 15.8 0.0 1.7 0.0 0.5 0.0 0.0 1.5 0.3 0.0 0.0 63.7 0.5 5.2 0.8 0.0 10.9 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.2 0.0 0.2 10.4 0.0 0.0 3.3 0.0 0.0 0.6 0.6 6.8 0.9 0.8 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 4.9 0.0 0.0 0.0 0.0 0.4 CCDC126 FLJ23031 ENSG00000169193 "Coiled-coil domain containing 126" Q96EE4 7 23597379-23644708 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 75.4" "Group enriched" "Detected in many" 18 "Early spermatids: 588.1;Late spermatids: 350.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "basophil: 75.4" "Lineage enriched" "Detected in all" 18 "granulocytes: 75.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010969, HPA026883" Uncertain Approved "Golgi apparatus" "Secreted to blood" NA NA 31000000 "Golgi apparatus" "HPA010969: , HPA026883: AB_1846131" "unprognostic (2.02e-1)" "unprognostic (2.76e-2)" "unprognostic (9.03e-2)" "unprognostic (1.29e-1)" "unprognostic (1.18e-1)" "unprognostic (5.96e-3)" "unprognostic (1.16e-2)" "unprognostic (3.90e-1)" "unprognostic (9.30e-2)" "unprognostic (1.42e-2)" "unprognostic (3.44e-2)" "unprognostic (3.29e-2)" "unprognostic (7.35e-3)" "unprognostic (5.90e-2)" "unprognostic (1.20e-1)" "unprognostic (1.62e-1)" "unprognostic (3.28e-1)" 6.7 8.1 8.7 4.4 9.2 6.9 19.5 11.6 13.2 7.4 6.5 5.6 5.8 8.7 8.0 5.3 6.6 6.7 6.2 5.7 13.8 8.9 7.6 11.7 6.5 9.3 10.5 3.9 7.4 9.8 12.2 12.6 4.6 11.1 6.0 6.5 5.8 7.5 6.5 10.0 6.6 9.4 6.7 12.9 6.1 6.8 41.3 8.1 5.4 9.9 5.0 8.6 7.0 7.7 3.8 3.0 75.4 3.6 2.9 4.1 2.9 4.8 3.4 7.5 9.5 12.6 7.1 17.3 6.1 6.0 5.3 7.7 3.6 1.6 10.4 9.7 5.1 10.1 2.8 3.2 2.9 6.9 2.2 4.3 1.8 1.4 4.6 5.1 4.7 9.3 7.5 8.5 1.7 1.6 4.4 7.0 4.4 4.1 3.0 6.3 2.2 3.2 5.7 3.5 6.4 4.3 2.2 11.9 3.1 5.5 2.2 4.6 8.6 6.3 6.1 4.5 12.2 5.1 4.4 8.4 3.1 5.6 7.1 4.8 8.4 8.3 7.4 3.5 6.9 16.9 75.4 3.6 16.4 3.0 3.3 3.7 3.8 3.3 3.5 3.0 3.2 4.1 3.2 6.9 2.9 3.1 0.6 3.6 2.9 8.7 9.2 11.6 13.2 13.8 8.9 10.5 3.9 11.1 8.1 6.0 7.2 7.1 7.0 16.9 12.6 8.3 7.6 9.4 3.4 12.2 7.9 9.0 6.6 10.1 588.1 10.5 5.8 0.0 8.0 5.6 10.4 7.1 6.9 12.7 6.2 7.9 14.5 10.4 5.1 350.6 10.6 7.9 13.5 6.4 8.6 7.2 8.1 6.2 13.4 7.2 12.6 12.9 12.2 26.8 23.8 20.7 16.9 7.5 5.6 5.9 CCDC134 FLJ22349 ENSG00000100147 "Coiled-coil domain containing 134" Q9H6E4 22 41800679-41826299 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 15.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003936 Approved "Secreted to blood" NA NA "HPA003936: AB_1078419" "unprognostic (2.09e-2)" "unprognostic (1.00e-1)" "unprognostic (3.82e-2)" "prognostic favorable (4.09e-4)" "unprognostic (1.73e-1)" "unprognostic (3.85e-2)" "prognostic unfavorable (7.42e-7)" "unprognostic (4.35e-1)" "unprognostic (1.69e-1)" "unprognostic (3.08e-1)" "unprognostic (3.30e-2)" "unprognostic (7.32e-2)" "prognostic favorable (1.36e-5)" "unprognostic (6.24e-3)" "unprognostic (2.52e-2)" "unprognostic (5.47e-1)" "unprognostic (6.63e-2)" 3.8 23.4 3.3 8.1 5.0 15.1 4.4 19.1 5.2 4.6 5.7 7.7 5.7 5.5 5.9 15.0 6.9 7.3 4.8 4.6 4.3 3.1 7.5 6.9 5.6 7.3 4.2 2.4 4.4 8.1 12.2 12.3 6.6 5.6 5.2 4.9 8.6 12.9 9.0 6.5 5.9 5.8 3.4 5.1 7.3 6.1 17.2 5.4 12.6 8.7 3.5 11.8 4.4 4.1 4.2 2.2 9.4 8.2 4.5 7.1 3.4 7.8 6.8 6.1 12.1 3.5 0.9 7.1 6.4 5.3 12.0 14.1 10.3 5.2 7.1 11.1 5.2 7.1 8.7 6.1 6.4 6.7 7.8 9.7 6.6 16.9 7.2 1.6 9.2 9.3 1.9 2.5 13.8 2.8 4.5 6.2 6.8 4.4 14.7 6.6 5.3 5.9 5.5 4.7 11.1 5.0 11.2 9.4 10.0 8.7 7.1 3.6 2.8 11.7 9.4 4.7 3.7 11.9 5.3 3.4 6.3 10.5 4.3 11.0 16.9 10.1 5.4 6.7 5.9 12.5 0.0 4.9 9.4 5.8 8.0 3.6 4.2 3.6 4.4 2.2 2.5 7.1 3.8 2.6 4.5 8.2 2.0 6.0 3.4 3.3 5.0 19.1 5.2 4.3 3.1 4.2 2.4 5.6 5.4 3.0 1.3 0.0 1.5 0.2 1.2 0.7 2.5 1.4 0.0 3.5 2.0 4.0 0.0 4.2 0.6 0.7 3.0 0.0 1.7 15.4 0.9 1.8 0.0 1.7 3.9 0.0 0.0 0.0 0.6 0.4 0.6 0.9 1.7 5.4 1.1 0.9 2.0 1.9 0.4 1.0 2.1 0.0 1.0 4.2 1.6 0.0 2.4 2.9 2.1 1.4 CCDC3 DKFZp761F241 ENSG00000151468 "Coiled-coil domain containing 3" Q9BQI4 10 12896625-13099652 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 89.3" "Cell type enhanced" "Detected in many" 14 "Basal keratinocytes: 44.5;Peritubular cells: 57.0;Sertoli cells: 32.3;Smooth muscle cells: 95.9;Suprabasal keratinocytes: 32.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 7.5;HAP1: 13.6;HDLM-2: 22.3;hTERT-RPE1: 10.7;U-2 OS: 14.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA062425 Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA Nucleoplasm Cytosol "HPA062425: AB_2684759" "unprognostic (2.26e-1)" "unprognostic (6.65e-3)" "unprognostic (1.70e-1)" "unprognostic (4.30e-3)" "unprognostic (1.72e-1)" "unprognostic (5.08e-2)" "unprognostic (3.11e-2)" "unprognostic (2.99e-2)" "unprognostic (5.56e-3)" "unprognostic (5.41e-2)" "unprognostic (4.25e-3)" "unprognostic (2.22e-2)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.54e-2)" "unprognostic (1.49e-1)" "unprognostic (2.29e-1)" "unprognostic (3.88e-2)" 37.1 5.0 14.0 2.5 9.0 0.2 33.6 4.9 15.0 23.0 4.2 2.9 3.4 2.9 16.2 18.6 26.9 21.8 89.3 11.0 8.0 3.0 4.2 8.5 8.0 12.3 4.3 8.7 39.1 2.9 3.8 4.2 9.6 3.2 14.3 3.4 8.8 2.8 10.3 12.0 55.7 5.5 11.8 3.4 9.8 5.8 11.0 3.1 10.4 8.3 9.6 2.0 12.4 14.2 0.1 0.0 0.0 0.0 0.0 0.9 1.0 0.0 0.2 1.2 6.7 0.0 0.0 0.1 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.5 0.0 7.5 1.3 13.6 2.5 0.4 22.3 5.7 0.0 0.2 0.0 0.5 0.0 0.0 1.7 1.6 0.3 0.0 10.7 0.6 0.5 0.0 0.1 0.7 0.1 0.0 3.7 1.0 0.0 0.0 0.0 3.0 0.2 0.0 0.0 2.6 1.1 4.9 0.7 0.0 3.3 0.0 0.0 0.0 0.0 14.8 0.8 0.2 0.0 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.0 14.0 9.0 4.9 15.0 8.0 3.0 4.3 8.7 3.2 3.1 0.0 0.0 0.0 6.2 44.5 1.0 4.4 0.0 0.0 1.2 0.0 0.0 0.2 1.7 0.0 0.2 8.3 0.0 0.0 0.0 0.1 9.1 1.9 0.0 0.2 0.3 0.0 0.0 8.0 0.0 1.1 20.8 1.6 13.5 0.0 0.0 0.5 0.1 0.0 57.0 0.3 1.9 32.3 95.9 0.0 3.8 32.5 0.2 0.0 0.0 1.0 CLEC18A MRCL ENSG00000157322 "C-type lectin domain family 18 member A" A5D8T8 16 69950705-69964452 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 19.6" "Cell type enriched" "Detected in some" 18 "Proximal tubular cells: 57.3" "Cancer enriched" "Detected in single" 7 "renal cancer: 1.5" "Cell type enhanced" "Detected in single" "neutrophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 2.8;BEWO: 3.6" HPA048976 Uncertain "Secreted to blood" NA NA "HPA048976: AB_2680582" "unprognostic (1.68e-1)" "unprognostic (3.06e-2)" "unprognostic (1.19e-2)" "unprognostic (1.48e-1)" "unprognostic (3.14e-2)" "unprognostic (4.62e-2)" "unprognostic (1.36e-1)" "unprognostic (4.14e-2)" "unprognostic (1.04e-1)" "unprognostic (4.40e-2)" "unprognostic (6.77e-4)" "unprognostic (6.73e-2)" "unprognostic (4.58e-2)" "unprognostic (2.06e-1)" "unprognostic (9.03e-4)" "unprognostic (1.52e-1)" "unprognostic (2.53e-2)" 0.1 1.3 0.3 0.0 0.8 0.3 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.3 0.5 19.6 0.1 0.1 0.1 0.3 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.7 0.1 0.0 0.1 0.5 0.0 1.0 0.7 0.5 3.4 0.1 0.1 0.4 0.0 0.9 0.3 1.6 0.0 0.5 0.1 0.0 0.3 0.3 2.8 0.2 0.0 0.8 3.6 0.0 0.0 0.6 0.2 0.6 0.1 0.5 0.3 0.0 0.5 0.0 0.0 0.4 0.3 0.6 0.9 0.0 0.0 1.5 0.0 0.7 1.8 0.0 1.4 1.4 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.7 0.1 0.0 0.2 0.4 0.0 0.0 1.0 1.6 0.1 0.8 0.0 0.1 0.5 0.7 1.6 0.0 0.7 1.9 0.2 0.0 0.7 0.8 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.9 0.0 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.5 0.0 0.1 1.2 0.4 0.0 0.0 0.0 0.0 2.0 0.1 1.7 0.2 0.2 0.2 1.1 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.3 3.2 0.0 1.3 0.0 0.6 0.3 0.1 0.0 0.0 0.9 1.5 0.5 0.0 0.0 57.3 1.1 0.0 0.2 0.5 0.1 0.0 0.2 0.0 1.6 0.1 CLEC18B MRCL2 ENSG00000140839 "C-type lectin domain family 18 member B" Q6UXF7 16 74408270-74421953 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "kidney: 28.1" "Cell type enriched" "Detected in some" 11 "Proximal tubular cells: 18.2" "Group enriched" "Detected in some" 12 "glioma: 2.7;ovarian cancer: 1.2;renal cancer: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.9;JURKAT: 4.1;K-562: 7.3;U-266/70: 2.7" HPA048976 Uncertain "Secreted to blood" NA NA "HPA048976: AB_2680582" "unprognostic (5.69e-2)" "unprognostic (1.46e-1)" "unprognostic (5.30e-3)" "unprognostic (9.37e-2)" "prognostic unfavorable (2.07e-4)" "unprognostic (7.15e-2)" "unprognostic (7.51e-2)" "unprognostic (4.49e-3)" "unprognostic (2.17e-1)" "unprognostic (2.28e-1)" "unprognostic (9.91e-2)" "unprognostic (3.58e-2)" "unprognostic (1.42e-2)" "unprognostic (2.31e-2)" "unprognostic (5.87e-2)" "unprognostic (5.43e-2)" "unprognostic (4.27e-2)" 0.1 1.1 1.1 0.3 1.4 0.1 0.1 2.5 1.2 0.1 0.1 0.4 0.1 0.6 1.2 0.1 0.3 0.0 1.0 1.0 28.1 0.1 0.0 0.1 1.0 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.2 0.0 0.2 0.1 2.0 0.1 0.1 6.1 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 1.6 2.9 1.8 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.2 1.1 0.5 0.5 1.0 0.9 0.0 0.1 0.3 0.2 0.4 0.3 0.1 0.7 0.0 0.3 1.7 0.4 0.1 0.1 0.7 0.0 4.1 7.3 0.0 0.3 0.0 0.0 0.0 1.2 0.3 0.8 0.4 0.0 1.6 0.0 0.3 0.6 0.3 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.3 0.4 0.2 0.9 2.7 1.6 0.3 0.5 0.2 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.3 0.6 0.4 0.0 0.0 18.2 1.1 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.0 0.0 CLEC18C "MGC34761, MRCL3" ENSG00000157335 "C-type lectin domain family 18 member C" Q8NCF0 16 70173322-70187361 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 13 "kidney: 16.5;testis: 4.6" "Cell type enriched" "Detected in single" 48 "Proximal tubular cells: 18.8" "Cancer enriched" "Detected in single" 9 "renal cancer: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.0;RT4: 1.3;TIME: 3.0" HPA048976 Uncertain "Secreted to blood" NA NA "HPA048976: AB_2680582" "unprognostic (3.90e-1)" "unprognostic (3.03e-1)" "unprognostic (1.20e-4)" "unprognostic (5.55e-2)" "unprognostic (5.72e-3)" "unprognostic (2.92e-1)" "unprognostic (7.64e-2)" "unprognostic (3.79e-2)" "unprognostic (3.61e-3)" "unprognostic (6.98e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 16.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 4.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.6 0.3 1.3 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.6 3.0 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 CLEC3B "TN, TNA" ENSG00000163815 "C-type lectin domain family 3 member B" P05452 3 45001548-45036071 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 185.2;lung: 216.5" "Cell type enhanced" "Detected in some" 15 "Fibroblasts: 14.4;Ito cells: 43.0;Late spermatids: 15.2;Leydig cells: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 51.1;ASC TERT1: 101.9;U-2197: 20.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002582, HPA034794" Approved "Secreted to blood" NA NA 6540000000 46000000000 "CAB002582: AB_564027, HPA034794: AB_2674332" "unprognostic (2.04e-1)" "unprognostic (1.80e-3)" "unprognostic (2.58e-1)" "unprognostic (4.57e-2)" "unprognostic (7.75e-2)" "prognostic favorable (1.53e-4)" "prognostic favorable (9.99e-9)" "unprognostic (1.75e-2)" "unprognostic (2.25e-1)" "unprognostic (4.02e-1)" "prognostic favorable (5.68e-4)" "unprognostic (9.33e-2)" "unprognostic (2.39e-2)" "unprognostic (7.46e-2)" "unprognostic (1.39e-1)" "unprognostic (5.54e-2)" "unprognostic (4.21e-2)" 70.8 11.5 6.6 16.9 8.9 0.5 185.2 5.9 10.2 17.4 20.3 4.8 39.0 8.4 15.7 54.2 17.2 6.9 38.8 72.8 8.1 6.8 20.6 7.0 216.5 8.3 8.8 7.4 5.1 6.1 2.1 5.0 37.7 13.2 7.4 10.1 17.7 9.7 19.2 26.5 27.6 16.3 90.3 10.0 65.5 8.3 24.9 1.5 2.3 15.8 40.8 5.4 28.0 24.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 51.1 101.9 0.0 6.7 10.5 0.2 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 20.5 0.0 0.2 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.6 8.9 5.9 10.2 8.1 6.8 8.8 7.4 13.2 1.5 0.0 0.0 0.0 0.0 3.1 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 3.3 0.0 2.8 10.5 0.0 0.0 0.2 0.0 14.4 0.0 0.0 0.0 0.8 0.0 0.0 43.0 1.2 15.2 27.9 0.8 3.3 1.0 0.0 0.0 0.1 0.0 6.0 0.0 0.1 0.0 4.2 0.0 0.0 3.3 0.1 0.0 0.0 0.0 COLEC10 CL-L1 ENSG00000184374 "Collectin subfamily member 10" Q9Y6Z7 8 118995452-119106582 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 47.4" "Cell type enriched" "Detected in single" 42 "Ito cells: 16.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.4;HHSteC: 3.5;SK-BR-3: 15.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 5700000 "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" "unprognostic (3.79e-4)" "unprognostic (6.25e-3)" "unprognostic (1.80e-3)" "unprognostic (7.73e-2)" "prognostic favorable (5.79e-4)" "unprognostic (1.05e-1)" "unprognostic (1.61e-1)" "unprognostic (1.13e-1)" "unprognostic (9.25e-2)" "unprognostic (9.02e-5)" "unprognostic (2.47e-1)" "unprognostic (1.82e-1)" "unprognostic (5.85e-5)" "unprognostic (7.12e-2)" 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.1 0.1 0.3 47.4 0.7 0.6 0.1 0.0 0.0 0.0 0.0 0.1 8.5 0.1 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.7 8.4 0.1 0.1 0.1 0.3 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 15.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.2 0.0 1.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 CPN2 ACBP ENSG00000178772 "Carboxypeptidase N subunit 2" P22792 3 194339765-194351328 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "liver: 225.5" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 157.2" "Cancer enriched" "Detected in some" 32 "liver cancer: 72.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 25 "Hep G2: 37.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA004732 Uncertain "Secreted to blood" NA NA 42000000000 "HPA004732: AB_1078561" "unprognostic (4.27e-2)" "unprognostic (3.04e-1)" "unprognostic (1.42e-1)" "unprognostic (4.12e-2)" "prognostic favorable (2.05e-4)" "unprognostic (1.27e-1)" "unprognostic (8.65e-2)" "unprognostic (8.56e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (4.59e-4)" "unprognostic (2.91e-2)" "unprognostic (2.40e-1)" "unprognostic (6.90e-5)" "unprognostic (8.42e-2)" 0.2 1.1 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 8.5 225.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 2.5 0.3 0.2 0.6 0.0 0.1 0.0 0.2 0.2 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.5 0.3 0.3 0.0 0.0 0.1 0.0 0.1 0.2 0.3 37.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.3 0.4 0.0 0.1 0.1 0.2 0.2 0.1 0.0 0.1 0.3 0.0 0.1 0.2 0.2 0.1 0.2 0.1 0.2 0.2 0.1 0.9 1.1 0.1 1.4 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.3 0.5 0.5 0.2 0.4 0.2 0.5 0.4 0.0 0.6 0.3 0.6 2.5 0.2 0.1 0.4 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 157.2 0.2 0.0 0.0 3.7 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRELD2 MGC11256 ENSG00000184164 "Cysteine rich with EGF like domains 2" Q6UXH1 22 49918167-49927540 "Predicted secreted proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 98.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA000603, CAB025604" Approved "Secreted to blood" NA NA 270000 "CAB025604: , HPA000603: AB_1078565" "unprognostic (1.12e-1)" "unprognostic (7.35e-2)" "unprognostic (1.10e-1)" "prognostic favorable (2.42e-7)" "unprognostic (5.04e-2)" "unprognostic (5.43e-2)" "unprognostic (3.21e-3)" "unprognostic (2.71e-1)" "unprognostic (3.60e-1)" "unprognostic (1.24e-1)" "unprognostic (2.57e-2)" "unprognostic (7.97e-2)" "prognostic unfavorable (1.34e-9)" "unprognostic (6.13e-2)" "unprognostic (3.01e-1)" "unprognostic (7.30e-2)" "unprognostic (4.02e-1)" 10.2 10.1 8.1 14.1 11.5 8.6 17.2 7.2 7.9 11.1 12.5 7.7 18.0 15.0 10.8 26.1 8.5 10.0 13.2 11.3 7.5 9.6 10.5 39.3 15.7 24.3 9.5 6.6 9.5 98.1 4.8 23.1 8.1 10.9 10.8 9.5 6.9 24.9 17.6 7.3 5.4 10.9 10.0 8.1 13.8 17.6 12.8 7.5 7.4 31.1 7.8 10.5 11.6 7.1 15.8 29.4 13.0 8.2 18.8 13.7 6.8 12.9 9.1 10.5 35.0 11.4 13.0 14.5 26.8 16.6 15.3 13.1 15.5 16.0 7.0 21.7 23.3 15.4 13.0 13.3 13.6 6.6 3.8 20.7 3.8 13.6 19.3 47.3 15.1 15.1 11.8 12.2 13.2 11.1 10.8 15.5 7.9 5.5 29.6 11.4 41.1 5.9 16.0 7.6 25.7 18.6 14.0 18.8 16.7 7.3 11.9 7.1 20.0 23.0 27.5 10.7 7.3 11.3 18.5 11.3 13.3 21.9 12.1 8.4 23.7 5.6 6.1 19.5 11.4 20.7 13.0 6.8 8.9 10.4 8.2 10.6 15.8 8.9 13.7 7.6 11.5 7.3 6.1 3.5 18.8 4.6 29.4 5.9 6.8 8.1 11.5 7.2 7.9 7.5 9.6 9.5 6.6 10.9 7.5 6.0 17.3 30.4 27.9 29.1 34.1 14.8 20.4 20.1 23.9 8.7 23.6 26.3 6.6 36.6 77.4 28.6 31.5 23.3 54.9 90.3 53.6 71.5 35.7 52.1 67.2 23.8 38.2 45.4 27.6 20.1 40.9 33.7 91.1 24.4 37.3 35.9 49.0 25.4 38.9 14.0 28.3 12.9 36.2 131.8 131.6 26.8 46.1 46.8 32.5 34.2 CRHBP "CRF-BP, CRFBP" ENSG00000145708 "Corticotropin releasing hormone binding protein" P24387 5 76952713-76981158 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9;liver: 99.9" "Cell type enriched" "Detected in some" 15 "Ito cells: 1768.4" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Region enhanced" "Detected in many" "hypothalamus: 24.9" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 5.0;BJ hTERT+ SV40 Large T+ RasG12V: 4.9;HBF TERT88: 8.9;RPMI-8226: 3.0;U-698: 9.7;U-87 MG: 5.4;WM-115: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036234, HPA046120" Approved Supported "Secreted to blood" NA NA 43000000 "HPA036234: , HPA046120: AB_10959760" "unprognostic (1.41e-1)" "unprognostic (2.00e-2)" "unprognostic (1.14e-1)" "unprognostic (1.78e-3)" "unprognostic (1.18e-1)" "unprognostic (1.65e-1)" "unprognostic (2.36e-3)" "unprognostic (4.44e-5)" "unprognostic (2.16e-1)" "unprognostic (7.08e-2)" "unprognostic (4.98e-4)" "unprognostic (1.09e-1)" "unprognostic (6.63e-5)" "unprognostic (2.76e-2)" "unprognostic (4.64e-1)" "unprognostic (1.74e-1)" "unprognostic (2.95e-2)" 8.4 5.6 3.5 0.4 5.4 1.2 2.6 0.0 7.8 1.6 0.3 3.2 1.8 0.4 1.2 0.7 0.2 0.9 0.5 3.2 4.0 24.9 16.1 99.9 0.3 0.4 2.7 5.4 0.8 0.2 0.4 0.0 18.1 1.8 0.6 0.3 1.5 0.6 1.9 0.5 0.2 0.3 0.8 2.2 13.9 0.3 0.5 1.2 0.0 1.9 0.9 0.4 0.5 0.2 0.0 0.0 1.2 0.1 0.0 0.2 0.8 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.1 5.0 4.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.9 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.7 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 2.6 0.0 0.1 0.0 9.7 5.4 0.0 4.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.8 3.5 5.4 0.0 7.8 4.0 24.9 2.7 5.4 1.8 1.2 0.0 0.0 23.4 0.0 0.3 0.0 0.6 22.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 18.4 0.0 0.0 0.2 0.3 0.4 0.0 0.0 4.9 1.6 0.0 0.0 1768.4 116.1 0.6 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.3 0.0 0.0 CRISPLD2 "DKFZP434B044, LCRISP2, LGL1" ENSG00000103196 "Cysteine rich secretory protein LCCL domain containing 2" Q9H0B8 16 84819984-84920768 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 19 "Leydig cells: 251.5;Peritubular cells: 250.0;Smooth muscle cells: 678.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 36.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 36.0" "Cell line enhanced" "Detected in many" "ASC diff: 15.3;BEWO: 23.8;HHSteC: 56.8;HSkMC: 23.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA030054, HPA030055" Approved Approved Nucleoplasm,Nucleoli "Secreted to blood" No No 219000000000 "Nucleoplasm, Nucleoli" "HPA030054: AB_2732452, HPA030055: AB_10611821" "unprognostic (8.91e-3)" "unprognostic (3.05e-1)" "unprognostic (2.63e-2)" "unprognostic (2.02e-2)" "unprognostic (7.12e-2)" "unprognostic (2.30e-1)" "unprognostic (2.11e-2)" "unprognostic (5.58e-3)" "unprognostic (1.48e-1)" "unprognostic (5.50e-2)" "unprognostic (2.67e-1)" "unprognostic (2.87e-2)" "prognostic unfavorable (1.97e-6)" "unprognostic (7.35e-3)" "unprognostic (3.38e-2)" "unprognostic (2.99e-3)" "unprognostic (5.15e-3)" 29.2 11.6 2.2 41.1 5.0 3.0 57.2 2.1 3.6 44.1 26.0 2.5 10.6 4.2 38.5 58.7 21.1 43.6 107.4 19.1 2.1 2.0 10.1 6.7 31.0 21.4 5.5 1.6 37.1 9.1 1.0 6.4 50.2 7.1 31.6 7.3 21.9 6.8 23.6 15.9 12.0 17.5 48.0 8.6 10.0 22.5 16.8 3.1 0.4 15.9 11.4 3.3 40.3 32.7 0.0 0.5 36.0 7.9 0.0 0.1 1.3 0.3 0.7 0.2 2.0 15.3 5.7 23.8 11.6 10.3 9.3 6.6 1.5 0.9 0.0 1.0 10.1 2.7 0.3 0.0 0.0 9.4 0.0 0.0 0.1 0.2 0.0 56.8 0.0 0.1 23.8 0.0 2.7 0.0 3.1 0.0 0.0 0.1 0.1 1.0 0.4 0.1 0.5 0.6 1.5 0.6 0.0 0.1 0.1 0.1 1.8 2.3 0.1 2.7 1.2 0.2 3.4 4.7 0.3 1.3 0.1 0.6 9.7 0.3 0.1 0.0 1.9 0.0 0.2 1.4 4.4 7.9 0.2 0.0 0.5 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 1.3 2.2 5.0 2.1 3.6 2.1 2.0 5.5 1.6 7.1 3.1 3.0 2.9 0.8 7.9 41.0 0.6 7.6 0.0 1.4 2.3 0.0 0.0 6.0 0.0 1.1 10.8 12.0 0.4 0.0 0.4 24.6 126.1 19.2 6.9 0.0 4.4 1.6 2.9 60.2 40.4 10.7 251.5 12.2 45.5 0.0 4.2 5.0 0.8 0.0 250.0 0.0 0.5 90.5 678.7 0.9 0.9 37.4 7.6 4.8 1.3 5.2 CRTAP "CASP, LEPREL3, P3H5" ENSG00000170275 "Cartilage associated protein" O75718 3 33113979-33147773 "Disease related genes, Predicted secreted proteins" "Disease mutation, Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Kupffer cells: 172.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "classical monocyte: 67.8" "Group enriched" "Detected in all" 5 "dendritic cells: 55.8;monocytes: 67.8" "Cell line enhanced" "Detected in many" "ASC diff: 122.6;ASC TERT1: 80.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043598, HPA044150" Approved Approved "Intermediate filaments,Actin filaments,Cytosol" "Secreted to blood" NA NA "Intermediate filaments, Actin filaments, Cytosol" "HPA043598: AB_10960991, HPA044150: AB_10959594" "unprognostic (5.29e-2)" "unprognostic (2.64e-1)" "unprognostic (2.13e-1)" "unprognostic (1.85e-3)" "unprognostic (7.36e-2)" "unprognostic (4.73e-3)" "unprognostic (4.28e-2)" "unprognostic (1.87e-1)" "unprognostic (9.97e-2)" "unprognostic (4.62e-2)" "unprognostic (3.70e-1)" "unprognostic (1.40e-1)" "unprognostic (2.10e-1)" "unprognostic (1.41e-1)" "unprognostic (1.79e-1)" "unprognostic (9.93e-2)" "unprognostic (1.28e-3)" 59.2 33.4 16.3 13.4 22.2 13.6 63.2 5.4 14.1 57.5 39.4 23.3 32.7 12.8 54.2 41.1 42.8 35.1 43.5 37.0 16.8 13.1 25.7 16.8 35.9 37.8 24.2 13.0 48.5 13.3 14.6 7.6 25.4 13.8 54.5 19.7 35.4 16.4 42.2 23.9 24.6 18.8 66.1 22.8 17.6 25.2 26.1 19.0 5.1 34.1 25.8 18.3 62.4 59.7 7.6 55.8 5.5 67.8 6.9 12.9 30.8 9.1 18.1 5.7 17.8 122.6 80.3 33.0 20.0 43.7 24.3 23.2 6.1 5.2 6.4 22.4 38.0 19.6 11.8 10.1 15.3 17.6 15.8 15.7 10.0 14.2 6.3 36.7 6.4 8.2 64.0 31.4 21.9 27.9 47.3 25.5 4.0 8.5 12.3 24.5 7.8 2.3 6.6 6.8 9.8 24.7 8.5 16.7 12.3 19.0 6.1 1.2 9.2 13.5 11.9 28.8 13.8 12.8 15.9 16.6 31.9 13.6 17.3 21.1 8.9 30.1 0.9 25.0 13.0 17.4 2.1 67.8 4.9 6.9 26.3 10.0 7.6 10.1 7.7 55.8 6.8 5.8 5.4 5.5 6.9 7.8 15.0 12.9 30.8 16.3 22.2 5.4 14.1 16.8 13.1 24.2 13.0 13.8 19.0 8.9 42.6 18.6 27.6 53.7 18.7 29.5 25.5 4.0 19.4 36.6 7.9 42.5 10.0 19.9 1.0 55.3 18.1 0.0 27.7 59.7 94.1 20.8 46.2 44.4 93.2 33.4 5.8 103.2 172.9 2.2 132.3 73.7 75.9 27.9 22.6 17.7 20.2 10.5 136.2 43.7 10.5 109.9 117.1 1.4 7.9 40.8 23.5 20.8 33.1 22.1 CUTA "ACHAP, C6orf82" ENSG00000112514 "CutA divalent cation tolerance homolog" O60888 6 33416442-33418317 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016787, HPA064369" Uncertain Approved "Plasma membrane,Focal adhesion sites" "Secreted to blood" NA NA 35000000 "Plasma membrane, Focal adhesion sites" "CAB016787: , HPA064369: AB_2685248" "unprognostic (7.03e-2)" "unprognostic (5.44e-2)" "unprognostic (4.56e-2)" "unprognostic (8.91e-2)" "unprognostic (1.86e-1)" "unprognostic (1.03e-1)" "unprognostic (1.98e-2)" "prognostic favorable (8.50e-4)" "unprognostic (1.87e-1)" "unprognostic (2.78e-2)" "unprognostic (1.27e-3)" "unprognostic (1.91e-1)" "unprognostic (5.55e-2)" "unprognostic (9.90e-2)" "unprognostic (1.54e-1)" "unprognostic (7.94e-2)" "unprognostic (2.74e-1)" 26.6 65.6 47.9 28.3 60.1 33.5 47.6 37.7 73.7 47.7 37.9 36.8 53.9 42.1 40.1 78.5 30.5 46.0 48.8 49.6 45.2 44.9 46.3 61.6 39.0 77.4 46.5 37.8 57.7 66.6 43.8 86.1 45.7 39.8 38.8 28.9 34.2 74.3 69.7 34.6 32.7 37.2 32.4 47.0 36.0 38.7 27.3 31.6 52.2 69.7 30.3 31.3 42.6 28.9 56.5 31.4 27.1 32.0 49.9 69.8 60.8 43.8 26.3 42.1 53.3 31.7 31.2 20.4 40.1 75.1 77.6 82.7 26.2 27.4 31.0 31.2 45.9 56.4 26.8 27.3 40.8 43.8 26.2 60.5 32.3 43.6 68.6 41.3 25.1 24.6 41.3 34.5 37.3 31.5 54.0 20.8 32.9 39.6 63.1 56.7 34.1 38.0 53.5 37.7 38.0 34.7 41.8 25.1 81.9 53.4 19.1 82.4 42.0 24.0 41.8 72.8 25.2 30.7 52.8 22.9 42.0 35.7 29.8 41.8 62.0 61.6 33.9 36.3 55.6 34.1 27.1 32.0 16.5 45.7 22.9 63.2 56.5 67.6 52.7 31.4 44.2 68.5 53.2 4.6 49.9 16.8 27.1 69.8 60.8 47.9 60.1 37.7 73.7 45.2 44.9 46.5 37.8 39.8 31.6 122.1 105.5 178.5 242.5 204.8 84.5 113.4 239.5 131.2 121.7 300.1 64.8 309.8 240.4 162.1 64.8 93.9 157.7 23.3 122.9 203.5 204.8 237.5 167.3 299.7 277.3 73.1 280.4 131.3 162.9 285.6 185.2 150.2 300.3 80.2 266.0 150.8 114.3 196.4 180.0 440.5 69.0 90.5 220.1 100.6 65.6 201.4 203.1 245.2 291.8 203.9 EFNA4 "EPLG4, LERK4" ENSG00000243364 "Ephrin A4" P52798 1 155063731-155069553 "Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Extravillous trophoblasts: 72.2;Paneth cells: 37.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" CAB021350 Uncertain "Secreted to blood" NA NA "CAB021350: " "unprognostic (4.65e-2)" "unprognostic (8.07e-2)" "unprognostic (3.43e-2)" "unprognostic (7.04e-2)" "unprognostic (7.91e-2)" "unprognostic (4.81e-1)" "prognostic unfavorable (1.00e-5)" "unprognostic (1.37e-2)" "unprognostic (3.89e-2)" "unprognostic (6.17e-2)" "unprognostic (2.87e-2)" "unprognostic (7.97e-3)" "prognostic unfavorable (3.14e-4)" "prognostic favorable (3.60e-5)" "unprognostic (3.35e-2)" "unprognostic (1.97e-1)" "unprognostic (6.29e-2)" 5.5 10.8 3.5 6.1 1.9 0.9 16.8 2.0 2.1 12.0 18.9 1.9 13.2 9.7 9.4 12.3 20.0 4.9 9.6 6.5 3.0 1.3 8.4 12.8 5.3 10.8 2.4 2.5 16.1 6.3 4.2 2.7 9.7 2.6 11.5 11.5 7.5 20.1 9.5 2.2 25.3 27.0 4.0 1.9 7.0 5.0 5.1 2.2 6.4 12.0 13.5 16.3 6.6 11.5 17.1 18.2 7.8 9.2 2.6 9.5 4.7 6.1 4.6 11.5 16.9 6.8 4.4 9.5 2.7 5.3 5.5 5.1 6.8 10.3 7.9 15.9 2.8 4.3 14.6 6.8 4.2 2.2 3.6 2.0 0.7 4.2 9.5 2.4 1.7 12.5 2.6 13.0 2.7 3.3 4.8 10.9 6.6 3.2 5.3 3.0 13.6 4.0 4.4 21.0 23.5 9.7 14.0 4.5 7.7 8.5 5.3 2.8 12.6 5.5 20.9 2.4 8.7 13.6 5.5 5.6 3.2 9.7 6.5 4.1 5.4 5.6 7.7 3.1 4.2 3.3 0.0 7.4 5.0 5.9 6.6 6.1 17.1 6.5 6.7 6.0 14.1 9.5 6.3 7.8 2.6 9.2 18.2 6.2 4.7 3.5 1.9 2.0 2.1 3.0 1.3 2.4 2.5 2.6 2.2 0.0 4.6 5.4 6.7 22.2 0.2 1.2 7.6 5.3 4.5 15.7 0.0 7.9 1.7 23.3 0.0 5.8 20.0 0.0 12.2 72.2 10.5 12.9 1.1 1.8 10.8 0.0 2.9 4.9 5.1 0.0 7.2 5.4 16.9 7.2 17.5 5.2 17.8 37.9 5.3 3.8 0.0 0.0 5.1 0.4 2.7 28.5 8.2 7.4 25.2 8.4 ENHO "C9orf165, UNQ470" ENSG00000168913 "Energy homeostasis associated" Q6UWT2 9 34521040-34523041 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "brain: 79.6" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 53.5" "Cancer enhanced" "Detected in many" "glioma: 44.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "myeloid DC: 19.4" "Lineage enriched" "Detected in many" 7 "dendritic cells: 19.4" "Cell line enhanced" "Detected in many" "AN3-CA: 13.4;NTERA-2: 18.5;SCLC-21H: 9.4;SH-SY5Y: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042575 Approved "Secreted to blood" NA NA 4240000 "HPA042575: AB_10794914" "unprognostic (2.63e-2)" "unprognostic (9.53e-3)" "unprognostic (2.46e-1)" "prognostic unfavorable (3.71e-4)" "unprognostic (1.30e-1)" "unprognostic (7.51e-2)" "unprognostic (9.93e-2)" "unprognostic (1.34e-2)" "unprognostic (5.86e-2)" "unprognostic (2.19e-2)" "unprognostic (2.78e-4)" "unprognostic (1.75e-1)" "unprognostic (2.57e-3)" "unprognostic (6.47e-2)" "unprognostic (1.87e-1)" "unprognostic (5.50e-2)" "unprognostic (8.76e-2)" 1.5 1.9 58.0 1.9 59.3 1.7 3.7 15.5 79.6 2.9 3.9 13.9 0.0 3.0 1.4 1.4 1.5 3.6 1.8 1.8 36.3 37.5 1.5 12.0 2.0 1.4 52.0 27.1 1.5 2.6 1.2 1.0 1.3 13.7 5.2 3.2 0.1 1.8 1.7 1.6 3.8 3.6 1.3 17.1 1.6 5.3 6.4 13.4 0.0 1.4 0.0 1.4 1.5 0.0 0.0 19.4 0.0 2.5 2.7 0.0 0.4 0.1 1.0 5.3 13.4 0.1 0.0 0.3 0.0 0.0 2.1 2.2 0.5 0.2 2.2 3.7 0.0 4.3 0.2 6.1 0.4 0.4 0.3 5.9 0.0 0.1 1.2 0.2 0.0 3.0 0.0 0.1 0.0 0.2 0.0 0.0 4.3 0.0 1.9 0.5 0.3 0.0 0.0 18.5 1.0 3.7 0.1 0.0 0.3 0.5 0.0 9.4 8.9 0.7 4.1 0.4 0.7 0.3 1.7 0.0 0.4 2.1 0.1 0.1 1.1 1.3 0.1 0.5 0.0 3.1 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 2.7 0.7 1.0 0.0 0.4 58.0 59.3 15.5 37.0 36.3 37.5 52.0 27.1 13.7 13.4 0.0 0.3 0.0 2.5 2.5 4.3 0.4 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.7 0.7 0.0 0.0 0.0 0.2 0.2 1.0 10.2 0.0 2.6 2.6 4.8 1.7 1.3 0.3 2.7 0.3 3.2 1.7 1.0 0.0 53.5 0.0 0.0 0.4 0.3 2.8 0.0 0.1 0.5 5.9 2.8 0.0 0.0 0.0 0.5 ERVMER34-1 envMER34 ENSG00000226887 "Endogenous retrovirus group MER34 member 1, envelope" Q9H9K5 4 52722618-52751640 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "parathyroid gland: 32.0;placenta: 26.9" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 66.3;Extravillous trophoblasts: 80.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 28.2;hTCEpi: 20.3;RPTEC TERT1: 15.1" "HPA011423, HPA024053" Approved Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 5000000 Nucleoplasm Cytosol "HPA011423: AB_2668510, HPA024053: " "unprognostic (5.34e-2)" "unprognostic (1.29e-1)" "unprognostic (1.91e-3)" "unprognostic (5.86e-2)" "unprognostic (4.08e-4)" "prognostic unfavorable (3.55e-4)" "unprognostic (5.88e-4)" "unprognostic (5.28e-2)" "unprognostic (2.99e-2)" "unprognostic (2.39e-3)" "unprognostic (2.62e-3)" "unprognostic (4.23e-2)" "unprognostic (1.03e-2)" "unprognostic (1.32e-2)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" "unprognostic (1.82e-1)" 0.3 1.3 1.2 0.4 0.7 0.2 2.8 0.5 3.0 1.3 0.5 0.0 1.4 0.5 0.9 1.3 3.7 0.7 0.4 6.2 0.8 1.0 4.4 0.3 1.8 1.9 0.6 0.2 3.9 1.7 32.0 0.2 26.9 0.8 0.7 0.7 0.8 1.3 3.0 0.2 1.0 0.5 0.4 1.5 1.9 1.1 1.7 0.3 0.0 2.5 3.7 1.2 1.0 1.8 0.6 0.4 1.2 0.1 0.4 0.3 0.0 4.5 0.2 0.9 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 28.2 6.0 0.0 0.6 0.1 0.4 0.3 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.0 1.3 20.3 0.0 3.0 0.0 0.0 0.0 1.6 0.0 0.1 0.3 0.0 0.0 1.9 1.8 0.8 0.0 0.0 0.0 15.1 0.4 1.2 0.3 1.9 0.8 0.0 3.0 2.5 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.1 0.5 0.3 0.1 0.2 0.3 0.3 0.2 0.1 0.6 0.3 0.2 1.1 0.4 0.1 0.4 0.2 0.0 1.2 0.7 0.5 3.0 0.8 1.0 0.6 0.2 0.8 0.3 0.0 0.0 0.0 1.1 0.5 0.0 2.4 0.0 0.0 0.0 7.0 0.0 66.3 0.0 2.3 3.2 0.1 0.0 0.0 0.7 80.6 1.3 1.2 0.0 0.0 6.3 0.0 0.0 0.0 0.0 2.5 2.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.3 0.2 0.4 0.1 14.5 0.0 0.4 1.1 FAM177A1 C14orf24 ENSG00000151327 "Family with sequence similarity 177 member A1" Q8N128 14 35044907-35113130 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053222, HPA055440" Uncertain Approved Nucleoplasm,Vesicles "Secreted to blood" NA NA 180000 Vesicles Nucleoplasm "HPA053222: AB_2682083, HPA055440: AB_2682817" "unprognostic (6.86e-2)" "unprognostic (2.03e-1)" "unprognostic (2.12e-1)" "unprognostic (7.01e-2)" "unprognostic (1.91e-2)" "prognostic unfavorable (9.70e-4)" "unprognostic (4.64e-3)" "unprognostic (6.28e-2)" "unprognostic (7.79e-2)" "prognostic favorable (8.51e-5)" "unprognostic (1.12e-2)" "unprognostic (7.22e-3)" "unprognostic (1.04e-1)" "unprognostic (2.56e-1)" "unprognostic (1.69e-1)" "unprognostic (8.28e-2)" "unprognostic (1.91e-1)" 20.8 25.6 29.5 17.5 29.2 24.9 20.6 14.1 25.9 27.2 45.8 29.2 19.6 32.6 16.3 17.9 22.2 12.7 22.0 44.2 31.6 35.3 35.5 49.1 36.0 10.4 41.1 24.2 14.4 21.5 14.2 43.8 17.7 39.6 37.9 41.6 13.6 19.5 22.3 33.8 17.4 34.0 25.5 45.4 15.7 24.1 42.6 22.2 13.3 31.0 19.0 12.8 27.6 18.2 14.1 16.8 56.7 15.1 9.4 18.5 9.7 20.3 16.5 12.6 10.1 21.8 21.9 17.0 33.3 18.1 17.3 19.0 16.8 27.0 8.5 23.8 31.6 23.6 21.4 15.2 18.8 22.2 23.8 11.6 6.5 20.9 56.8 26.9 9.9 15.1 19.6 24.8 20.9 16.5 25.5 19.8 15.4 15.4 26.2 33.3 29.2 12.2 9.2 10.3 32.1 23.5 7.0 17.8 11.8 31.3 22.1 17.6 15.8 39.3 30.9 25.6 26.0 28.6 7.6 23.2 22.7 20.1 25.2 17.0 20.4 24.4 10.0 14.0 6.6 22.1 20.9 15.1 24.9 10.7 11.4 12.6 14.1 14.2 12.2 10.9 11.3 11.3 11.0 56.7 9.4 9.7 16.8 18.5 9.7 29.5 29.2 14.1 25.9 31.6 35.3 41.1 24.2 39.6 22.2 223.4 156.1 82.9 157.1 142.8 34.3 125.5 66.2 148.5 129.7 99.5 25.5 63.2 101.2 106.7 472.3 134.1 241.2 46.7 217.0 95.5 80.8 234.3 79.8 184.5 67.0 22.3 128.5 82.9 53.3 400.3 50.0 70.6 141.7 179.5 172.8 36.1 275.5 227.7 49.8 271.4 43.2 45.3 134.8 116.8 87.3 149.8 103.1 90.6 196.2 201.3 FGL1 HFREP-1 ENSG00000104760 "Fibrinogen like 1" Q08830 8 17864380-17910365 "Plasma proteins, Predicted secreted proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 450.7" "Cell type enriched" "Detected in many" 23 "Hepatocytes: 6738.7" "Cancer enriched" "Detected in some" 40 "liver cancer: 399.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "A549: 22.2;Hep G2: 52.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Secreted to blood" NA NA 1800000 "unprognostic (3.62e-2)" "unprognostic (1.14e-2)" "unprognostic (1.75e-5)" "unprognostic (3.00e-1)" "unprognostic (3.54e-2)" "unprognostic (7.89e-2)" "unprognostic (2.15e-1)" "unprognostic (2.62e-1)" "unprognostic (2.71e-1)" "unprognostic (1.09e-2)" "unprognostic (2.86e-7)" "prognostic unfavorable (5.38e-4)" "unprognostic (3.62e-1)" "unprognostic (2.58e-2)" "unprognostic (1.35e-1)" 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 450.7 0.2 0.1 0.1 0.1 0.1 71.3 0.0 0.1 0.6 0.2 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 22.2 0.0 2.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 52.2 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 3.4 104.9 0.1 0.0 0.0 1.0 298.1 0.0 0.0 0.0 0.0 0.2 0.0 4.2 35.8 0.0 0.0 140.2 59.6 0.4 0.0 8.5 0.0 6738.7 15.3 0.0 0.0 190.3 185.3 19.0 0.6 0.0 0.0 2.8 0.0 0.0 121.6 0.0 0.4 0.0 0.0 0.0 0.3 0.7 0.5 0.0 0.8 0.0 0.0 0.1 FGL2 "pT49, T49" ENSG00000127951 "Fibrinogen like 2" Q14314 7 77193371-77199848 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.0" "Group enriched" "Detected in many" 5 "Kupffer cells: 431.4;Macrophages: 384.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 50 "classical monocyte: 59.3;eosinophil: 52.6;intermediate monocyte: 82.0;myeloid DC: 38.1;neutrophil: 68.4;non-classical monocyte: 73.5" "Group enriched" "Detected in many" 56 "dendritic cells: 38.1;granulocytes: 68.4;monocytes: 82.0" "Cell line enhanced" "Detected in some" "ASC diff: 4.1;Karpas-707: 3.8;LHCN-M2: 4.2;NB-4: 4.6;RPTEC TERT1: 8.0;U-937: 8.4;WM-115: 9.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021011, HPA026682" Enhanced "Secreted to blood" NA NA 38800000 6400000 "HPA021011: AB_1848532, HPA026682: AB_1848533" "unprognostic (9.80e-3)" "unprognostic (4.70e-3)" "unprognostic (1.19e-1)" "unprognostic (3.51e-3)" "unprognostic (1.62e-1)" "unprognostic (1.00e-2)" "unprognostic (1.44e-2)" "unprognostic (1.23e-2)" "unprognostic (3.49e-1)" "unprognostic (2.70e-1)" "unprognostic (3.19e-1)" "unprognostic (1.27e-1)" "unprognostic (1.19e-1)" "unprognostic (5.00e-2)" "unprognostic (1.91e-2)" "unprognostic (2.33e-1)" "unprognostic (7.01e-2)" 30.0 8.7 6.0 28.7 10.7 1.5 18.0 5.7 4.7 8.0 29.5 5.0 7.7 14.2 7.6 18.4 41.4 13.8 16.2 17.8 5.1 5.5 23.3 14.3 17.0 28.1 10.3 4.1 6.4 3.0 1.8 8.0 7.0 11.4 17.9 20.3 6.8 11.7 4.4 6.2 8.6 40.9 73.7 18.4 63.4 16.9 3.4 8.6 12.0 19.2 18.3 9.1 55.8 7.7 1.0 38.1 68.4 82.0 0.7 1.1 34.6 0.0 0.0 0.0 0.0 4.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 3.8 4.2 0.1 0.0 4.6 0.3 0.0 0.2 0.2 0.5 0.4 8.0 1.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 3.0 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.3 8.4 9.0 0.6 59.3 52.6 1.1 82.0 0.5 1.0 0.7 1.0 38.1 0.5 0.4 0.8 68.4 0.7 73.5 1.2 1.1 34.6 6.0 10.7 5.7 4.7 5.1 5.5 10.3 4.1 11.4 8.6 6.0 18.4 34.2 1.0 33.9 1.1 3.2 0.0 4.0 9.1 83.7 9.8 1.1 5.0 0.2 7.0 45.8 11.9 0.0 0.0 1.0 69.5 0.8 9.3 4.2 36.4 1.6 0.0 56.4 431.4 7.1 25.6 384.4 47.2 1.0 0.3 11.3 0.1 2.8 18.4 5.4 7.7 0.0 9.5 0.5 0.3 27.4 3.1 19.2 0.3 1.4 FST FS ENSG00000134363 Follistatin P19883 5 53480409-53487134 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 42.7" "Cell type enhanced" "Detected in many" 16 "Fibroblasts: 85.9;Hepatocytes: 22.9;Urothelial cells: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 1.0;naive CD4 T-cell: 2.0;non-classical monocyte: 1.0" "Group enriched" "Detected in many" 5 "monocytes: 1.0;T-cells: 2.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 59.4;HaCaT: 50.3;HBEC3-KT: 32.1;HMC-1: 36.1;PC-3: 97.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA016612, CAB026025" Approved Approved Vesicles "Secreted to blood" NA NA 1800000 Vesicles "CAB026025: , HPA016612: " "unprognostic (1.43e-1)" "unprognostic (6.50e-2)" "unprognostic (1.44e-1)" "unprognostic (7.73e-3)" "unprognostic (2.30e-1)" "unprognostic (1.50e-3)" "unprognostic (8.02e-2)" "unprognostic (2.32e-2)" "unprognostic (3.06e-1)" "unprognostic (1.57e-1)" "unprognostic (1.93e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (4.44e-5)" "unprognostic (1.21e-3)" "unprognostic (2.48e-1)" "unprognostic (2.07e-2)" "unprognostic (2.18e-1)" 12.4 3.2 2.0 3.1 0.8 0.1 7.1 0.2 0.7 3.5 5.2 0.3 1.1 0.9 2.3 9.5 3.6 4.9 4.1 5.6 1.0 1.0 1.7 42.7 4.3 0.8 0.4 0.6 20.7 19.4 0.0 2.9 13.5 1.0 9.3 1.7 5.7 5.5 6.5 12.6 9.0 4.3 3.7 0.4 0.2 4.8 4.9 0.5 1.2 2.0 6.7 7.1 6.2 13.8 0.1 0.2 0.0 1.0 0.0 2.0 0.1 3.3 0.3 5.9 0.0 6.7 2.3 9.8 13.0 59.4 8.0 7.8 0.0 0.0 0.0 0.1 3.4 0.4 50.3 0.0 32.1 5.7 0.1 0.0 0.6 0.2 5.3 3.6 0.0 36.1 5.5 0.0 14.7 9.6 5.5 6.8 0.0 0.0 0.1 5.0 0.0 0.0 0.2 9.0 0.0 97.2 0.6 7.5 0.0 0.0 5.5 0.0 0.0 0.5 0.0 0.3 15.8 0.0 0.0 0.0 22.0 6.3 2.2 1.9 0.0 0.0 0.0 2.5 0.7 20.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.2 0.1 2.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 2.0 0.8 0.2 0.7 1.0 1.0 0.4 0.6 1.0 0.5 0.0 1.4 0.0 12.8 17.7 0.0 7.3 0.0 0.0 12.5 0.0 0.0 0.6 0.0 0.6 0.3 1.6 0.0 0.0 3.8 7.6 85.9 5.3 0.0 22.9 1.6 0.0 0.0 1.3 0.3 0.9 2.8 0.4 5.0 0.0 0.0 0.0 10.0 0.0 10.6 0.0 0.0 12.9 12.5 0.3 0.7 4.1 5.0 0.0 0.0 26.0 FSTL4 KIAA1061 ENSG00000053108 "Follistatin like 4" Q6MZW2 5 133196455-133612564 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.5" "Cell type enhanced" "Detected in many" 11 "Cone photoreceptor cells: 13.7;Early spermatids: 31.1;Late spermatids: 13.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SCLC-21H: 33.1;U-266/70: 11.9;U-266/84: 11.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045920 Uncertain Approved "Nuclear membrane,Mitochondria" "Secreted to blood" NA NA Mitochondria "Nuclear membrane" "HPA045920: AB_10965844" "unprognostic (5.52e-2)" "unprognostic (2.54e-1)" "unprognostic (5.74e-2)" "unprognostic (8.14e-2)" "unprognostic (1.87e-1)" "unprognostic (3.97e-2)" "unprognostic (6.35e-2)" "unprognostic (2.30e-1)" "unprognostic (1.11e-1)" "unprognostic (2.01e-1)" "unprognostic (4.74e-2)" "unprognostic (8.66e-2)" "unprognostic (3.73e-4)" "unprognostic (2.02e-2)" "unprognostic (9.91e-3)" "unprognostic (1.03e-2)" "unprognostic (4.25e-2)" 0.7 2.2 8.4 1.0 14.6 3.0 1.1 18.5 18.0 1.0 1.6 1.7 0.0 1.1 0.5 2.8 3.1 1.6 0.7 0.6 1.5 3.2 4.8 0.5 2.0 0.4 1.9 10.1 0.8 2.9 7.1 4.0 6.4 2.6 2.9 1.9 1.4 1.4 0.1 1.5 5.3 1.2 0.3 1.0 0.5 2.3 2.8 4.7 0.0 1.3 0.0 1.7 10.2 1.6 2.8 1.2 3.4 1.1 0.8 2.3 1.2 4.4 7.6 0.8 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 6.8 0.9 0.3 6.2 0.0 0.8 0.1 0.9 0.2 0.0 0.4 0.3 0.3 7.4 0.6 0.0 0.0 0.4 0.1 1.1 0.0 0.0 0.2 0.0 0.3 3.4 4.0 0.0 7.2 0.8 0.3 8.2 7.8 0.8 0.3 0.7 7.7 0.0 8.4 33.1 0.7 1.7 1.4 0.1 7.8 2.8 0.3 0.2 0.3 1.4 0.4 0.2 11.9 11.8 0.3 0.1 0.0 0.2 3.4 1.1 0.6 1.2 0.4 2.3 2.8 1.7 1.2 0.6 2.6 2.1 1.3 2.4 0.8 0.7 1.2 1.6 1.2 8.4 14.6 18.5 18.0 1.5 3.2 1.9 10.1 2.6 4.7 0.0 1.9 0.0 1.7 1.4 10.3 7.3 0.0 6.7 7.9 0.0 13.7 0.3 0.0 0.2 31.1 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 1.6 8.6 0.0 0.0 13.9 0.3 0.0 10.1 0.0 0.0 3.3 0.8 0.0 0.7 2.3 2.4 6.5 0.0 0.4 0.6 1.4 0.0 0.0 0.0 2.6 GRP ENSG00000134443 "Gastrin releasing peptide" P07492 18 59220168-59230774 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 15.6;pituitary gland: 13.2;retina: 22.5" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 8.5;Glandular cells: 6.6;Late spermatids: 9.9;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "BJ hTERT+: 8.6;fHDF/TERT166: 10.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebral cortex: 12.7;hippocampal formation: 34.7;midbrain: 24.8" "Secreted to blood" NA NA 340000 "unprognostic (3.91e-2)" "unprognostic (1.85e-1)" "unprognostic (2.30e-3)" "unprognostic (3.21e-2)" "unprognostic (7.86e-3)" "unprognostic (3.01e-3)" "unprognostic (1.14e-1)" "unprognostic (2.03e-1)" "unprognostic (1.11e-1)" "unprognostic (2.37e-1)" "unprognostic (1.79e-1)" "unprognostic (5.86e-4)" "unprognostic (2.65e-4)" "unprognostic (9.94e-2)" "unprognostic (6.99e-2)" "unprognostic (5.16e-2)" 0.7 0.7 3.6 0.5 0.7 0.2 5.2 0.5 3.7 0.5 2.3 1.3 0.0 0.4 0.9 0.9 0.6 0.3 1.3 0.2 11.7 5.6 0.3 0.2 15.6 0.2 4.9 0.7 0.2 4.7 4.7 13.2 0.2 10.5 1.9 0.4 22.5 0.2 0.5 0.2 0.4 0.7 2.3 1.6 0.3 12.7 3.0 0.1 0.1 11.2 0.2 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.3 0.0 0.0 0.0 0.7 0.0 10.8 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.7 0.5 3.7 11.7 5.6 4.9 0.7 10.5 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.3 1.8 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 6.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.1 GUCA2A "GUCA2, STARA" ENSG00000197273 "Guanylate cyclase activator 2A" Q02747 1 42162691-42164718 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "intestine: 265.7" "Group enriched" "Detected in some" 16 "Enterocytes: 4125.7;Paneth cells: 4082.4" "Group enriched" "Detected in many" 7 "colorectal cancer: 31.6;urothelial cancer: 8.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "OE19: 34.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA018215 Enhanced "Secreted to blood" NA NA 26000000 "HPA018215: AB_1850443" "unprognostic (7.98e-3)" "unprognostic (1.60e-1)" "unprognostic (1.16e-1)" "unprognostic (9.07e-2)" "unprognostic (1.14e-1)" "unprognostic (8.06e-2)" "unprognostic (2.89e-1)" "unprognostic (3.10e-1)" "unprognostic (9.15e-2)" 0.2 0.1 0.2 8.0 0.2 0.0 0.2 0.2 0.2 0.2 87.3 0.2 0.2 6.6 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.1 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.7 0.0 0.2 3.5 0.2 0.2 91.9 0.2 0.2 0.2 0.2 0.1 265.7 2.1 0.2 0.2 0.1 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 34.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.1 0.0 4125.7 0.0 1.0 2.7 0.0 0.0 23.0 0.0 0.0 0.0 45.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 263.8 0.0 0.1 4082.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 76.4 0.1 GUCA2B ENSG00000044012 "Guanylate cyclase activator 2B" Q16661 1 42153421-42155824 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "intestine: 92.4" "Group enriched" "Detected in some" 27 "Enterocytes: 716.3;Paneth cells: 2864.6" "Cancer enhanced" "Detected in many" "liver cancer: 5.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 19 "intermediate monocyte: 1.9" "Lineage enriched" "Detected in single" 19 "monocytes: 1.9" "Group enriched" "Detected in some" 6 "A549: 3.3;CACO-2: 9.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 740000 "unprognostic (2.59e-2)" "unprognostic (1.44e-2)" "unprognostic (1.34e-1)" "unprognostic (6.22e-2)" "unprognostic (1.86e-1)" 0.1 0.0 0.1 1.2 0.1 0.0 0.1 0.1 0.1 0.1 55.2 0.1 0.1 13.5 0.1 0.1 0.1 0.0 0.7 0.1 0.1 0.0 0.1 2.1 0.1 0.1 0.1 0.1 0.1 0.6 0.0 0.1 0.1 0.1 0.1 8.7 0.1 0.1 0.1 0.1 0.0 92.4 0.1 0.1 0.2 5.2 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 9.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 716.3 0.0 43.1 0.1 0.0 0.0 23.0 2.6 0.1 0.0 21.9 0.6 0.0 1.1 0.0 0.0 0.0 0.0 67.1 0.0 3.8 2864.6 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 33.2 0.0 IGFBPL1 bA113O24.1 ENSG00000137142 "Insulin like growth factor binding protein like 1" Q8WX77 9 38408994-38424447 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 11.0;pituitary gland: 7.4;thyroid gland: 27.2" "Group enriched" "Detected in some" 6 "Hofbauer cells: 1.4;Intestinal endocrine cells: 1.7;Spermatogonia: 1.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 67.8;NTERA-2: 18.6;RH-30: 19.5;SCLC-21H: 69.8;SH-SY5Y: 67.7;SuSa: 43.0" "Group enriched" "Detected in some" 4 "basal ganglia: 12.5;olfactory region: 16.2" "Low region specificity" "Detected in many" HPA051354 Uncertain Uncertain Nucleoplasm,Vesicles "Secreted to blood" NA NA "Nucleoplasm, Vesicles" "HPA051354: " "unprognostic (5.63e-2)" "unprognostic (3.33e-1)" "unprognostic (5.22e-2)" "unprognostic (2.42e-1)" "unprognostic (2.56e-2)" "unprognostic (1.92e-1)" "unprognostic (1.30e-1)" "unprognostic (5.66e-2)" "unprognostic (2.26e-1)" "unprognostic (3.05e-1)" "unprognostic (2.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.94e-1)" "unprognostic (3.92e-2)" "unprognostic (1.59e-2)" "unprognostic (6.67e-2)" 1.6 2.6 3.8 1.1 11.0 0.3 0.4 4.7 4.7 0.7 1.0 1.0 0.0 1.9 2.1 0.5 0.7 1.0 1.9 3.7 3.3 2.3 0.7 0.6 1.2 0.4 1.4 1.5 0.5 1.6 0.4 7.4 1.1 1.8 1.6 0.7 0.2 0.5 2.9 0.3 0.3 1.2 2.1 0.6 0.4 2.5 3.3 1.5 2.6 27.2 0.0 0.4 1.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 67.8 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 8.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 18.6 0.0 0.1 0.0 19.5 0.1 0.0 0.0 69.8 67.7 1.1 0.0 0.0 43.0 0.3 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 11.0 4.7 4.7 3.3 2.3 1.4 1.5 1.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.1 0.0 0.0 0.0 IGIP "C5orf53, LOC492311" ENSG00000182700 "IgA inducing protein" A6NJ69 5 140125935-140129392 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 14.4;ASC TERT1: 13.9" "Low region specificity" "Detected in all" "HPA041877, HPA048615" Uncertain Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA041877: AB_2677721, HPA048615: AB_2680462" "unprognostic (1.15e-1)" "unprognostic (1.12e-1)" "unprognostic (5.85e-2)" "unprognostic (2.00e-2)" "unprognostic (2.46e-1)" "unprognostic (1.16e-2)" "unprognostic (1.28e-1)" "unprognostic (1.10e-1)" "unprognostic (2.38e-1)" "unprognostic (5.05e-2)" "prognostic favorable (3.94e-4)" "unprognostic (1.94e-1)" "prognostic favorable (6.25e-6)" "unprognostic (2.93e-3)" "unprognostic (1.70e-1)" "unprognostic (5.98e-2)" "unprognostic (7.77e-2)" 5.1 7.6 13.9 2.0 13.1 0.0 5.3 16.0 13.7 7.3 3.8 3.4 1.6 2.8 3.8 8.0 2.5 3.5 3.8 4.6 13.4 13.7 7.6 6.2 3.8 3.1 17.8 3.3 5.3 3.6 16.2 6.1 3.7 9.8 5.8 3.1 3.7 4.3 7.3 7.7 7.5 3.7 8.2 14.4 3.8 3.4 1.9 9.4 2.0 7.1 2.8 3.0 3.7 3.4 0.6 0.1 1.0 0.5 0.5 2.2 0.1 2.0 0.6 1.0 2.9 14.4 13.9 1.3 5.1 5.1 1.2 1.5 2.0 1.6 3.8 5.5 6.9 0.7 2.1 1.1 3.1 2.3 3.3 1.9 0.8 2.8 1.5 3.4 1.0 1.4 4.7 7.9 2.3 4.4 8.9 1.5 2.8 0.6 1.5 4.4 1.7 1.1 2.5 0.2 1.6 1.6 1.2 2.4 1.7 6.8 1.8 1.0 1.5 2.8 1.8 2.9 1.1 1.4 3.0 8.9 3.6 0.3 1.2 2.8 3.7 2.4 1.3 3.8 2.6 2.6 0.0 0.2 1.0 0.7 0.1 1.9 0.6 1.0 0.8 0.1 0.5 2.2 1.8 0.0 0.5 0.5 0.1 1.1 0.1 13.9 13.1 16.0 12.9 13.4 13.7 17.8 3.3 9.8 9.4 11.9 3.2 0.5 1.7 1.8 19.0 13.8 10.2 2.7 5.7 3.5 13.7 1.9 0.0 2.5 1.5 3.7 3.9 0.0 1.6 1.1 2.9 3.5 8.1 4.7 0.9 27.0 8.6 4.3 2.6 0.5 6.1 2.2 6.8 1.8 4.4 5.6 2.5 5.1 15.9 2.2 9.4 0.0 5.0 2.3 0.9 3.4 1.5 0.8 3.4 1.7 IGLL1 "14.1, CD179B, IGL5, IGLL, IGVPB" ENSG00000128322 "Immunoglobulin lambda like polypeptide 1" P15814 22 23573125-23580308 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 35 "blood: 11.6;bone marrow: 37.7;lymphoid tissue: 29.4;testis: 20.8" "Group enriched" "Detected in some" 10 "Early spermatids: 60.5;Late spermatids: 104.2;Melanocytes: 113.1" "Cancer enhanced" "Detected in some" "stomach cancer: 2.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "memory B-cell: 11.6;naive B-cell: 9.8" "Lineage enriched" "Detected in many" 8 "B-cells: 11.6" "Cell line enriched" "Detected in some" 34 "REH: 129.9" "HPA051134, HPA071406" Enhanced Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 100000000000 "Endoplasmic reticulum" "HPA051134: AB_2681356, HPA071406: AB_2686393" "unprognostic (6.21e-2)" "unprognostic (5.12e-2)" "unprognostic (7.31e-2)" "unprognostic (4.75e-2)" "unprognostic (1.56e-1)" "unprognostic (5.91e-6)" "unprognostic (1.08e-1)" "unprognostic (5.27e-2)" "unprognostic (6.17e-3)" "unprognostic (5.89e-2)" "unprognostic (9.07e-2)" "unprognostic (1.99e-4)" "unprognostic (2.35e-2)" "unprognostic (5.16e-1)" "unprognostic (2.28e-2)" "unprognostic (1.21e-2)" 0.0 0.0 0.1 0.1 0.2 37.7 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 20.8 0.0 29.4 0.0 0.0 1.1 0.0 0.0 11.6 1.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.4 0.0 0.0 0.0 129.9 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 1.5 0.1 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 60.5 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.0 104.2 1.1 0.0 113.1 0.0 0.0 0.0 0.0 0.0 0.4 4.4 0.0 0.0 0.0 9.7 0.5 0.3 0.0 0.0 0.0 0.1 IGLL5 ENSG00000254709 "Immunoglobulin lambda like polypeptide 5" B9A064 22 22887780-22896107 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 87.9;lymphoid tissue: 102.9" "Cell type enriched" "Detected in some" 923 "Melanocytes: 89092.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 230 "memory B-cell: 87.9;naive B-cell: 72.8" "Lineage enriched" "Detected in single" 252 "B-cells: 87.9" "Group enriched" "Detected in some" 7 "Daudi: 103.5;U-266/70: 74.1;U-698: 70.4" "Secreted to blood" NA NA 120000000000 "prognostic favorable (6.10e-4)" "unprognostic (7.64e-3)" "unprognostic (4.33e-2)" "unprognostic (1.51e-3)" "unprognostic (2.82e-2)" "prognostic favorable (3.41e-5)" "unprognostic (1.76e-2)" "unprognostic (2.18e-1)" "unprognostic (7.28e-2)" "unprognostic (1.87e-2)" "unprognostic (1.01e-1)" "unprognostic (3.73e-1)" "prognostic unfavorable (5.94e-8)" "unprognostic (1.85e-1)" "unprognostic (4.63e-1)" "unprognostic (8.52e-2)" "unprognostic (6.50e-2)" 3.5 1.8 1.3 82.6 1.5 6.5 12.3 1.3 1.5 3.3 37.7 1.4 1.3 39.0 1.5 1.7 7.5 4.3 5.8 1.3 1.3 0.3 4.6 3.6 10.8 22.8 1.5 1.3 2.1 1.3 0.0 1.3 1.5 1.7 2.1 23.3 3.3 42.9 2.8 1.5 0.6 25.2 1.3 1.3 102.9 27.7 3.1 1.3 5.8 5.8 2.9 69.8 38.2 2.6 87.9 0.3 0.1 0.0 0.0 0.0 10.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 103.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 74.1 12.0 70.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.9 0.0 0.0 0.1 72.8 0.0 0.0 0.1 0.0 0.0 0.3 0.0 10.7 1.3 1.5 1.3 1.5 1.3 0.3 1.5 1.3 1.7 1.3 3.0 54.3 41.7 0.0 96.5 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 23.3 0.0 0.0 1.0 0.0 10.5 0.0 0.0 0.0 1.2 1.3 0.3 2.7 0.0 1.6 89092.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.8 0.0 0.9 0.0 0.0 IL18BP IL18BPa ENSG00000137496 "Interleukin 18 binding protein" O95998 11 71998541-72005715 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 54.3;lymphoid tissue: 71.5" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 11.8;Hofbauer cells: 10.7;Macrophages: 11.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "CAB025980, HPA041061" Enhanced Approved "Endoplasmic reticulum" "Secreted to blood" NA NA 3070000 14000000 "Endoplasmic reticulum" "CAB025980: , HPA041061: AB_2677280" "unprognostic (2.66e-3)" "unprognostic (2.04e-3)" "unprognostic (9.14e-3)" "unprognostic (1.70e-2)" "unprognostic (5.58e-3)" "unprognostic (7.75e-2)" "unprognostic (1.41e-1)" "unprognostic (6.20e-2)" "unprognostic (1.19e-2)" "unprognostic (1.75e-3)" "unprognostic (1.74e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.93e-6)" "unprognostic (1.19e-1)" "unprognostic (4.14e-2)" "unprognostic (6.76e-2)" "unprognostic (1.93e-2)" 23.7 10.6 6.5 19.7 7.7 6.0 7.2 6.2 5.7 6.3 6.7 6.7 1.0 7.1 6.1 4.1 4.1 5.8 7.2 4.7 3.8 4.1 37.0 54.3 20.8 20.2 7.0 1.9 10.1 4.9 2.8 6.4 28.4 9.0 8.9 9.8 5.3 6.4 4.0 6.2 5.1 9.2 11.4 6.1 71.5 6.1 3.0 6.3 6.1 17.3 3.6 15.6 8.6 6.2 13.6 22.3 22.2 30.5 1.9 23.4 13.9 2.0 2.7 6.2 3.6 1.3 1.9 7.0 3.4 2.0 3.3 4.5 13.2 2.6 1.2 2.7 1.7 3.8 5.1 3.7 2.8 2.6 3.0 4.4 5.2 7.0 3.7 1.4 3.0 12.6 2.9 3.2 3.0 1.6 4.5 6.4 8.1 8.9 2.3 1.8 3.4 3.8 6.5 4.5 2.4 2.5 5.8 6.4 2.1 2.2 5.5 3.3 6.4 3.8 4.3 5.0 6.6 4.3 2.8 13.8 5.4 4.2 6.2 2.1 3.7 2.2 2.5 2.3 11.0 2.6 2.3 8.5 22.2 23.4 30.5 10.5 13.6 12.4 13.8 15.5 7.0 10.4 15.0 3.6 1.9 23.7 22.3 6.1 13.9 6.5 7.7 6.2 5.7 3.8 4.1 7.0 1.9 9.0 6.3 6.0 3.5 5.7 0.4 1.8 3.1 0.8 0.0 2.7 1.2 0.0 9.8 0.7 0.0 1.9 0.0 7.9 0.7 0.0 11.8 0.9 2.3 0.9 7.0 0.5 10.7 3.2 0.0 8.0 7.2 0.0 0.9 11.1 0.0 0.0 0.7 1.6 7.3 0.0 0.7 0.7 3.0 0.0 1.2 0.5 0.4 1.8 0.7 3.2 0.6 0.1 IL1RN "ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430" ENSG00000136689 "Interleukin 1 receptor antagonist" P18510 2 113107214-113134016 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 217.8;lymphoid tissue: 194.7;tongue: 123.7" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 163.8;Hofbauer cells: 319.3;Suprabasal keratinocytes: 294.2;Urothelial cells: 333.6" "Cancer enhanced" "Detected in all" "head and neck cancer: 92.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 17.1;myeloid DC: 17.1;neutrophil: 65.2" "Group enriched" "Detected in many" 332 "dendritic cells: 17.1;granulocytes: 65.2;monocytes: 17.1" "Cell line enhanced" "Detected in some" "A-431: 21.1;HaCaT: 41.7;RT4: 40.8;THP-1: 11.8" "Not detected" "Not detected" "HPA001482, CAB009633" Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Secreted to blood" NA NA 291000 Nucleoplasm "Centrosome, Cytosol" "CAB009633: AB_2125576, HPA001482: AB_1078437" "unprognostic (3.85e-3)" "unprognostic (3.96e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (3.00e-4)" "unprognostic (2.21e-1)" "unprognostic (3.63e-2)" "unprognostic (3.15e-2)" "unprognostic (2.55e-1)" "unprognostic (4.46e-2)" "unprognostic (9.54e-2)" "prognostic unfavorable (6.85e-4)" "unprognostic (5.59e-3)" "prognostic unfavorable (2.66e-6)" "unprognostic (2.05e-1)" "prognostic unfavorable (8.23e-4)" "unprognostic (4.25e-2)" "unprognostic (1.03e-1)" 17.3 0.2 0.2 7.2 0.3 32.9 1.1 0.2 0.5 27.2 3.8 0.6 1.4 1.1 1.5 0.7 217.8 0.2 4.1 0.5 0.2 0.0 0.5 23.5 2.9 1.9 0.3 0.2 0.4 0.4 0.1 0.3 3.1 0.6 1.6 0.3 0.4 30.9 1.3 0.5 14.4 3.7 0.7 0.2 3.6 5.7 1.4 0.2 1.0 0.7 123.7 194.7 3.3 42.2 0.0 17.1 65.2 17.1 0.0 0.0 4.9 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.4 41.7 0.0 1.2 0.0 0.0 0.0 0.1 0.0 7.0 0.0 0.1 7.9 0.0 5.4 0.2 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.2 0.0 5.6 0.0 4.7 0.0 0.0 0.0 0.0 0.0 40.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.8 0.1 0.5 0.0 0.3 0.0 0.3 0.0 0.1 4.0 4.7 0.1 0.0 17.1 0.3 0.0 7.6 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 65.2 0.0 3.4 0.1 0.0 4.9 0.2 0.3 0.2 0.5 0.2 0.0 0.3 0.2 0.6 0.2 6.0 10.6 0.5 50.9 163.8 0.0 0.3 12.7 18.7 17.0 3.5 0.0 1.3 0.0 17.2 35.3 2.2 6.5 0.0 25.2 2.5 6.6 30.8 9.3 38.4 319.3 0.0 0.0 3.1 35.8 72.7 0.6 100.5 23.6 1.0 0.6 0.0 89.0 0.0 0.4 0.0 0.0 0.0 6.6 0.7 0.1 294.2 3.8 0.9 2.2 333.6 ITIH5 MGC10848 ENSG00000123243 "Inter-alpha-trypsin inhibitor heavy chain family member 5" 10 7559270-7666998 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 58.6" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 223.5;Sertoli cells: 77.6;Smooth muscle cells: 89.6;Syncytiotrophoblasts: 185.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "WM-115: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA038305 Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA "Golgi apparatus" Vesicles "HPA038305: AB_10670662" "unprognostic (1.28e-1)" "unprognostic (1.98e-1)" "unprognostic (3.11e-3)" "unprognostic (6.80e-2)" "unprognostic (1.80e-1)" "unprognostic (5.84e-3)" "unprognostic (1.63e-1)" "unprognostic (2.55e-2)" "unprognostic (1.53e-1)" "unprognostic (2.90e-1)" "unprognostic (5.80e-3)" "unprognostic (6.11e-2)" "unprognostic (1.36e-1)" "unprognostic (6.79e-3)" "unprognostic (2.00e-2)" "unprognostic (4.50e-2)" "unprognostic (3.48e-2)" 42.6 2.4 3.7 15.2 5.0 0.0 33.7 2.9 5.1 8.1 9.4 3.6 4.4 4.1 12.0 8.6 6.9 3.4 18.8 4.8 4.4 4.0 5.3 2.3 6.9 3.2 4.4 4.3 7.2 4.4 1.4 3.1 58.6 4.6 11.0 5.3 12.7 3.4 16.2 4.7 4.1 5.7 37.5 3.9 2.2 5.6 4.0 2.2 0.0 6.4 5.2 5.5 24.0 11.7 0.8 0.4 1.4 0.5 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 8.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 7.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 48.0 1.4 0.3 0.3 0.4 0.4 0.5 0.4 0.6 0.4 0.2 0.8 0.6 0.5 1.0 0.5 0.5 0.4 0.5 0.1 3.7 5.0 2.9 5.1 4.4 4.0 4.4 4.3 4.6 2.2 3.0 2.4 0.0 2.3 10.1 1.3 4.0 5.1 1.4 6.8 0.0 2.0 223.5 0.0 15.3 1.6 30.5 0.0 0.0 0.3 45.7 53.7 1.2 2.3 0.0 18.1 0.0 0.0 1.8 0.0 1.6 4.9 3.3 13.5 1.0 0.0 25.4 0.5 0.0 14.5 1.0 2.1 77.6 89.6 1.9 7.5 7.8 185.6 0.0 0.0 1.4 ITLN1 "FLJ20022, hIntL, HL-1, ITLN, LFR" ENSG00000179914 "Intelectin 1" Q8WWA0 1 160876539-160885170 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 119.2;heart muscle: 48.6;intestine: 157.9;lymphoid tissue: 40.1" "Cell type enriched" "Detected in many" 16 "Mucus-secreting cells: 1345.2" "Cancer enhanced" "Detected in many" "colorectal cancer: 61.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "intermediate monocyte: 6.9;non-classical monocyte: 17.3" "Lineage enriched" "Detected in many" 15 "monocytes: 17.3" "Group enriched" "Detected in some" 4 "HEL: 3.8;HL-60: 2.8;OE19: 10.5;U-937: 10.6" "Not detected" "Not detected" "CAB012652, HPA063275, HPA067326" Enhanced "Secreted to blood" NA NA 294000000 160000000 "CAB012652: , HPA063275: AB_2684974, HPA067326: AB_2732764" "unprognostic (9.69e-2)" "unprognostic (2.48e-2)" "unprognostic (1.31e-3)" "unprognostic (2.28e-1)" "unprognostic (1.79e-2)" "unprognostic (1.11e-1)" "unprognostic (1.59e-2)" "unprognostic (1.70e-1)" "unprognostic (5.22e-3)" "unprognostic (1.66e-2)" "unprognostic (4.38e-1)" "unprognostic (9.96e-2)" "unprognostic (3.67e-1)" "unprognostic (8.99e-2)" "unprognostic (1.92e-1)" "unprognostic (2.34e-2)" 119.2 0.0 0.2 40.1 0.2 0.0 0.2 0.2 0.2 0.4 52.5 0.2 1.0 31.9 0.5 8.8 0.7 1.2 8.7 48.6 0.2 0.0 0.5 2.6 13.9 0.2 0.2 0.3 4.3 0.2 0.0 0.4 0.4 0.3 3.0 157.9 0.2 2.6 0.6 1.5 0.1 48.6 0.8 0.2 0.6 1.9 2.7 0.2 0.4 0.2 1.4 1.5 1.6 0.8 0.0 1.1 0.1 17.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 3.8 0.0 0.0 1.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 10.5 0.0 0.0 0.0 1.5 0.0 0.3 0.1 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 10.6 0.0 0.0 0.3 0.0 0.0 6.9 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.1 0.0 17.3 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.3 0.3 0.2 0.0 6.7 0.9 0.1 0.0 0.0 6.1 2.5 1.4 3.4 3.5 0.0 0.0 0.0 0.0 0.5 0.0 20.4 0.0 3.3 0.7 0.0 0.3 1.1 0.0 0.8 0.0 17.2 81.0 86.0 0.4 13.6 0.0 0.0 0.0 1345.2 0.0 4.3 11.5 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 43.2 0.1 JCHAIN "IGCJ, IGJ, JCH" ENSG00000132465 "Joining chain of multimeric IgA and IgM" P01591 4 70655541-70681817 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 213.0;intestine: 403.3;lymphoid tissue: 209.3;salivary gland: 220.1" "Cell type enhanced" "Detected in some" 26 "Alveolar cells type 2: 174.1;B-cells: 379.6;Erythroid cells: 864.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 118 "memory B-cell: 213.0;naive B-cell: 91.6;plasmacytoid DC: 160.7" "Group enriched" "Detected in many" 142 "B-cells: 213.0;dendritic cells: 160.7" "Cell line enhanced" "Detected in some" "Daudi: 162.4;Karpas-707: 86.7;RPMI-8226: 172.1;U-266/70: 366.4;U-266/84: 142.2;U-698: 211.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB034436, HPA044132" Enhanced "Secreted to blood" NA NA 4200000000 "CAB034436: AB_2233368, HPA044132: AB_2678826" "prognostic favorable (1.81e-6)" "unprognostic (1.45e-3)" "unprognostic (7.44e-3)" "unprognostic (1.82e-2)" "unprognostic (4.23e-2)" "prognostic favorable (7.56e-7)" "unprognostic (2.37e-2)" "unprognostic (2.70e-2)" "unprognostic (6.30e-2)" "unprognostic (2.64e-3)" "unprognostic (3.36e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (3.43e-1)" "unprognostic (3.03e-2)" "unprognostic (2.22e-1)" "unprognostic (1.96e-1)" 4.4 1.6 0.9 209.3 0.9 0.4 69.6 0.9 0.9 27.2 403.3 2.1 0.7 132.7 1.7 1.5 29.2 9.8 79.4 2.4 0.9 1.0 19.9 12.7 62.8 111.7 0.9 0.6 14.0 8.6 0.0 1.4 0.7 0.8 5.7 142.5 8.2 220.1 30.1 1.1 1.7 361.5 4.0 1.0 161.3 124.6 7.0 0.7 8.0 7.1 36.8 96.7 42.1 5.9 213.0 160.7 1.3 0.3 0.2 0.9 52.6 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 162.4 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 86.7 0.0 0.0 0.2 0.6 0.2 0.0 0.0 0.2 0.1 172.1 0.0 0.0 0.1 0.6 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.2 0.5 0.2 0.2 366.4 142.2 211.2 0.0 0.2 0.0 0.7 0.3 0.1 0.2 0.0 0.9 213.0 0.1 0.2 0.3 91.6 0.1 0.1 1.3 0.2 0.1 160.7 0.1 52.6 0.9 0.9 0.9 0.9 0.9 1.0 0.9 0.6 0.8 0.7 20.8 174.1 379.6 2.5 0.0 0.0 0.3 10.2 6.7 14.8 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 864.3 0.0 0.1 0.0 0.5 73.2 1.5 0.3 0.0 7.0 91.4 24.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.9 0.2 0.0 0.2 10.2 0.0 0.3 LEP "OB, OBS" ENSG00000174697 Leptin P41159 7 128241284-128257628 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes, Diabetes mellitus, Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "adipose tissue: 85.2;breast: 63.7;placenta: 24.3" "Cell type enriched" "Detected in some" 28 "Syncytiotrophoblasts: 361.5" "Cancer enhanced" "Detected in some" "breast cancer: 1.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "neutrophil: 3.8" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.8" "Group enriched" "Detected in some" 11 "BEWO: 5.6;HSkMC: 2.3;SuSa: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" CAB010490 Approved "Secreted to blood" NA NA 17000000 26000000 "CAB010490: AB_2296951" "unprognostic (8.19e-3)" "unprognostic (5.33e-1)" "unprognostic (1.60e-4)" "unprognostic (1.19e-1)" "unprognostic (7.99e-3)" "unprognostic (1.83e-1)" "unprognostic (6.56e-3)" "unprognostic (1.98e-2)" "unprognostic (1.42e-2)" "unprognostic (2.45e-2)" "unprognostic (2.63e-1)" "unprognostic (1.02e-3)" "unprognostic (2.83e-1)" "unprognostic (1.92e-1)" "unprognostic (2.23e-2)" "unprognostic (6.84e-2)" 85.2 0.3 0.0 1.5 0.0 0.0 63.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.7 0.0 0.0 0.1 0.0 0.4 2.0 0.0 0.0 0.1 0.7 0.0 0.0 24.3 0.0 0.0 0.1 0.0 0.4 0.0 0.6 1.1 0.4 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 1.5 2.1 0.4 0.4 3.8 0.5 0.5 0.3 0.2 0.0 0.2 0.1 0.3 0.2 0.0 5.6 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.2 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.2 0.1 0.3 0.1 7.1 0.2 0.1 0.0 0.2 0.2 0.4 0.2 0.2 0.1 0.2 0.3 0.1 0.3 0.9 0.5 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.1 0.4 0.2 0.3 3.8 0.5 0.4 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.2 0.1 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 361.5 0.0 0.0 0.1 LGI2 "FLJ10675, KIAA1916" ENSG00000153012 "Leucine rich repeat LGI family member 2" Q8N0V4 4 24998847-25030879 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "parathyroid gland: 113.9" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 2.6;Collecting duct cells: 5.2;Hofbauer cells: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "classical monocyte: 1.3" "Lineage enriched" "Detected in single" 10 "monocytes: 1.3" "Cell line enhanced" "Detected in some" "AF22: 22.7;HAP1: 4.1;RPMI-8226: 10.4;SCLC-21H: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017140 Approved Uncertain Centrosome "Secreted to blood" NA NA Centrosome "HPA017140: AB_1852833" "unprognostic (1.62e-1)" "unprognostic (1.40e-1)" "unprognostic (4.31e-2)" "unprognostic (1.20e-5)" "unprognostic (3.99e-2)" "unprognostic (1.41e-1)" "unprognostic (2.72e-2)" "unprognostic (8.54e-2)" "unprognostic (1.03e-1)" "unprognostic (1.29e-1)" "unprognostic (3.47e-2)" "unprognostic (1.62e-1)" "unprognostic (9.38e-5)" "unprognostic (5.78e-2)" "unprognostic (1.61e-1)" "unprognostic (2.06e-4)" "unprognostic (5.03e-3)" 2.5 1.6 2.8 6.7 3.3 0.8 2.3 7.9 7.8 3.7 4.0 0.0 1.0 1.1 8.9 4.9 4.1 11.4 4.2 3.7 2.4 3.9 3.0 0.9 1.4 2.0 7.2 0.4 9.1 2.6 113.9 0.5 2.6 18.7 1.0 1.6 6.0 0.9 1.4 0.9 0.9 2.6 7.1 2.9 1.2 2.4 2.0 0.9 0.6 1.8 0.6 4.6 1.8 1.1 0.0 0.1 0.0 1.3 0.0 0.0 0.2 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.6 0.0 0.2 0.0 4.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 3.7 0.0 0.8 0.0 0.9 10.4 0.4 0.0 14.7 0.0 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.2 1.6 0.0 0.6 0.0 0.0 0.0 0.4 0.4 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.8 3.3 7.9 7.8 2.4 3.9 7.2 0.4 18.7 0.9 0.0 0.0 0.0 0.1 0.1 0.4 2.6 0.0 0.0 0.0 5.2 0.0 0.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.8 1.6 0.0 1.3 0.6 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 1.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 LRG1 LRG ENSG00000171236 "Leucine rich alpha-2-glycoprotein 1" P02750 19 4536409-4540474 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "liver: 636.5" "Cell type enriched" "Detected in many" 9 "Hepatocytes: 728.6" "Cancer enriched" "Detected in many" 9 "liver cancer: 160.9" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 19 "neutrophil: 58.9" "Lineage enriched" "Detected in many" 42 "granulocytes: 58.9" "Cell line enhanced" "Detected in some" "Hep G2: 8.2;HMC-1: 8.3;SK-BR-3: 8.8;THP-1: 14.8;U-937: 27.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA001888, HPA001889" Enhanced Approved Vesicles "Secreted to blood" NA NA 21000000000 74000000000 Vesicles "HPA001888: AB_1079276, HPA001889: AB_1079275" "unprognostic (5.54e-3)" "unprognostic (1.78e-1)" "unprognostic (1.78e-1)" "unprognostic (1.42e-1)" "unprognostic (2.64e-2)" "unprognostic (1.05e-1)" "unprognostic (1.88e-1)" "unprognostic (1.13e-1)" "unprognostic (1.01e-1)" "unprognostic (1.16e-2)" "unprognostic (1.46e-3)" "unprognostic (9.83e-2)" "prognostic unfavorable (3.66e-6)" "unprognostic (4.06e-2)" "unprognostic (1.45e-1)" "prognostic favorable (3.49e-4)" "unprognostic (2.60e-2)" 1.7 0.9 0.2 3.3 0.4 5.4 0.9 0.2 0.3 1.7 1.3 0.2 2.2 1.1 0.3 1.1 4.5 1.9 3.0 0.9 0.4 0.2 3.5 636.5 2.2 5.7 0.7 0.1 1.5 8.1 0.0 0.7 0.4 0.4 1.1 0.8 0.3 4.1 3.0 0.5 0.8 0.6 0.2 0.3 4.3 2.3 0.5 0.3 0.3 0.9 1.7 3.4 1.4 1.3 0.1 0.3 58.9 1.4 0.0 0.2 0.4 5.9 0.1 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.6 4.3 2.1 7.7 0.0 0.3 0.8 0.0 1.0 0.0 7.7 0.2 0.1 0.1 8.2 0.0 0.2 8.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.3 0.0 6.0 0.1 4.7 0.0 0.0 0.1 6.2 0.6 1.1 0.0 0.0 0.0 8.8 0.1 0.8 2.6 14.8 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 27.4 0.0 0.5 1.4 3.0 0.0 0.4 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 58.9 0.0 0.2 0.0 0.2 0.4 0.2 0.4 0.2 0.3 0.4 0.2 0.7 0.1 0.4 0.3 11.9 51.2 16.5 26.9 7.1 0.0 0.4 58.6 78.9 39.8 14.0 0.0 0.5 1.7 54.6 0.0 8.3 25.4 0.0 54.4 10.6 1.4 2.9 11.5 728.6 5.4 1.6 4.7 42.4 17.4 0.0 0.0 7.6 1.7 10.0 20.0 0.0 55.9 7.0 0.0 3.6 0.0 0.0 2.1 0.0 0.2 5.1 1.1 2.9 16.7 29.6 MANF "ARMET, ARP" ENSG00000145050 "Mesencephalic astrocyte derived neurotrophic factor" 3 51385047-51389397 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 383.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 32.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011175 Approved Supported "Endoplasmic reticulum" "Secreted to blood" NA NA "Endoplasmic reticulum" "HPA011175: AB_1845039" "unprognostic (2.90e-2)" "unprognostic (5.24e-2)" "unprognostic (1.11e-2)" "unprognostic (2.51e-2)" "unprognostic (5.84e-2)" "prognostic unfavorable (9.58e-6)" "prognostic unfavorable (7.48e-4)" "unprognostic (7.37e-2)" "unprognostic (1.25e-1)" "unprognostic (1.12e-3)" "unprognostic (1.35e-1)" "unprognostic (3.01e-1)" "unprognostic (1.21e-2)" "unprognostic (1.46e-1)" "unprognostic (1.99e-2)" "unprognostic (1.27e-1)" "unprognostic (5.10e-2)" 13.2 14.6 11.6 18.9 16.8 8.3 19.8 6.7 12.4 20.7 16.1 5.2 47.4 11.6 15.1 52.8 19.9 14.0 16.1 23.4 9.7 9.8 22.2 65.6 16.9 15.9 12.9 5.7 11.5 64.2 6.5 23.4 23.3 20.9 16.1 16.8 5.1 64.7 37.9 7.8 13.1 11.9 14.3 8.8 21.7 16.4 14.3 12.5 12.7 64.4 20.7 21.4 14.0 37.2 5.4 32.7 19.2 4.8 7.4 11.2 4.9 18.5 9.3 24.9 30.7 17.2 22.4 26.6 29.9 24.7 30.5 29.3 14.4 43.5 40.7 25.0 18.5 70.4 11.1 30.9 30.8 29.8 18.7 15.6 32.7 14.0 33.1 56.3 15.6 21.0 9.6 26.0 31.6 42.5 29.4 39.3 16.9 7.0 44.6 28.2 11.3 25.9 31.2 21.6 44.2 40.4 11.2 16.0 41.8 25.6 12.4 9.4 30.4 25.1 15.1 18.1 28.6 12.1 21.0 18.4 17.3 17.0 21.0 32.8 36.2 14.7 26.3 30.3 31.2 33.5 19.2 4.8 2.7 8.9 3.8 11.2 5.4 6.5 8.5 4.7 3.5 4.9 5.1 2.4 7.4 2.4 32.7 3.9 4.9 11.6 16.8 6.7 12.4 9.7 9.8 12.9 5.7 20.9 12.5 29.8 19.2 79.0 180.0 144.9 12.1 43.7 68.8 24.1 18.2 52.4 5.9 166.0 36.5 141.5 75.3 67.4 57.1 0.0 109.7 259.3 107.8 169.1 63.3 130.9 163.5 11.1 111.7 81.0 38.0 80.4 55.5 75.0 172.1 98.2 64.3 32.2 172.7 66.6 48.4 54.7 15.7 64.7 82.0 145.8 74.5 140.4 383.9 60.7 57.1 181.4 METTL9 DREV1 ENSG00000197006 "Methyltransferase like 9" Q9H1A3 16 21597218-21657473 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 326.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053588, HPA056347" Uncertain Approved "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to blood" NA NA "Nucleoplasm, Cell Junctions" Cytosol "HPA053588: AB_2682203, HPA056347: " "unprognostic (1.55e-1)" "unprognostic (2.18e-2)" "unprognostic (1.98e-3)" "unprognostic (5.43e-2)" "unprognostic (5.81e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (8.71e-4)" "unprognostic (3.44e-2)" "unprognostic (1.11e-2)" "unprognostic (7.57e-3)" "unprognostic (1.73e-2)" "unprognostic (3.18e-1)" "unprognostic (1.49e-3)" "unprognostic (2.14e-1)" "unprognostic (3.28e-1)" "unprognostic (5.17e-2)" "unprognostic (1.65e-1)" 24.0 45.5 29.6 18.8 34.9 50.0 45.1 12.2 31.9 34.2 19.1 18.7 15.5 14.9 23.4 35.6 30.2 23.8 19.4 32.0 22.2 20.0 61.0 8.7 24.0 38.8 26.8 8.4 22.8 28.8 37.2 25.0 25.4 17.7 23.8 20.3 32.5 22.1 19.3 30.6 21.5 20.6 21.1 25.0 29.6 18.8 10.8 18.1 39.8 37.8 20.0 25.9 24.9 24.6 4.9 14.1 30.5 24.5 5.6 7.3 7.6 13.6 10.4 26.4 22.8 27.3 49.5 9.5 21.9 31.4 17.3 21.0 7.5 24.9 24.0 18.7 38.3 16.7 8.6 17.5 19.6 23.7 18.2 14.3 10.4 10.5 27.9 19.6 8.1 21.6 29.1 20.9 17.9 23.4 32.6 33.1 26.9 15.3 19.8 34.2 15.1 21.1 13.6 23.7 17.0 10.8 30.8 20.5 21.8 28.5 13.4 15.3 27.6 18.6 12.9 46.7 20.7 13.1 4.2 18.7 28.8 12.6 17.6 13.4 16.8 27.0 19.3 28.3 20.2 20.3 30.5 24.5 10.7 4.0 4.5 4.8 4.6 6.8 7.3 14.1 4.9 7.3 5.4 12.5 5.6 3.9 4.4 5.4 7.6 29.6 34.9 12.2 31.9 22.2 20.0 26.8 8.4 17.7 18.1 17.9 25.0 67.7 73.4 63.7 38.7 50.8 28.1 17.4 25.0 82.0 43.2 62.9 238.8 101.7 6.4 91.1 45.1 0.0 107.0 99.3 82.6 115.4 48.3 10.4 80.8 42.9 81.5 80.4 211.5 4.5 58.7 86.5 99.5 101.8 76.5 49.9 98.9 45.6 61.2 326.8 37.5 64.7 68.4 13.2 20.0 67.2 116.4 146.0 75.0 107.4 MST1 "D3F15S2, DNF15S2, HGFL, MSP, NF15S2" ENSG00000173531 "Macrophage stimulating 1" 3 49683947-49689501 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "liver: 117.0" "Cell type enriched" "Detected in many" 7 "Hepatocytes: 361.8" "Cancer enriched" "Detected in many" 7 "liver cancer: 42.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.1;memory B-cell: 1.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 42.3;NB-4: 8.6;U-266/70: 11.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024036 Approved "Secreted to blood" NA NA "HPA024036: AB_1854147" "unprognostic (5.13e-3)" "unprognostic (1.45e-1)" "unprognostic (1.58e-1)" "unprognostic (1.04e-1)" "unprognostic (1.83e-1)" "unprognostic (2.00e-2)" "unprognostic (1.16e-2)" "unprognostic (9.42e-3)" "unprognostic (8.24e-2)" "unprognostic (2.97e-1)" "prognostic favorable (7.14e-4)" "unprognostic (3.07e-2)" "unprognostic (1.57e-2)" "unprognostic (1.11e-1)" "unprognostic (2.48e-1)" "unprognostic (8.03e-2)" "unprognostic (1.68e-3)" 3.7 3.5 4.0 0.3 4.8 1.4 1.0 4.9 5.4 0.9 1.4 2.5 1.9 14.4 1.2 3.3 0.8 1.7 1.9 0.5 6.5 1.1 8.8 117.0 1.6 0.7 2.0 2.9 1.7 1.9 3.8 4.8 1.5 4.8 1.5 0.5 1.6 3.4 3.7 2.8 4.0 8.2 1.3 4.2 1.7 0.8 9.9 2.3 0.9 5.0 0.3 1.1 0.8 0.7 1.2 0.9 0.0 0.2 0.0 1.1 0.2 0.1 0.2 0.6 1.0 1.9 4.1 1.9 0.5 0.7 0.3 0.4 2.0 0.6 0.1 1.3 0.6 0.3 0.4 0.3 0.8 0.3 0.6 0.3 0.3 0.9 42.3 3.1 0.0 0.8 5.5 1.3 0.3 1.1 7.5 0.7 1.8 0.3 5.2 1.0 0.3 0.2 8.6 0.1 0.5 0.5 0.2 0.2 1.1 2.3 0.3 0.1 1.5 0.0 0.9 0.2 1.3 0.7 2.8 0.5 1.0 0.3 0.0 0.1 11.5 1.4 0.2 1.1 1.6 0.7 0.0 0.0 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.2 4.0 4.8 4.9 5.4 6.5 1.1 2.0 2.9 4.8 2.3 6.0 3.8 6.0 4.8 2.6 7.2 1.7 38.2 5.3 4.5 26.2 7.9 3.6 53.0 5.4 4.2 2.1 4.6 46.7 3.3 13.8 3.3 1.1 1.1 361.8 1.2 1.6 7.9 11.6 9.5 0.5 2.8 1.4 3.3 0.0 7.3 7.7 2.3 7.0 1.8 54.1 6.9 0.0 2.0 18.7 4.4 4.1 4.2 2.1 12.1 2.7 MTRNR2L1 ENSG00000256618 "MT-RNR2-like 1" P0CJ68 17 22523111-22524663 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in all" 4 "blood: 249.5" "Cell type enriched" "Detected in many" 13 "Cardiomyocytes: 14115.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 249.5" "Lineage enriched" "Detected in all" 7 "granulocytes: 249.5" "Cell line enhanced" "Detected in all" "HeLa: 188.9;Hep G2: 129.8" "Secreted to blood" NA NA "unprognostic (2.31e-2)" "unprognostic (1.50e-1)" "unprognostic (1.08e-1)" "unprognostic (4.41e-3)" "unprognostic (2.99e-2)" "unprognostic (9.82e-3)" "prognostic favorable (8.99e-4)" "unprognostic (2.14e-1)" "unprognostic (2.59e-2)" "unprognostic (1.48e-2)" "unprognostic (2.42e-2)" "unprognostic (1.63e-2)" "unprognostic (2.56e-2)" "unprognostic (3.35e-2)" "unprognostic (1.64e-1)" "unprognostic (1.49e-2)" "unprognostic (5.21e-3)" 9.4 16.2 7.9 3.7 10.0 2.3 3.0 4.0 8.4 2.5 8.9 3.3 4.8 4.5 2.6 6.8 4.8 2.6 3.3 34.3 8.1 6.1 17.8 12.8 4.2 5.6 8.9 3.0 4.1 15.0 1.5 3.4 2.5 4.6 3.5 7.7 3.3 5.9 5.0 55.5 5.3 5.2 7.5 5.9 3.3 5.6 4.4 4.0 1.8 2.7 6.8 1.8 3.3 2.6 29.4 21.6 249.5 34.3 15.0 18.3 28.7 20.6 48.2 18.6 62.5 29.5 12.2 23.6 19.5 4.6 4.5 5.3 29.6 33.5 28.1 21.3 10.0 3.2 55.0 1.4 7.0 5.6 16.5 34.6 25.7 188.9 129.8 9.6 6.0 31.0 27.3 15.1 5.0 12.2 32.8 4.8 18.4 20.8 17.2 13.4 16.7 9.3 41.3 5.3 16.1 10.8 15.3 11.8 14.6 25.7 29.5 9.9 17.6 9.4 17.9 28.7 18.7 16.8 43.0 9.3 24.9 21.0 29.6 12.0 16.0 5.1 13.3 14.2 38.0 5.4 74.4 34.3 62.1 10.9 16.7 13.5 28.7 13.9 11.8 12.1 29.4 18.3 15.9 249.5 15.0 16.1 21.6 12.1 28.7 7.9 10.0 4.0 6.8 8.1 6.1 8.9 3.0 4.6 4.0 122.1 126.9 16.9 1081.8 75.0 0.0 14115.0 2.5 184.7 263.9 73.3 0.0 0.7 94.5 0.5 4.6 52.2 1.1 0.0 0.6 0.6 57.9 106.8 153.5 10.2 0.7 0.0 1.7 4.9 6.9 6.9 14.4 92.3 59.1 0.0 1.3 0.0 0.2 1.4 3.9 12.2 0.0 0.0 31.1 6.6 18.6 149.7 0.8 7.5 1.2 234.3 MTRNR2L10 ENSG00000256045 "MT-RNR2-like 10" P0CJ77 X 55181391-55182920 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 60.2" "Cell type enriched" "Detected in many" 21 "Cardiomyocytes: 8067.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Group enriched" "Detected in all" 5 "basophil: 16.9;eosinophil: 19.1;neutrophil: 60.2" "Lineage enriched" "Detected in all" 9 "granulocytes: 60.2" "Group enriched" "Detected in many" 4 "A549: 22.8;HeLa: 83.8;Hep G2: 71.6" "Secreted to blood" NA NA "unprognostic (4.42e-1)" "unprognostic (3.04e-2)" "unprognostic (1.15e-1)" "unprognostic (5.10e-4)" "unprognostic (1.59e-1)" "unprognostic (1.27e-1)" "unprognostic (1.71e-2)" "unprognostic (8.42e-2)" "unprognostic (1.58e-2)" "unprognostic (9.01e-2)" "unprognostic (5.26e-2)" "unprognostic (1.22e-1)" "unprognostic (3.01e-1)" "unprognostic (6.28e-2)" "unprognostic (2.97e-2)" "unprognostic (4.99e-2)" "unprognostic (3.97e-4)" 4.2 3.8 3.2 0.6 4.6 0.0 1.0 1.3 4.4 1.2 4.5 1.2 0.6 0.6 1.0 4.7 2.2 1.5 1.5 19.8 4.1 2.2 14.3 8.5 2.0 5.1 2.6 0.6 1.2 2.4 0.0 2.5 1.0 2.7 1.1 8.4 0.6 3.0 0.6 16.9 1.1 1.0 2.6 2.1 1.0 1.1 3.7 1.0 0.6 1.0 1.6 1.7 1.0 1.0 6.1 3.9 60.2 6.9 3.5 3.4 7.4 1.3 22.8 0.3 6.5 0.5 0.3 1.6 2.0 0.1 0.1 0.0 1.4 3.3 3.1 0.4 0.1 0.2 4.8 0.0 0.1 0.0 0.9 4.7 1.5 83.8 71.6 0.1 0.5 0.8 0.8 0.3 0.0 0.2 5.6 0.0 2.4 2.7 1.8 0.2 8.4 0.4 3.6 0.1 0.1 1.8 1.2 1.3 1.4 0.5 13.9 0.3 1.3 0.6 0.5 2.2 3.2 1.9 2.7 3.3 2.4 0.5 0.8 0.2 0.6 0.3 0.2 1.5 0.6 0.5 16.9 6.9 19.1 1.5 3.8 1.8 5.8 2.4 2.0 3.2 6.1 3.1 3.4 60.2 3.5 3.5 3.9 2.4 7.4 3.2 4.6 1.3 4.4 4.1 2.2 2.6 0.6 2.7 1.0 0.0 0.0 8.0 376.7 7.2 0.0 8067.8 0.0 0.0 0.0 40.1 0.0 0.2 71.3 0.0 0.2 2.2 0.0 0.0 0.0 0.2 13.1 232.2 0.0 4.9 0.5 0.0 0.0 1.8 3.2 0.4 0.6 10.6 15.1 0.0 0.0 0.0 0.0 0.0 1.1 4.3 0.0 0.0 22.6 0.5 0.7 8.0 0.2 0.0 0.0 338.2 MTRNR2L11 ENSG00000270188 "MT-RNR2-like 11" S4R3Y5 1 237943724-237945275 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "blood: 64.8;skeletal muscle: 46.5" "Cell type enriched" "Detected in many" 26 "Cardiomyocytes: 1023.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 64.8" "Lineage enriched" "Detected in all" 9 "granulocytes: 64.8" "Cell line enhanced" "Detected in many" "HeLa: 66.8;Hep G2: 42.8" "Secreted to blood" NA NA "unprognostic (1.07e-1)" "unprognostic (9.70e-2)" "unprognostic (4.49e-2)" "unprognostic (5.26e-2)" 9.9 11.8 3.7 0.9 3.8 1.4 5.5 2.1 8.5 2.0 7.0 1.4 3.7 2.9 2.0 3.1 2.0 2.0 0.2 12.4 4.2 2.3 11.1 7.2 3.0 2.8 2.2 2.6 2.0 3.3 0.0 2.0 1.3 4.6 2.1 3.1 0.9 4.4 6.5 46.5 2.0 3.5 0.7 3.3 2.0 4.3 4.0 3.0 0.8 2.0 7.4 0.3 2.0 2.0 5.9 3.4 64.8 7.0 2.9 3.1 8.2 7.1 16.9 7.9 22.1 6.8 1.7 6.3 12.0 0.9 0.7 0.9 7.1 10.4 12.3 7.7 2.3 1.3 21.8 0.2 1.6 0.6 5.3 11.8 12.3 66.8 42.8 2.2 3.4 9.9 6.8 2.3 0.8 3.0 15.5 1.0 8.0 8.6 7.4 2.0 6.1 3.4 11.7 2.1 8.9 3.1 6.5 6.4 5.0 4.6 9.9 3.0 5.3 4.7 5.5 8.7 8.1 6.7 10.8 19.3 8.9 6.3 7.2 3.4 5.6 1.8 5.0 4.9 12.1 2.1 14.8 7.0 16.1 1.4 3.2 1.7 5.5 2.2 1.9 2.7 5.9 3.1 3.1 64.8 2.9 3.1 3.4 2.0 8.2 3.7 3.8 2.1 5.1 4.2 2.3 2.2 2.6 4.6 3.0 0.0 0.0 0.0 22.2 3.5 0.0 1023.1 0.0 0.0 0.0 12.2 0.0 0.1 39.7 0.0 0.0 2.2 0.0 0.0 0.0 0.1 2.4 23.0 0.0 1.3 0.1 0.0 0.0 1.3 0.3 0.0 0.0 2.4 8.5 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 3.1 0.3 0.2 3.4 0.0 0.0 0.0 20.9 MTRNR2L12 ENSG00000269028 "MT-RNR2-like 12" P0DMP1 3 96617188-96618236 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in all" 5 "blood: 603.3" "Cell type enriched" "Detected in many" 12 "Cardiomyocytes: 31937.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 603.3" "Lineage enriched" "Detected in all" 7 "granulocytes: 603.3" "Cell line enhanced" "Detected in all" "HeLa: 496.6" "Secreted to blood" NA NA "unprognostic (3.79e-2)" "unprognostic (1.05e-1)" "unprognostic (1.88e-2)" "unprognostic (1.37e-1)" "unprognostic (1.09e-1)" "unprognostic (9.76e-3)" "unprognostic (1.69e-3)" "unprognostic (1.81e-2)" "unprognostic (7.77e-2)" "unprognostic (3.55e-2)" "unprognostic (2.08e-2)" "unprognostic (4.90e-2)" "unprognostic (9.59e-3)" "unprognostic (1.81e-2)" "unprognostic (2.61e-1)" "unprognostic (2.08e-1)" "unprognostic (1.85e-2)" 18.0 29.1 32.5 5.2 31.0 4.5 7.5 8.8 19.2 5.1 20.2 6.4 5.7 8.1 5.1 75.3 10.9 3.8 40.2 114.2 26.3 19.8 32.9 29.8 5.4 7.8 26.2 7.5 4.9 9.7 4.3 6.6 5.0 10.4 6.9 16.5 6.8 10.8 9.3 101.3 10.6 9.3 6.9 15.3 5.3 13.3 9.7 8.7 72.1 5.1 11.0 5.3 6.0 8.5 69.1 53.1 603.3 81.8 37.9 45.5 57.6 99.3 122.4 91.7 329.0 142.5 76.9 84.3 129.6 26.5 25.0 32.3 67.2 160.7 219.2 105.6 48.9 14.5 274.9 6.4 54.7 34.2 64.2 118.4 232.2 496.6 283.0 54.2 46.0 128.5 139.1 65.6 26.3 72.2 153.1 27.8 99.1 164.5 75.6 84.7 52.0 39.7 145.5 26.7 60.3 36.9 63.6 88.2 67.6 149.9 74.0 41.8 81.5 84.4 85.9 111.3 85.1 88.3 134.4 122.9 103.5 86.0 115.6 36.6 40.2 25.1 108.9 64.2 290.2 27.9 183.7 81.8 153.2 28.1 44.0 37.0 65.7 35.7 29.9 31.2 69.1 45.5 40.8 603.3 37.9 42.3 53.1 31.4 57.6 32.5 31.0 8.8 19.0 26.3 19.8 26.2 7.5 10.4 8.7 2513.2 2660.0 61.6 386.4 99.9 0.0 31937.7 112.1 2625.9 2640.0 80.3 0.0 6.1 53.0 0.7 11.2 82.6 5.6 163.5 1.6 7.5 167.2 335.7 1581.1 147.2 10.6 0.0 4.7 79.2 93.4 36.3 39.7 230.1 183.9 1.0 7.8 0.0 1.3 7.0 21.5 70.0 0.0 45.3 270.2 25.4 36.6 70.6 8.8 96.9 2.4 333.1 MTRNR2L4 ENSG00000232196 "MT-RNR2-like 4" P0CJ71 16 3370979-3372740 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 4 "blood: 49.5;skeletal muscle: 52.2" "Cell type enriched" "Detected in some" 24 "Cardiomyocytes: 125.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 49.5" "Lineage enriched" "Detected in all" 8 "granulocytes: 49.5" "Cell line enhanced" "Detected in many" "AN3-CA: 22.3;HaCaT: 23.3;HeLa: 31.2" "Secreted to blood" NA NA "unprognostic (8.53e-2)" "unprognostic (1.10e-1)" "unprognostic (1.44e-1)" "unprognostic (1.80e-1)" "unprognostic (1.05e-1)" "unprognostic (3.66e-3)" "unprognostic (1.58e-1)" "unprognostic (1.37e-2)" "unprognostic (2.26e-1)" "unprognostic (1.71e-1)" "unprognostic (6.81e-3)" "unprognostic (1.65e-1)" "unprognostic (2.79e-1)" "unprognostic (1.19e-1)" "unprognostic (9.27e-2)" "unprognostic (1.90e-1)" "unprognostic (1.65e-1)" 2.5 10.3 3.5 1.3 4.4 0.9 1.2 2.7 6.6 1.5 2.2 0.5 0.3 3.4 1.6 0.9 1.5 2.0 1.7 11.7 2.3 1.2 5.8 2.5 1.0 0.3 6.3 4.8 5.8 9.7 0.0 3.1 1.0 2.5 1.7 1.1 1.2 2.7 3.3 52.2 1.2 3.6 2.1 1.5 1.1 3.1 2.3 3.1 0.3 2.6 1.1 0.8 1.5 1.3 5.4 3.8 49.5 6.4 2.5 2.5 5.0 6.0 4.0 1.2 22.3 0.5 0.7 6.9 3.3 0.1 0.4 0.3 1.8 13.1 4.5 6.7 0.2 0.1 23.3 0.0 0.2 0.2 3.4 2.2 4.0 31.2 16.2 0.1 1.3 10.9 0.4 0.3 0.1 0.2 0.5 0.0 0.5 3.0 6.3 0.7 1.3 2.8 10.5 1.8 0.2 0.8 5.2 3.2 4.1 0.9 4.6 2.7 6.0 2.1 5.3 8.0 0.4 7.4 10.1 2.9 7.2 6.4 8.3 2.3 3.3 1.1 4.2 4.9 10.3 1.6 12.1 6.4 19.1 1.4 3.7 1.7 4.2 1.9 1.9 3.1 5.4 2.1 2.5 49.5 2.5 3.6 3.8 2.1 5.0 3.5 4.4 2.7 5.5 2.3 1.2 6.3 4.8 2.5 3.1 0.0 0.0 0.0 2.4 0.1 0.0 125.1 5.1 0.0 0.0 1.8 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 1.7 0.5 0.2 0.3 0.1 0.0 0.0 1.4 MTRNR2L6 ENSG00000270672 "MT-RNR2-like 6" P0CJ73 7 142666272-142667718 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 81.7;skeletal muscle: 39.1" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 849.8" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 81.7" "Lineage enriched" "Detected in all" 10 "granulocytes: 81.7" "Cell line enhanced" "Detected in many" "HeLa: 50.0;Hep G2: 44.1" "Secreted to blood" NA NA "unprognostic (5.34e-2)" "unprognostic (1.34e-3)" "unprognostic (3.80e-1)" "unprognostic (4.45e-3)" "unprognostic (1.33e-1)" "unprognostic (2.89e-1)" "unprognostic (1.40e-2)" "unprognostic (3.49e-2)" "unprognostic (1.30e-1)" "unprognostic (1.10e-2)" "unprognostic (6.02e-2)" "unprognostic (1.04e-1)" "unprognostic (3.69e-1)" "unprognostic (3.03e-2)" "unprognostic (2.66e-2)" "unprognostic (8.07e-3)" 3.4 8.2 1.4 0.8 2.3 0.1 1.1 1.2 5.5 1.1 3.9 1.5 0.8 1.1 1.1 0.8 1.7 1.1 0.8 17.9 6.1 1.4 7.3 4.7 1.1 5.9 2.2 3.9 1.1 2.2 0.0 1.1 0.8 4.5 1.1 2.3 0.8 2.5 0.8 39.1 1.5 2.6 0.8 3.5 1.1 2.2 1.7 1.8 0.8 1.5 0.8 0.8 1.8 1.1 8.4 4.2 81.7 8.2 4.7 3.9 9.5 5.6 9.6 3.3 22.6 3.8 2.0 5.5 6.0 0.5 0.6 1.0 3.1 10.3 4.9 8.2 1.1 0.5 19.9 0.1 1.1 0.5 3.1 3.7 6.8 50.0 44.1 1.2 1.4 7.3 3.4 1.4 0.5 1.6 12.7 0.5 6.1 5.8 7.3 1.8 3.1 2.8 15.2 1.2 3.1 1.1 4.5 2.8 3.7 3.9 8.3 2.2 8.2 1.6 3.8 11.5 4.9 5.3 9.6 6.9 6.5 6.6 7.8 2.0 2.9 1.3 3.1 3.9 8.7 1.6 20.0 8.2 21.6 2.4 4.9 2.4 8.4 2.9 2.9 4.1 7.7 3.2 3.9 81.7 4.7 4.4 4.2 3.1 9.5 1.4 2.3 1.2 2.9 6.1 1.4 2.2 3.9 4.5 1.8 35.7 50.8 1.4 7.4 5.7 0.0 849.8 0.0 75.0 127.4 31.4 0.0 0.5 38.1 0.0 0.3 1.5 0.0 23.3 0.0 0.6 7.1 3.3 51.1 1.9 0.5 0.0 0.0 0.6 0.6 0.6 2.3 14.5 3.3 0.0 0.0 0.0 0.0 0.0 0.4 4.9 0.0 0.0 4.7 0.3 2.0 3.9 0.2 1.0 0.0 3.7 MTRNR2L8 ENSG00000255823 "MT-RNR2-like 8" P0CJ75 11 10507887-10509189 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "blood: 329.5;skeletal muscle: 107.4" "Cell type enriched" "Detected in many" 28 "Cardiomyocytes: 28256.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 89.7;eosinophil: 97.5;neutrophil: 329.5" "Lineage enriched" "Detected in all" 8 "granulocytes: 329.5" "Cell line enhanced" "Detected in many" "HeLa: 192.6;Hep G2: 140.8" "Secreted to blood" NA NA "unprognostic (6.19e-2)" "unprognostic (1.43e-1)" "unprognostic (6.66e-2)" "unprognostic (3.26e-2)" "unprognostic (3.71e-2)" "unprognostic (3.52e-2)" "unprognostic (2.81e-2)" "unprognostic (3.45e-2)" "unprognostic (5.28e-2)" "unprognostic (1.41e-1)" "unprognostic (4.87e-2)" "unprognostic (1.90e-1)" "unprognostic (4.59e-2)" "unprognostic (4.59e-2)" "unprognostic (3.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.96e-2)" 35.7 33.4 22.5 4.2 22.8 6.6 4.3 7.3 17.5 6.5 15.6 3.6 19.3 10.2 3.8 6.1 12.7 4.6 14.1 73.2 20.1 14.7 30.7 21.7 6.3 4.0 22.0 7.3 7.0 10.9 1.9 6.9 7.0 9.0 7.7 15.5 3.3 12.3 14.8 107.4 12.0 12.9 8.8 16.1 9.7 10.2 28.4 6.5 2.2 4.4 32.3 4.3 10.0 5.8 35.3 24.5 329.5 42.7 16.6 19.0 36.2 30.8 55.6 21.8 97.9 21.9 12.0 30.1 29.2 4.3 4.1 5.2 33.8 47.5 43.4 34.3 6.3 3.2 87.4 0.6 6.6 4.4 18.4 48.1 40.4 192.6 140.8 8.5 7.4 39.0 21.3 10.4 3.3 10.0 43.4 4.0 24.4 34.1 22.6 12.6 19.7 11.3 55.8 7.2 14.6 15.5 19.5 18.7 20.8 24.9 31.3 12.3 28.0 14.6 21.4 44.5 21.4 25.1 56.1 26.1 28.8 25.6 30.4 11.4 12.7 6.0 23.0 18.9 66.2 6.9 89.7 42.7 97.5 11.6 21.0 14.3 33.7 14.8 13.0 16.3 35.3 19.0 17.5 329.5 16.6 20.1 24.5 14.9 36.2 22.5 22.8 7.3 16.7 20.1 14.7 22.0 7.3 9.0 6.5 771.2 760.8 62.0 993.3 419.0 0.0 28256.5 137.6 867.3 881.5 54.1 0.0 5.8 61.3 0.0 12.2 397.4 0.0 140.2 0.0 5.0 628.6 627.3 501.1 277.9 11.0 0.0 0.0 103.2 108.7 41.9 60.7 803.5 686.7 0.0 0.3 0.0 0.1 0.0 42.1 73.2 0.0 64.7 701.4 22.4 27.9 427.3 9.4 68.2 0.6 948.0 NELL2 NRP2 ENSG00000184613 "Neural EGFL like 2" Q99435 12 44508275-44921848 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 36.8;brain: 73.3;fallopian tube: 35.1" "Group enriched" "Detected in many" 6 "Bipolar cells: 38.4;Ciliated cells: 40.2;Club cells: 11.4;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 43.8" "Cancer enhanced" "Detected in many" "thyroid cancer: 33.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 24.5;naive CD8 T-cell: 36.8" "Lineage enriched" "Detected in many" 11 "T-cells: 36.8" "Cell line enhanced" "Detected in some" "AF22: 41.8;HEK 293: 10.9;NTERA-2: 16.4;SCLC-21H: 30.4;U-266/70: 11.1;U-266/84: 11.1;U-698: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035714, HPA035715" Uncertain Approved Vesicles "Secreted to blood" NA NA 4700000 Vesicles "HPA035714: AB_2674746, HPA035715: AB_10669602" "unprognostic (4.25e-3)" "unprognostic (4.27e-2)" "unprognostic (1.06e-1)" "unprognostic (3.10e-2)" "unprognostic (3.01e-2)" "unprognostic (7.18e-2)" "unprognostic (5.85e-2)" "unprognostic (2.59e-2)" "unprognostic (4.85e-2)" "unprognostic (2.80e-1)" "prognostic favorable (5.56e-4)" "unprognostic (1.19e-1)" "unprognostic (1.71e-5)" "unprognostic (8.45e-2)" "unprognostic (2.92e-1)" "unprognostic (3.60e-3)" "unprognostic (3.75e-2)" 2.0 10.5 22.4 6.1 24.8 4.2 1.6 15.7 73.3 14.9 2.9 3.6 0.0 15.3 1.9 0.8 1.3 35.1 1.7 0.8 40.2 20.4 1.2 1.1 3.4 11.2 6.6 27.0 1.0 1.1 0.6 18.4 0.8 7.5 18.8 1.8 9.3 1.5 1.8 0.7 5.0 8.6 2.2 2.6 3.8 2.1 2.2 2.4 0.4 4.4 0.0 9.1 2.3 2.0 0.0 0.0 0.1 0.0 3.3 36.8 8.5 0.1 0.0 41.8 1.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.2 5.0 0.0 0.0 0.1 9.9 0.0 0.0 0.0 10.9 0.1 3.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.1 0.0 0.1 16.4 0.0 5.4 0.0 5.0 0.0 0.0 0.0 30.4 0.7 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.2 1.5 0.0 0.7 11.1 11.1 15.1 0.1 0.1 0.2 0.0 0.0 0.0 1.6 0.0 8.5 0.0 10.3 18.1 0.0 0.0 24.5 36.8 0.1 3.3 0.0 0.0 0.1 8.5 22.4 24.8 15.7 50.4 40.2 20.4 6.6 27.0 7.5 2.4 0.0 2.2 0.0 0.0 1.0 38.4 0.4 0.0 40.2 11.4 0.0 31.4 0.1 0.0 0.0 0.2 0.5 5.4 0.0 0.2 0.2 1.4 0.2 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 5.2 0.3 0.0 0.4 0.1 43.8 0.0 1.4 1.5 3.4 1.0 0.1 5.3 0.6 0.0 NMB "MGC17211, MGC2277, MGC3936" ENSG00000197696 "Neuromedin B" P08949 15 84655129-84658563 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adipose tissue: 37.2;brain: 28.5;breast: 59.9" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 91.4" "Cancer enhanced" "Detected in all" "glioma: 93.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 28.0" "Region enriched" "Detected in many" 16 "olfactory region: 206.6" "Group enriched" "Detected in many" 6 "olfactory region: 80.6;pons and medulla: 17.5" CAB019302 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Secreted to blood" NA NA "Nucleoplasm, Vesicles" "Plasma membrane" "CAB019302: " "unprognostic (2.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.34e-3)" "unprognostic (3.79e-1)" "prognostic favorable (3.43e-4)" "unprognostic (3.81e-1)" "unprognostic (6.45e-2)" "unprognostic (1.45e-2)" "unprognostic (2.17e-1)" "unprognostic (4.36e-1)" "unprognostic (7.24e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.25e-4)" "unprognostic (7.92e-3)" "unprognostic (1.45e-1)" "unprognostic (1.71e-2)" "unprognostic (1.00e-1)" 37.2 8.0 4.6 2.8 7.5 3.3 59.9 2.4 28.5 4.0 6.5 13.7 1.0 2.3 3.1 3.2 2.5 5.0 4.5 7.0 7.0 12.2 4.4 1.9 3.8 3.6 6.6 3.5 3.4 3.3 2.7 4.2 1.4 5.6 1.9 2.1 2.6 4.6 1.8 2.0 1.8 1.4 2.9 9.9 2.0 2.5 6.4 4.8 2.2 8.9 4.9 1.9 4.7 8.5 7.0 10.4 5.9 0.8 1.3 6.4 2.6 28.0 10.7 2.0 0.4 5.5 2.5 0.2 1.7 3.3 3.8 5.2 3.7 7.7 1.2 4.5 4.4 0.0 5.0 10.7 2.2 2.2 10.5 13.5 4.3 4.2 17.4 1.4 2.9 4.7 2.5 0.9 5.9 2.3 2.5 5.5 7.7 0.0 0.4 2.1 16.4 2.7 9.5 7.9 5.9 3.1 8.4 0.0 12.4 3.6 2.2 1.1 12.2 2.8 1.6 12.7 2.1 1.9 11.2 1.4 0.7 3.7 3.5 2.7 0.2 3.0 2.6 8.7 16.2 4.5 0.0 0.8 5.9 6.3 0.6 2.3 4.9 5.0 6.4 3.5 7.0 4.8 3.6 1.2 1.3 0.3 10.4 5.6 2.6 4.6 7.5 2.4 8.5 7.0 12.2 6.6 3.5 5.6 4.8 3.0 2.4 14.3 22.9 13.9 1.6 2.2 7.6 10.7 7.9 29.6 0.0 1.7 11.6 91.4 24.0 11.3 1.7 0.0 50.2 7.5 17.3 30.7 5.7 2.9 30.9 4.8 17.9 4.9 4.8 7.5 4.0 28.4 32.1 29.7 4.9 7.0 39.2 7.0 3.5 22.5 2.3 12.9 29.9 11.1 21.2 11.2 2.6 11.4 8.0 39.6 NPTX2 ENSG00000106236 "Neuronal pentraxin 2" P47972 7 98617297-98629868 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 24.0;brain: 45.6;pancreas: 19.5;pituitary gland: 71.6;testis: 20.7" "Group enriched" "Detected in many" 6 "Peritubular cells: 306.6;Sertoli cells: 148.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 16 "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 16 "dendritic cells: 1.5" "Cell line enriched" "Detected in some" 12 "LHCN-M2: 128.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB020801, HPA049799, HPA058320" Enhanced Approved "Golgi apparatus,Actin filaments,Centrosome" "Secreted to blood" NA NA 2490000 320000 "Golgi apparatus, Actin filaments" Centrosome "CAB020801: , HPA049799: AB_2680889, HPA058320: AB_2732621" "unprognostic (1.18e-1)" "unprognostic (9.61e-2)" "unprognostic (1.56e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (1.91e-3)" "unprognostic (9.20e-2)" "unprognostic (2.42e-2)" "unprognostic (6.04e-3)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (7.64e-2)" "unprognostic (2.35e-1)" "prognostic unfavorable (5.46e-9)" "unprognostic (1.06e-2)" "unprognostic (1.21e-1)" "unprognostic (5.33e-2)" "unprognostic (3.69e-2)" 4.3 24.0 7.1 2.3 8.4 1.0 1.4 0.2 45.6 8.2 3.8 3.2 0.1 1.1 1.8 3.9 2.2 1.5 1.6 3.2 9.2 11.0 0.9 0.9 0.8 0.7 9.4 2.2 1.5 19.5 0.8 71.6 0.8 7.0 2.1 1.4 1.3 1.5 2.2 2.9 4.0 1.3 2.9 2.9 6.1 1.9 20.7 5.0 0.0 1.6 0.1 0.9 1.4 2.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.4 0.2 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.7 0.0 0.9 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 6.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 7.1 8.4 0.2 24.6 9.2 11.0 9.4 2.2 7.0 5.0 0.0 1.1 0.0 0.4 3.4 17.7 2.8 5.1 0.0 2.3 0.0 3.9 0.0 0.0 5.8 9.7 2.9 2.4 0.0 11.0 0.2 6.2 3.2 0.0 0.2 0.4 0.0 15.3 6.2 0.0 19.9 13.0 0.0 11.8 0.0 0.0 0.8 4.7 0.0 306.6 0.0 2.4 148.8 3.8 14.0 40.1 2.6 0.1 0.0 0.4 0.5 NUCB2 NEFA ENSG00000070081 "Nucleobindin 2" 11 17208153-17349980 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 160.3" "Cell type enhanced" "Detected in all" 8 "Ciliated cells: 702.6;Early spermatids: 595.9;Syncytiotrophoblasts: 968.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 188.9" "Low region specificity" "Detected in many" "HPA008395, CAB015931, CAB079781" Enhanced Supported Enhanced "Golgi apparatus" "Secreted to blood" NA NA 1250000 "Golgi apparatus" "CAB015931: , CAB079781: AB_2313672, HPA008395: AB_1854683" "unprognostic (2.49e-1)" "unprognostic (1.75e-2)" "unprognostic (1.39e-1)" "prognostic favorable (8.27e-6)" "unprognostic (5.24e-3)" "unprognostic (2.51e-1)" "unprognostic (3.96e-3)" "unprognostic (3.66e-3)" "unprognostic (1.81e-1)" "prognostic favorable (1.98e-4)" "unprognostic (1.46e-2)" "unprognostic (3.38e-2)" "prognostic unfavorable (3.94e-5)" "unprognostic (2.39e-1)" "unprognostic (1.61e-1)" "unprognostic (4.78e-2)" "unprognostic (8.02e-3)" 10.2 13.9 9.5 7.5 13.1 66.4 17.9 13.5 7.5 18.3 7.8 3.8 79.5 6.6 11.4 59.6 29.7 13.7 7.3 25.0 7.5 10.9 10.8 51.1 12.5 13.5 8.5 7.6 15.4 92.8 58.9 69.7 35.8 10.3 13.4 8.3 5.8 160.3 104.9 7.2 4.2 6.8 11.3 9.4 9.8 11.4 18.7 6.1 86.1 22.7 17.7 10.4 12.1 11.0 3.7 71.7 28.8 7.6 45.2 49.5 20.1 12.2 5.1 5.7 17.2 12.9 17.8 6.9 27.4 40.0 12.3 21.8 5.0 2.8 18.9 6.9 26.0 11.5 5.3 3.6 6.9 19.3 13.0 8.0 13.9 6.4 8.7 37.3 188.9 25.6 7.7 9.2 8.8 21.6 30.7 15.0 71.0 12.0 38.3 12.1 10.8 66.5 68.3 1.3 20.0 5.4 24.6 13.9 1.5 5.5 3.9 6.8 3.8 12.0 12.1 6.1 8.7 9.9 51.4 13.4 13.1 12.1 39.5 11.5 7.5 4.1 10.4 15.1 66.8 11.1 28.8 7.6 27.6 17.1 5.0 22.3 3.7 16.3 31.5 6.9 2.4 46.0 49.5 7.0 45.2 4.0 71.7 7.0 20.1 9.5 13.1 13.5 7.5 7.5 10.9 8.5 7.6 10.3 6.1 41.7 59.0 14.1 53.1 24.5 64.5 145.2 50.9 702.6 152.4 40.1 51.1 105.9 23.2 65.4 595.9 97.2 5.4 23.3 116.0 281.9 179.4 156.8 63.8 119.0 65.3 33.4 40.7 105.0 27.2 377.7 138.7 39.7 65.8 11.8 82.2 101.2 103.6 8.6 107.5 16.5 80.2 45.3 51.5 125.6 53.1 26.3 968.6 104.6 35.5 54.9 OIT3 "FLJ39116, LZP" ENSG00000138315 "Oncoprotein induced transcript 3" Q8WWZ8 10 72893581-72933033 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "liver: 49.1" "Cell type enriched" "Detected in some" 10 "Ito cells: 487.3" "Cancer enhanced" "Detected in many" "liver cancer: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 5.8;Hep G2: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted to blood" NA NA 150000000 "unprognostic (2.42e-2)" "unprognostic (6.76e-2)" "unprognostic (7.98e-4)" "unprognostic (9.26e-2)" "unprognostic (9.47e-4)" "unprognostic (3.05e-1)" "unprognostic (4.33e-2)" "unprognostic (1.99e-2)" "unprognostic (1.00e-1)" "unprognostic (1.11e-1)" "unprognostic (8.50e-3)" "unprognostic (1.41e-1)" "unprognostic (4.11e-2)" "unprognostic (1.35e-1)" "unprognostic (2.44e-1)" "unprognostic (3.68e-3)" "unprognostic (1.19e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.1 0.1 0.1 0.1 2.2 0.1 0.1 0.3 0.0 0.1 2.0 0.1 0.0 0.6 49.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 2.5 0.1 0.1 6.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.3 0.3 0.0 0.1 0.0 0.0 0.0 5.8 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.4 0.3 6.1 0.2 0.2 0.1 0.4 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 487.3 50.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 PINLYP ENSG00000234465 "Phospholipase A2 inhibitor and LY6/PLAUR domain containing" A6NC86 19 43576800-43583964 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 19.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 17.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 33.8;HMC-1: 22.6;JURKAT: 17.5;REH: 13.7;THP-1: 17.0" HPA061218 Uncertain Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA061218: AB_2684453" "unprognostic (6.72e-2)" "unprognostic (6.21e-2)" "unprognostic (4.72e-1)" "unprognostic (3.13e-2)" "unprognostic (2.46e-3)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (1.22e-2)" "unprognostic (5.07e-2)" "unprognostic (2.00e-1)" "unprognostic (2.85e-2)" "unprognostic (1.14e-1)" "unprognostic (4.36e-3)" "unprognostic (1.95e-2)" "unprognostic (1.68e-1)" "unprognostic (1.08e-1)" "unprognostic (3.60e-2)" 3.6 2.0 5.6 1.8 6.5 1.2 4.0 3.7 2.5 7.4 3.9 0.6 6.8 7.1 5.0 13.1 6.6 4.2 4.4 4.6 7.9 0.3 2.9 2.9 4.2 13.1 0.6 0.0 5.6 1.6 4.5 2.0 2.3 8.1 0.0 2.0 1.7 8.3 2.9 3.0 2.1 1.8 4.0 3.3 2.7 4.4 3.2 17.4 6.6 1.2 0.9 3.3 1.5 0.3 0.1 0.9 0.0 1.6 2.2 0.1 0.4 0.6 0.8 2.1 0.0 0.0 0.0 0.1 8.9 0.8 2.0 0.0 0.0 0.8 0.0 0.1 33.8 0.3 0.0 5.1 0.0 22.6 5.0 0.3 5.1 0.0 2.4 1.4 17.5 0.4 0.4 0.3 0.2 4.0 0.5 0.8 0.0 0.3 13.7 0.1 0.0 0.4 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 17.0 0.6 2.2 0.4 0.0 1.5 0.0 0.0 2.0 7.8 0.0 0.1 6.6 1.2 0.5 2.6 0.8 3.2 1.4 0.8 2.1 1.8 3.2 0.2 3.3 0.0 0.9 0.2 17.4 1.6 1.5 11.9 2.7 1.3 8.9 3.2 5.6 2.2 12.7 17.4 7.9 8.7 5.9 0.4 19.9 1.0 4.7 4.5 0.0 0.0 0.3 0.4 6.7 3.3 0.0 0.0 4.1 6.4 0.0 6.2 0.6 4.2 10.6 1.8 5.0 5.4 0.5 5.5 0.3 0.0 9.2 14.0 3.4 0.0 5.1 2.6 0.9 2.8 0.1 0.0 0.4 6.4 PLA2G12B PLA2G13 ENSG00000138308 "Phospholipase A2 group XIIB" Q9BX93 10 72935170-72954778 "Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 47.8;liver: 42.8" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 47.8" "Cancer enriched" "Detected in many" 8 "liver cancer: 35.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "CACO-2: 12.1;Hep G2: 20.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA057745, HPA059562" Approved "Secreted to blood" NA NA "HPA057745: AB_2683514, HPA059562: AB_2684064" "unprognostic (1.11e-2)" "unprognostic (2.66e-2)" "unprognostic (2.02e-3)" "unprognostic (3.41e-1)" "unprognostic (1.68e-1)" "unprognostic (1.89e-1)" "unprognostic (1.26e-1)" "unprognostic (3.14e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 25.6 0.0 0.0 15.4 0.1 0.3 0.1 0.1 0.0 3.5 0.1 0.1 8.0 42.8 0.9 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.7 0.1 0.1 0.0 0.1 0.1 47.8 0.0 0.1 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 20.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 2.6 0.9 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 47.8 0.0 0.0 0.0 1.8 0.6 0.5 0.0 0.0 0.0 0.0 0.1 0.3 0.0 2.9 0.0 9.8 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 PLGLB1 "PLGL, PRP-B" ENSG00000183281 "Plasminogen-like B1" Q02325 2 87002559-87021852 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in many" 5 "liver: 66.8" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 67.6" "Cancer enriched" "Detected in single" 7 "liver cancer: 0.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Secreted to blood" NA NA "unprognostic (7.25e-2)" "unprognostic (7.25e-2)" "unprognostic (2.35e-1)" "unprognostic (1.15e-1)" "unprognostic (1.75e-2)" "unprognostic (1.39e-5)" "unprognostic (7.04e-3)" "unprognostic (1.15e-1)" "unprognostic (8.53e-4)" "unprognostic (1.60e-1)" "unprognostic (4.56e-4)" "unprognostic (9.90e-3)" "unprognostic (2.96e-5)" "unprognostic (1.02e-1)" "unprognostic (1.16e-1)" "unprognostic (4.32e-2)" "unprognostic (3.98e-5)" 0.3 1.3 2.0 0.7 3.4 1.7 0.7 14.3 2.1 0.4 0.5 0.7 1.3 2.1 0.3 0.8 1.0 0.6 1.9 2.1 1.0 66.8 0.6 1.5 1.4 1.5 0.4 0.7 1.6 0.3 1.0 0.3 1.1 0.5 1.9 3.4 0.8 0.2 1.1 1.3 0.7 0.8 1.1 0.5 0.7 0.5 2.7 1.6 5.1 0.8 0.9 2.7 0.4 2.9 4.2 4.8 2.6 4.5 5.4 5.1 3.4 2.5 2.1 2.8 3.3 7.6 7.6 3.4 1.2 1.5 2.5 1.3 0.6 2.1 9.1 3.5 6.6 6.4 3.5 3.1 4.1 1.6 5.6 4.6 5.6 5.7 8.3 0.9 8.7 3.1 6.6 2.6 4.4 13.3 11.3 6.9 2.4 2.7 2.2 2.1 4.5 4.6 3.0 3.8 4.2 2.9 2.6 3.0 5.1 1.2 7.0 5.5 3.8 2.5 2.2 2.1 6.9 5.3 3.4 2.1 5.5 2.6 5.1 0.4 0.9 1.9 0.2 1.2 2.7 2.0 1.4 0.2 2.2 2.7 1.6 1.9 0.9 0.8 1.6 2.6 0.4 0.0 4.3 0.8 0.2 1.0 10.8 1.8 2.5 2.7 2.3 0.0 5.9 0.2 0.0 0.7 0.5 1.5 0.1 0.0 0.2 0.2 0.9 0.4 0.0 67.6 0.2 4.8 1.2 1.8 1.8 0.0 1.1 0.9 3.3 1.0 2.3 2.4 0.2 0.0 1.8 0.6 14.1 0.0 0.9 0.3 0.2 1.1 0.0 0.8 0.7 0.3 PLGLB2 PLGP1 ENSG00000125551 "Plasminogen-like B2" Q02325 2 87748087-87758793 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in some" 28 "liver: 105.2" "Cell type enriched" "Detected in some" 9 "Hepatocytes: 67.4" "Cancer enriched" "Detected in single" 25 "liver cancer: 1.2" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.7;T-reg: 3.7" "Lineage enriched" "Detected in single" 16 "T-cells: 3.7" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 6.1;U-266/84: 4.9" "Secreted to blood" NA NA "unprognostic (1.10e-2)" "unprognostic (8.78e-2)" "unprognostic (3.42e-2)" "unprognostic (7.03e-4)" "unprognostic (1.68e-2)" "unprognostic (3.77e-1)" "unprognostic (1.82e-2)" "unprognostic (5.74e-2)" "unprognostic (2.94e-1)" "unprognostic (5.04e-4)" "unprognostic (6.39e-2)" "unprognostic (4.06e-2)" "unprognostic (3.22e-2)" "unprognostic (7.11e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 105.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 3.7 0.2 0.0 1.3 4.3 1.4 0.0 1.3 0.0 3.7 2.2 0.6 2.5 0.0 1.4 2.7 2.6 0.5 0.1 1.0 0.5 0.0 0.8 0.0 1.1 0.9 3.2 0.0 0.3 0.6 0.5 0.0 0.0 0.3 0.4 6.1 0.5 2.6 0.3 0.0 0.9 0.0 2.5 0.0 0.0 0.4 0.0 2.4 0.0 0.0 4.3 0.3 0.0 3.2 0.8 1.0 0.1 0.6 0.2 1.7 0.0 0.0 1.9 0.9 1.3 2.8 4.9 0.4 1.5 0.0 1.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 2.7 0.8 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 3.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 7.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.4 0.1 0.0 0.0 1.3 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRADC1 "C2orf7, hPAP21, MGC13004, PAP21" ENSG00000135617 "Protease associated domain containing 1" Q9BSG0 2 73228006-73233238 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 59.4" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051066 Approved "Secreted to blood" NA NA "HPA051066: AB_2681333" "unprognostic (2.94e-1)" "unprognostic (1.93e-2)" "unprognostic (1.22e-1)" "unprognostic (1.12e-1)" "unprognostic (9.23e-2)" "unprognostic (3.93e-2)" "unprognostic (8.54e-2)" "unprognostic (9.08e-3)" "unprognostic (2.60e-2)" "unprognostic (1.73e-1)" "unprognostic (1.09e-3)" "unprognostic (9.99e-3)" "unprognostic (3.56e-2)" "unprognostic (2.96e-1)" "unprognostic (4.89e-1)" "unprognostic (1.93e-1)" "unprognostic (9.23e-2)" 10.3 12.0 11.6 5.6 13.9 4.2 22.5 9.3 13.3 6.2 12.3 6.7 6.6 13.6 4.5 9.5 9.1 4.1 6.4 37.3 10.6 7.7 11.8 23.3 6.4 14.4 10.6 7.3 3.9 39.7 4.8 8.3 4.7 10.9 6.6 12.0 6.9 25.6 8.7 59.4 6.7 16.2 13.1 9.6 8.5 8.7 9.6 7.0 4.1 7.8 22.2 5.8 7.5 5.7 6.2 25.6 11.6 33.8 13.3 10.5 15.0 8.2 7.0 7.0 13.4 22.0 8.6 9.3 13.8 6.5 14.2 8.2 19.5 8.8 9.1 8.0 16.1 12.8 7.8 11.1 9.6 10.1 13.7 10.0 13.7 10.0 14.6 6.8 7.2 13.7 11.1 5.9 12.7 6.8 4.1 13.1 16.6 11.9 20.0 16.2 17.5 20.0 13.7 2.1 39.3 28.2 11.6 27.3 28.6 7.9 8.1 14.6 4.8 6.6 18.3 6.4 7.9 9.7 6.5 6.8 16.5 6.5 14.1 12.4 21.0 15.8 8.2 10.6 15.9 6.7 4.1 12.3 11.6 9.1 28.9 7.4 6.1 8.9 8.5 12.7 6.2 8.4 7.4 1.6 13.3 33.8 25.6 10.5 15.0 11.6 13.9 9.3 13.3 10.6 7.7 10.6 7.3 10.9 7.0 8.9 5.8 9.3 10.2 13.9 13.7 52.0 15.3 6.7 5.7 14.0 7.9 22.4 61.3 20.8 39.5 14.7 47.7 0.0 40.8 39.3 23.7 7.9 28.8 55.1 42.8 11.1 31.0 30.7 18.1 109.7 15.5 14.2 15.1 1.0 41.5 20.9 19.4 28.1 15.2 56.4 20.4 32.3 14.7 23.2 19.6 21.0 11.3 11.3 48.1 8.2 PTX3 "TNFAIP5, TSG-14" ENSG00000163661 "Pentraxin 3" P26022 3 157436789-157443628 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 61.7;skeletal muscle: 67.7;urinary bladder: 77.0" "Cell type enhanced" "Detected in some" 10 "Ductal cells: 6.0;Fibroblasts: 10.1;Macrophages: 5.9;Melanocytes: 13.5" "Cancer enhanced" "Detected in many" "glioma: 22.5" "Group enriched" "Detected in some" 6 "hippocampal formation: 1.1;pons and medulla: 3.6" "Cell type enhanced" "Detected in some" "eosinophil: 3.2" "Group enriched" "Detected in many" 20 "dendritic cells: 1.3;granulocytes: 3.2;monocytes: 1.2" "Cell line enhanced" "Detected in many" "ASC diff: 86.4;ASC TERT1: 125.2;BJ hTERT+: 82.2;HHSteC: 160.8;HSkMC: 167.5;hTEC/SVTERT24-B: 88.5;TIME: 119.2;U-2197: 111.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA069320 Approved Approved "Plasma membrane" "Secreted to blood" NA NA 1090000 310000 "Plasma membrane" "HPA069320: AB_2686118" "unprognostic (1.93e-2)" "unprognostic (4.96e-3)" "unprognostic (1.35e-1)" "prognostic unfavorable (8.35e-9)" "unprognostic (5.79e-3)" "prognostic unfavorable (6.36e-4)" "unprognostic (6.03e-3)" "prognostic unfavorable (8.75e-6)" "unprognostic (2.45e-1)" "unprognostic (6.69e-2)" "unprognostic (7.60e-2)" "unprognostic (2.63e-1)" "unprognostic (2.76e-9)" "unprognostic (6.03e-3)" "unprognostic (5.98e-2)" "unprognostic (2.15e-4)" "unprognostic (1.92e-3)" 61.7 3.4 0.3 16.7 0.2 31.6 35.3 0.2 0.7 0.8 13.2 0.3 0.6 0.5 0.5 0.8 2.0 6.5 3.5 14.7 1.1 0.0 3.0 0.6 22.5 7.0 0.3 0.1 6.8 18.0 0.3 1.0 4.9 3.6 2.5 1.2 5.2 1.8 0.4 67.7 6.0 1.9 6.4 0.9 9.6 4.9 0.9 0.2 0.3 2.7 0.4 0.4 77.0 2.5 0.0 1.3 3.2 1.2 0.0 0.0 0.1 0.0 0.0 52.1 0.0 86.4 125.2 0.0 9.0 82.2 3.9 4.2 0.0 0.5 0.0 32.1 10.6 6.1 0.0 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 160.8 0.1 0.0 167.5 0.0 88.5 30.1 7.7 18.2 0.0 0.0 0.0 26.0 0.0 0.0 0.1 0.7 0.0 0.3 0.0 0.0 0.0 0.3 3.5 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.1 119.2 17.7 0.8 111.1 1.5 0.0 0.0 0.0 3.7 0.4 5.0 0.0 1.2 3.2 0.0 1.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.3 0.2 0.2 0.2 1.1 0.0 0.3 0.1 3.6 0.2 0.0 1.7 0.0 1.1 1.4 0.8 0.4 0.0 0.0 2.3 0.0 0.0 0.1 0.0 6.0 1.9 2.0 0.0 0.0 0.0 0.0 10.1 0.4 0.0 0.0 2.6 0.0 0.0 3.1 4.6 0.8 0.3 5.9 13.5 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.4 0.0 4.2 0.0 0.4 0.9 0.2 0.0 0.0 0.1 RSPRY1 KIAA1972 ENSG00000159579 "Ring finger and SPRY domain containing 1" Q96DX4 16 57186137-57240475 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 98.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003729 Approved "Secreted to blood" NA NA "HPA003729: AB_10964215" "unprognostic (2.73e-2)" "unprognostic (7.10e-2)" "unprognostic (1.32e-3)" "unprognostic (5.32e-2)" "unprognostic (1.63e-3)" "prognostic unfavorable (8.21e-5)" "unprognostic (6.84e-2)" "unprognostic (1.36e-1)" "unprognostic (4.63e-2)" "unprognostic (1.29e-1)" "unprognostic (2.26e-2)" "unprognostic (1.01e-1)" "unprognostic (4.89e-2)" "unprognostic (4.68e-2)" "unprognostic (3.35e-1)" "unprognostic (6.47e-2)" "unprognostic (4.81e-3)" 19.7 15.5 15.6 11.8 17.8 7.2 15.5 15.7 16.5 22.5 17.2 21.0 22.5 18.2 25.2 15.2 17.4 14.5 18.9 11.0 14.8 14.7 22.2 24.3 12.7 17.1 14.4 15.4 18.7 22.8 21.2 17.4 24.4 11.4 16.8 19.2 17.6 16.6 21.0 14.2 15.6 28.4 20.6 12.7 15.7 16.6 24.0 14.3 25.4 20.8 13.7 19.3 20.6 15.1 24.5 23.5 26.5 29.7 22.5 26.1 15.8 8.3 13.1 20.7 10.5 13.1 16.5 12.2 15.1 15.5 20.5 16.4 13.9 11.1 12.0 19.6 20.2 14.2 11.1 17.9 14.7 23.5 7.6 7.4 6.4 9.7 19.6 17.1 11.2 17.3 20.0 14.4 20.2 28.3 15.5 27.6 13.9 10.4 5.0 17.7 4.7 18.8 7.4 13.2 14.1 14.5 24.3 14.1 11.0 24.2 8.7 6.9 15.5 24.3 9.2 6.3 12.2 8.9 11.0 19.1 14.7 14.2 9.1 12.1 13.0 11.6 19.4 12.8 10.8 15.5 19.8 20.3 26.5 23.8 22.4 22.0 24.5 22.2 22.2 23.5 21.6 26.1 24.7 22.6 22.5 29.7 14.9 26.0 15.8 15.6 17.8 15.7 16.5 14.8 14.7 14.4 15.4 11.4 14.3 29.8 9.6 18.5 19.8 30.2 16.3 15.3 40.8 14.7 14.8 17.4 9.8 23.8 21.6 21.7 98.2 20.4 22.3 23.3 20.3 32.5 30.1 22.7 10.4 37.0 14.8 14.3 20.6 17.8 21.1 39.1 18.7 15.4 13.5 25.2 30.4 21.1 21.2 21.0 20.1 22.5 18.3 6.5 23.4 39.5 56.2 32.4 23.3 17.0 21.9 16.6 SCG2 "CHGC, SgII, SN" ENSG00000171951 "Secretogranin II" P13521 2 223596940-223602503 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adrenal gland: 133.0;brain: 94.1;pituitary gland: 76.5" "Group enriched" "Detected in some" 8 "Bipolar cells: 124.4;Intestinal endocrine cells: 272.8" "Group enriched" "Detected in many" 8 "glioma: 70.0;pancreatic cancer: 52.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 25.5;HSkMC: 21.8;hTERT-RPE1: 21.8;SCLC-21H: 22.2;SH-SY5Y: 9.7;WM-115: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011893, HPA075062" Enhanced Supported Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA 54000 "Golgi apparatus" Vesicles "HPA011893: AB_1856656, HPA075062: AB_2732277" "unprognostic (2.93e-2)" "unprognostic (1.44e-2)" "unprognostic (1.23e-3)" "unprognostic (6.82e-4)" "unprognostic (2.51e-2)" "unprognostic (1.13e-2)" "unprognostic (2.77e-3)" "unprognostic (6.73e-2)" "unprognostic (1.08e-1)" "unprognostic (4.69e-2)" "prognostic favorable (5.58e-4)" "unprognostic (1.34e-1)" "prognostic unfavorable (7.01e-10)" "unprognostic (2.47e-3)" "unprognostic (4.02e-1)" "unprognostic (1.57e-2)" "unprognostic (1.90e-3)" 3.5 133.0 13.3 11.0 94.1 0.9 0.9 5.6 55.9 1.4 5.4 5.8 0.0 17.3 2.1 0.9 1.0 0.8 2.2 1.4 10.5 79.4 1.0 0.8 1.9 0.9 21.7 11.0 1.3 10.7 1.1 76.5 1.1 57.7 2.1 5.5 1.5 0.9 1.3 0.8 1.0 8.0 5.2 10.3 0.8 8.0 0.9 5.0 0.0 3.1 0.0 0.8 1.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.8 4.0 1.1 25.5 0.1 0.2 0.9 1.8 4.7 0.2 0.4 0.0 0.4 0.3 2.9 0.1 0.1 0.0 2.4 0.0 0.2 0.0 0.2 0.0 0.3 0.3 2.1 21.8 0.1 2.7 0.9 21.8 0.0 0.0 0.1 0.2 2.3 0.1 0.0 0.1 3.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 22.2 9.7 0.0 0.2 1.1 0.8 0.0 0.0 0.0 2.5 1.0 0.1 1.6 0.0 0.0 0.1 0.7 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 13.3 94.1 5.6 23.0 10.5 79.4 21.7 11.0 57.7 5.0 6.0 0.0 0.0 0.2 0.0 124.4 0.2 0.0 1.4 2.3 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.2 2.9 0.0 0.0 0.1 7.9 272.8 1.3 0.8 0.0 0.6 0.0 1.7 0.0 0.7 11.9 24.2 2.9 0.4 0.0 12.7 0.0 0.5 0.1 0.2 0.1 0.1 0.0 0.3 0.6 SCUBE1 ENSG00000159307 "Signal peptide, CUB domain and EGF like domain containing 1" Q8IWY4 22 43197283-43343388 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 35.8;retina: 48.1" "Cell type enriched" "Detected in many" 5 "Peritubular cells: 42.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.4" "Group enriched" "Detected in some" 4 "HMC-1: 32.9;THP-1: 13.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003190 Approved "Secreted to blood" NA NA 2170000 130000 "HPA003190: AB_1079882" "unprognostic (5.29e-2)" "unprognostic (7.15e-6)" "unprognostic (6.03e-3)" "unprognostic (8.33e-2)" "unprognostic (3.65e-1)" "unprognostic (4.55e-2)" "unprognostic (1.34e-1)" "unprognostic (5.76e-2)" "unprognostic (1.10e-1)" "unprognostic (1.99e-1)" "unprognostic (3.74e-2)" "unprognostic (1.22e-1)" "unprognostic (1.23e-2)" "unprognostic (1.02e-2)" "unprognostic (2.70e-1)" "unprognostic (2.30e-1)" "unprognostic (6.87e-3)" 3.3 5.3 0.4 1.1 2.0 0.1 3.5 0.3 2.3 1.3 5.5 0.9 1.3 5.9 1.3 0.7 14.8 1.2 0.8 1.0 0.5 0.7 3.4 4.6 7.5 0.1 3.4 1.9 35.8 0.4 0.3 3.8 3.5 1.9 6.4 2.0 48.1 5.3 0.5 8.0 0.6 7.6 1.0 3.5 6.9 7.3 8.5 0.1 0.0 3.1 0.5 0.1 4.2 6.3 0.3 0.3 2.4 0.3 0.5 0.3 0.1 0.0 0.0 1.4 5.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.1 0.1 32.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.8 0.0 0.1 0.0 0.2 0.0 13.0 0.0 0.2 0.1 0.4 0.0 1.4 2.5 0.0 0.3 0.0 0.1 2.4 0.2 0.3 0.2 0.3 0.3 0.3 0.3 0.2 0.1 0.3 0.3 0.3 1.0 0.5 0.3 0.3 0.2 0.1 0.4 2.0 0.3 2.3 0.5 0.7 3.4 1.9 1.9 0.1 8.9 1.7 0.0 0.0 0.2 0.0 1.1 0.0 1.4 1.2 0.0 0.0 0.1 1.7 0.0 2.3 0.6 0.0 0.0 0.0 8.9 0.9 0.0 1.1 1.1 0.7 0.0 0.0 0.6 0.0 2.6 7.2 0.0 0.0 0.0 0.0 5.2 0.1 0.0 42.8 0.1 0.2 0.0 0.0 3.0 1.5 0.1 0.3 0.0 0.0 0.0 SCUBE3 "CEGF3, FLJ34743" ENSG00000146197 "Signal peptide, CUB domain and EGF like domain containing 3" Q8IX30 6 35214419-35253079 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 38.0" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 9.5;Intestinal endocrine cells: 10.4;Rod photoreceptor cells: 6.1" "Cancer enhanced" "Detected in many" "thyroid cancer: 9.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 10.6;ASC diff: 32.4;ASC TERT1: 43.5;HSkMC: 20.3;hTEC/SVTERT24-B: 12.4;U-138 MG: 12.1;WM-115: 10.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040606 Uncertain Approved "Plasma membrane" "Secreted to blood" NA NA 1890000 110000 "Plasma membrane" "HPA040606: AB_10795383" "unprognostic (1.45e-1)" "unprognostic (1.79e-2)" "unprognostic (2.22e-1)" "unprognostic (2.41e-3)" "unprognostic (1.52e-1)" "unprognostic (1.27e-1)" "unprognostic (4.43e-2)" "unprognostic (5.01e-2)" "unprognostic (2.00e-2)" "unprognostic (7.41e-2)" "unprognostic (1.57e-1)" "unprognostic (2.64e-2)" "unprognostic (4.83e-8)" "unprognostic (1.54e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (1.38e-4)" "unprognostic (3.06e-3)" 1.6 2.6 0.5 1.1 0.4 0.2 0.3 0.3 0.7 1.6 3.3 0.0 2.8 0.2 1.3 7.0 1.5 0.7 0.7 6.4 0.3 0.5 2.3 0.2 1.3 0.2 0.4 0.6 0.9 0.2 0.3 1.6 0.9 0.6 7.0 1.1 6.8 1.1 5.3 0.8 0.7 0.8 13.8 0.6 0.3 1.2 1.7 0.0 0.0 38.0 0.3 0.3 11.4 2.5 1.1 1.6 2.5 0.7 1.1 1.1 0.1 0.0 0.0 10.6 0.1 32.4 43.5 0.1 2.6 1.3 0.0 0.0 0.2 0.0 0.0 0.4 6.2 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 20.3 0.0 12.4 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.3 0.7 4.4 0.2 0.0 0.6 12.1 0.5 0.0 0.1 0.0 0.0 0.0 1.9 0.0 10.2 1.4 0.7 1.3 1.1 0.5 0.3 0.8 0.7 0.3 0.1 1.1 0.8 0.8 2.5 1.1 0.5 1.6 0.8 0.1 0.5 0.4 0.3 0.7 0.3 0.5 0.4 0.6 0.6 0.0 0.0 1.1 0.0 0.2 0.0 2.5 3.3 0.0 1.4 3.4 1.8 2.0 0.8 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.2 1.0 0.1 1.1 0.0 0.3 9.5 10.4 0.0 1.2 2.2 0.9 0.0 1.7 0.0 0.0 2.0 0.1 0.0 3.5 0.0 6.1 0.0 4.7 0.2 1.9 0.0 0.6 0.0 0.0 0.1 SDC1 "CD138, SDC, SYND1, syndecan" ENSG00000115884 "Syndecan 1" P18827 2 20200797-20225433 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 113.2;placenta: 228.8" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 298.1;Hepatocytes: 520.4;Urothelial cells: 356.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 17 "memory B-cell: 3.9" "Lineage enriched" "Detected in single" 40 "B-cells: 3.9" "Cell line enhanced" "Detected in many" "HBEC3-KT: 62.1;hTCEpi: 57.5;U-251 MG: 59.2;U-266/70: 61.4;U-266/84: 129.2" "Group enriched" "Detected in some" 4 "cerebellum: 10.7;olfactory region: 5.9" "Not detected" "Not detected" "CAB002424, HPA006185, HPA067477" Enhanced Approved "Focal adhesion sites" "Secreted to blood" NA NA 63100000 1600000 "Focal adhesion sites" "CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: " "prognostic unfavorable (2.22e-4)" "unprognostic (6.80e-3)" "unprognostic (6.80e-2)" "unprognostic (7.84e-2)" "prognostic unfavorable (5.02e-4)" "unprognostic (1.15e-1)" "unprognostic (4.02e-2)" "unprognostic (6.32e-2)" "unprognostic (1.70e-1)" "unprognostic (3.66e-1)" "unprognostic (2.27e-3)" "unprognostic (1.79e-1)" "unprognostic (1.63e-1)" "unprognostic (1.94e-2)" "unprognostic (4.27e-1)" "unprognostic (1.62e-2)" "unprognostic (1.52e-1)" 0.8 3.4 0.5 5.4 0.6 0.0 4.5 0.8 0.7 21.4 18.3 0.5 3.5 14.3 2.3 8.7 103.7 1.6 55.3 0.3 0.4 0.5 68.5 113.2 15.8 6.3 1.9 0.4 1.6 7.0 0.6 0.6 228.8 0.7 13.3 6.2 1.5 16.0 5.2 0.5 69.5 21.9 4.3 0.4 3.7 16.3 2.6 0.4 1.5 3.5 62.3 48.4 30.0 37.7 3.9 0.0 0.0 0.0 0.0 0.0 0.5 31.4 17.6 5.6 14.0 1.5 0.2 17.7 8.8 8.5 8.2 7.0 3.7 19.2 0.0 3.2 6.2 4.5 31.1 2.4 62.1 5.5 0.1 1.6 0.0 1.6 18.8 1.3 1.3 0.1 0.8 57.5 7.4 17.6 11.5 0.9 0.0 0.7 12.3 4.4 18.8 0.0 0.3 5.0 24.0 34.2 0.6 2.0 23.8 10.6 47.2 1.6 13.1 6.6 44.8 2.0 2.3 4.4 0.3 1.3 32.7 10.5 1.2 59.2 61.4 129.2 0.1 9.8 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.6 0.8 0.7 0.4 0.5 1.9 0.4 0.7 0.4 86.4 91.4 3.0 135.6 101.2 0.1 0.8 298.1 2.7 63.7 40.1 0.0 2.4 26.6 54.9 0.0 1.1 102.7 23.3 19.0 43.0 9.7 42.4 5.8 520.4 2.2 20.6 10.4 6.7 9.6 0.0 0.6 5.4 20.3 1.0 72.0 0.0 67.3 73.7 1.1 68.3 0.0 0.0 7.1 0.7 12.8 200.1 209.7 4.4 66.5 356.0 SDC4 "amphiglycan, ryudocan, SYND4" ENSG00000124145 "Syndecan 4" P31431 20 45325288-45348424 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 141.1" "Cell type enhanced" "Detected in many" 4 "Exocrine glandular cells: 450.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 75.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005716, CAB013240" Enhanced Approved "Golgi apparatus,Plasma membrane" "Secreted to blood" NA NA "Golgi apparatus" "Plasma membrane" "CAB013240: AB_2533250, HPA005716: AB_1080160" "unprognostic (1.34e-2)" "unprognostic (1.80e-1)" "unprognostic (1.71e-2)" "unprognostic (2.16e-1)" "unprognostic (5.39e-2)" "unprognostic (6.59e-3)" "unprognostic (1.16e-1)" "unprognostic (5.93e-2)" "unprognostic (2.68e-1)" "unprognostic (2.95e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (1.97e-1)" "prognostic favorable (2.44e-7)" "unprognostic (3.00e-1)" "unprognostic (2.18e-1)" "prognostic favorable (2.67e-4)" "unprognostic (7.42e-2)" 15.9 26.2 19.9 15.7 24.3 3.5 40.5 6.9 20.1 20.4 24.8 19.2 9.0 13.3 17.6 14.7 42.4 27.4 26.2 19.5 19.8 12.1 56.6 141.1 56.7 4.8 23.5 20.5 14.7 36.6 6.2 12.5 23.0 30.9 19.5 22.3 21.8 47.6 17.5 25.5 45.5 13.8 38.7 23.0 9.0 46.9 33.7 15.7 2.0 26.5 25.2 23.5 34.4 16.4 0.7 2.8 2.0 3.1 1.4 8.1 1.2 23.0 3.0 1.6 0.1 41.2 25.4 71.1 29.5 40.3 33.5 24.0 35.1 58.9 0.0 13.2 37.1 33.8 30.0 1.2 75.0 40.8 6.6 1.1 0.7 2.4 13.7 44.9 0.1 1.2 34.1 50.4 13.8 33.8 18.6 4.4 0.5 1.1 0.0 19.2 22.9 0.0 2.0 3.0 20.1 9.3 0.0 14.9 0.0 55.0 30.8 0.6 2.3 40.6 25.2 7.2 19.6 18.2 1.4 8.2 25.6 21.3 2.5 19.0 1.2 0.9 0.1 40.2 2.3 15.2 2.0 3.1 0.7 1.3 1.1 4.1 0.6 4.1 1.6 2.8 0.7 0.9 1.1 1.6 1.4 1.1 2.5 8.1 1.2 19.9 24.3 6.9 20.1 19.8 12.1 23.5 20.5 30.9 15.7 271.0 364.7 7.8 299.2 332.0 10.3 49.5 201.2 113.8 195.7 179.7 11.8 27.4 54.7 239.6 0.5 9.0 87.8 0.0 450.4 202.4 50.9 254.2 12.8 232.3 18.5 0.0 52.9 14.7 15.1 2.9 3.7 36.5 72.6 56.9 103.4 8.5 443.3 93.4 4.9 128.2 23.3 0.0 42.6 0.9 2.8 413.3 56.3 18.8 79.5 364.0 SELENOP "SELP, SeP, SEPP, SEPP1" ENSG00000250722 "Selenoprotein P" P49908 5 42799880-42887392 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 248.3;liver: 403.8" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 416.9;Alveolar cells type 2: 429.0;Hofbauer cells: 658.5;Proximal tubular cells: 719.9" "Cancer enhanced" "Detected in all" "liver cancer: 116.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Hep G2: 92.9;HSkMC: 81.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036287 Approved Uncertain "Nucleoplasm,Golgi apparatus" "Secreted to blood" NA NA 2220000000 2300000000 "Nucleoplasm, Golgi apparatus" "HPA036287: AB_10794618" "unprognostic (7.96e-2)" "unprognostic (2.10e-1)" "unprognostic (4.28e-3)" "unprognostic (1.19e-3)" "unprognostic (6.67e-2)" "unprognostic (6.37e-2)" "unprognostic (9.22e-2)" "unprognostic (2.19e-2)" "unprognostic (1.44e-2)" "unprognostic (2.88e-1)" "unprognostic (2.07e-2)" "unprognostic (1.05e-1)" "prognostic favorable (6.97e-6)" "unprognostic (1.35e-2)" "unprognostic (4.19e-2)" "unprognostic (2.89e-1)" "unprognostic (1.42e-1)" 53.8 31.4 17.5 13.5 54.6 2.2 41.1 11.9 24.0 34.9 56.8 52.8 24.2 40.9 22.3 39.0 20.5 26.2 44.4 26.6 27.6 17.5 57.5 403.8 55.0 30.4 106.2 16.1 49.1 15.3 18.2 21.4 62.7 63.6 30.5 48.5 27.1 19.5 41.2 16.4 18.1 248.3 16.1 137.1 87.1 21.6 19.6 70.3 6.3 24.5 14.7 11.3 30.0 33.0 2.2 3.6 2.2 0.7 2.7 2.4 1.4 0.1 0.3 1.4 0.1 7.7 2.1 1.4 0.6 1.9 0.0 0.0 2.0 11.0 0.3 6.9 0.2 0.2 0.3 0.0 0.0 0.0 0.4 8.9 0.5 0.0 92.9 4.7 0.5 0.0 81.3 0.1 0.0 0.0 0.3 0.0 0.3 1.0 2.2 4.0 0.2 0.1 1.1 5.4 3.1 0.1 0.2 0.3 15.9 2.1 1.3 0.3 0.5 0.5 2.8 0.2 10.6 21.7 0.1 0.1 0.5 0.3 0.9 0.1 1.5 0.2 0.3 0.3 1.0 0.2 0.3 0.6 1.8 2.2 0.6 2.4 1.6 1.6 1.7 1.2 2.2 2.4 2.0 2.2 2.7 0.7 3.6 1.5 1.4 17.5 54.6 11.9 24.0 27.6 17.5 106.2 16.1 63.6 70.3 416.9 429.0 0.0 0.0 0.0 0.0 0.0 0.0 96.4 187.7 118.7 0.0 169.8 167.5 38.5 0.0 0.0 0.0 0.0 45.9 18.4 0.0 0.0 24.4 0.0 658.5 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 1.8 0.0 0.0 47.6 0.0 0.0 719.9 0.0 0.0 0.0 0.0 0.0 0.0 94.4 0.0 0.0 0.0 SERPINF1 "EPC-1, PEDF, PIG35" ENSG00000132386 "Serpin family F member 1" P36955 17 1761959-1777574 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 360.1" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 695.7;Fibroblasts: 677.8;Hepatocytes: 664.1;Leydig cells: 1683.3;Peritubular cells: 982.9;Syncytiotrophoblasts: 447.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 8 "pons and medulla: 105.5" "Cell type enriched" "Detected in some" 18 "plasmacytoid DC: 143.3" "Lineage enriched" "Detected in many" 119 "dendritic cells: 143.3" "Cell line enhanced" "Detected in many" "ASC diff: 124.2;ASC TERT1: 96.9;Hep G2: 56.6;HHSteC: 41.5;HSkMC: 131.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005825 Uncertain "Secreted to blood" NA NA 9290000000 85000000000 "HPA005825: AB_1079921" "unprognostic (3.85e-1)" "prognostic favorable (5.49e-4)" "unprognostic (9.44e-2)" "unprognostic (2.32e-2)" "unprognostic (2.96e-2)" "unprognostic (2.09e-1)" "unprognostic (3.32e-3)" "unprognostic (2.33e-1)" "unprognostic (7.88e-2)" "unprognostic (5.92e-2)" "unprognostic (1.69e-1)" "unprognostic (4.18e-2)" "prognostic unfavorable (1.40e-8)" "unprognostic (2.11e-3)" "unprognostic (2.82e-1)" "unprognostic (4.53e-3)" "unprognostic (1.25e-3)" 70.0 7.5 2.3 15.1 4.5 1.1 61.6 0.7 13.9 84.1 16.4 20.8 14.8 5.0 48.9 71.9 24.3 75.3 66.8 50.3 11.6 1.9 6.9 190.1 20.1 30.6 1.9 5.9 68.1 54.7 0.6 11.0 38.6 105.5 53.2 6.5 360.1 17.8 14.2 51.4 21.5 15.7 27.6 2.4 21.2 17.8 86.3 1.4 6.0 27.4 38.5 14.6 32.1 37.9 0.8 143.3 0.1 1.2 0.1 0.5 1.3 0.0 0.4 0.3 0.2 124.2 96.9 2.0 5.8 4.8 0.0 0.0 1.0 0.0 0.2 0.2 6.8 0.0 0.3 8.2 0.4 0.0 0.0 4.4 0.1 0.0 56.6 41.5 0.1 0.1 131.8 0.7 0.1 0.1 1.1 0.0 0.4 11.6 0.0 6.0 0.0 0.7 0.7 3.2 0.0 0.1 0.3 22.8 0.1 0.0 0.6 0.1 4.2 0.0 0.0 5.8 0.3 0.7 17.4 0.2 0.0 1.9 1.4 0.1 0.0 0.2 2.9 0.1 0.1 0.0 0.0 1.2 0.1 0.0 0.4 0.0 0.8 0.0 0.1 7.9 0.4 0.2 0.5 0.1 0.1 0.0 143.3 0.0 1.3 2.3 4.5 0.7 13.9 11.6 1.9 1.9 5.9 105.5 1.4 3.0 7.2 12.3 167.2 84.3 39.9 7.8 10.2 101.7 131.9 1.8 210.1 695.7 0.0 0.3 9.0 23.3 0.0 23.3 21.6 72.9 677.8 14.0 23.0 664.1 130.4 3.2 0.0 36.2 38.0 21.6 1683.3 71.6 102.9 131.7 0.0 6.1 9.4 0.0 982.9 12.9 32.6 19.4 143.0 6.5 5.6 68.6 447.3 7.5 0.0 47.8 SOGA1 "C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA" ENSG00000149639 "Suppressor of glucose, autophagy associated 1" O94964 20 36777442-36863686 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 55.5" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043992 Approved Approved Nucleoli,Cytosol "Secreted to blood" NA Yes "Nucleoli, Cytosol" "HPA043992: AB_2678762" "unprognostic (2.34e-2)" "unprognostic (1.35e-1)" "unprognostic (6.58e-2)" "unprognostic (1.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.48e-1)" "unprognostic (2.27e-3)" "unprognostic (1.37e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (8.28e-5)" "unprognostic (1.09e-3)" "unprognostic (2.85e-1)" "prognostic unfavorable (4.49e-4)" "unprognostic (6.99e-2)" "unprognostic (4.16e-2)" "unprognostic (1.40e-2)" "unprognostic (4.45e-3)" 6.2 11.4 10.8 4.5 10.6 1.4 6.0 55.5 12.5 11.3 8.3 20.5 7.2 2.5 8.8 5.3 7.2 9.4 9.9 6.7 9.9 7.5 4.7 1.3 6.1 3.0 12.7 8.9 12.6 3.7 11.5 4.4 7.9 8.7 10.7 3.9 6.7 4.4 12.3 2.9 11.0 4.6 14.1 7.9 5.3 5.3 14.8 14.7 0.9 16.0 4.7 4.1 8.0 10.5 1.0 2.1 1.4 0.7 0.7 0.2 0.2 7.5 10.3 12.5 13.5 7.3 6.7 3.3 6.6 7.2 9.5 5.6 4.1 1.2 3.3 2.5 11.6 8.2 10.2 10.0 6.2 10.0 0.5 2.0 5.4 9.6 5.4 3.8 1.2 5.3 3.8 7.6 9.0 6.4 4.1 6.1 3.7 3.8 0.7 10.3 7.3 3.8 2.8 3.2 0.8 8.0 9.0 11.7 1.3 5.5 2.3 15.0 9.4 13.8 15.2 4.4 5.8 19.3 8.1 9.3 23.8 4.6 11.6 14.4 1.4 0.3 3.4 10.1 1.6 15.0 1.4 0.7 0.2 0.1 0.4 0.2 1.0 0.1 0.1 0.4 1.0 0.2 0.2 1.4 0.7 0.3 2.1 0.1 0.2 10.8 10.6 55.5 12.0 9.9 7.5 12.7 8.9 8.7 14.7 0.0 2.6 1.4 4.8 11.2 18.8 12.1 0.0 2.7 7.9 19.2 35.3 12.5 1.7 3.4 0.4 10.5 1.7 0.0 1.3 8.6 11.0 5.2 10.4 0.2 8.5 22.3 5.8 9.8 5.3 1.5 11.2 6.0 5.0 1.0 1.3 19.4 1.8 0.0 17.7 1.2 3.7 12.9 11.3 0.7 1.0 14.1 2.7 1.0 2.5 2.5 SPARC ON ENSG00000113140 "Secreted protein acidic and cysteine rich" P09486 5 151661096-151687165 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Fibroblasts: 896.1;Ito cells: 958.1;Peritubular cells: 1044.4;Sertoli cells: 2315.4;Smooth muscle cells: 1190.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 9.3" "Group enriched" "Detected in many" 7 "granulocytes: 9.3;monocytes: 3.0" "Cell line enhanced" "Detected in many" "ASC diff: 234.0;BJ: 191.0;fHDF/TERT166: 302.0;WM-115: 222.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002306, HPA002989, HPA003020" Supported Approved Vesicles "Secreted to blood" NA NA 190000000 Vesicles "CAB002306: AB_563919, HPA002989: AB_1079532, HPA003020: AB_1079531" "unprognostic (3.34e-2)" "unprognostic (8.57e-2)" "unprognostic (1.31e-1)" "unprognostic (3.97e-1)" "unprognostic (7.01e-2)" "unprognostic (1.49e-1)" "unprognostic (2.05e-1)" "unprognostic (8.36e-3)" "unprognostic (5.27e-2)" "unprognostic (1.22e-1)" "unprognostic (4.09e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (3.53e-5)" "unprognostic (2.59e-3)" "unprognostic (1.17e-2)" "unprognostic (3.53e-1)" "unprognostic (4.93e-3)" 178.3 58.3 50.2 47.4 93.3 3.4 68.6 33.8 131.3 115.6 42.8 92.3 22.9 13.2 89.0 65.9 36.9 38.5 177.8 65.5 68.3 100.3 46.3 25.0 66.8 25.4 124.7 18.0 55.1 14.1 36.7 16.8 249.1 153.5 46.3 22.4 47.5 15.8 45.3 31.2 40.2 20.6 144.0 202.0 43.8 20.4 75.2 68.8 7.4 38.6 39.4 14.8 104.6 35.9 0.0 0.8 9.3 3.0 0.0 0.3 40.6 0.2 0.2 56.5 2.6 234.0 79.4 5.3 191.0 63.0 79.1 81.6 0.2 0.1 0.0 45.3 302.0 12.9 2.6 7.1 14.5 27.3 0.2 2.6 2.5 0.0 5.2 70.1 0.1 0.2 123.9 20.9 58.2 8.1 93.3 108.6 0.6 2.3 2.0 44.9 0.0 0.2 1.6 26.1 0.0 0.2 0.1 56.1 0.1 0.0 0.0 2.1 4.2 0.1 0.0 25.4 95.1 0.2 6.2 128.2 37.0 57.1 16.7 59.9 0.1 0.2 0.2 32.3 0.1 222.0 2.2 3.0 0.9 0.3 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 9.3 0.0 0.0 0.7 0.0 40.6 50.2 93.3 33.8 24.6 68.3 100.3 124.7 18.0 153.5 68.8 77.4 37.5 11.1 26.9 146.3 50.1 28.0 7.6 9.4 30.7 15.7 2.0 100.4 0.0 4.6 11.1 490.8 0.0 23.3 0.3 315.9 896.1 5.2 11.5 5.5 99.3 1.6 0.0 958.1 70.8 28.8 295.7 31.0 222.7 5.4 0.0 10.6 8.6 0.0 1044.4 35.4 63.7 2315.4 1190.8 7.0 6.8 94.6 123.1 5.1 0.0 4.4 SPOCK1 "SPOCK, testican-1, TIC1" ENSG00000152377 "SPARC/osteonectin, cwcv and kazal like domains proteoglycan 1" Q08629 5 136975298-137598379 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 92.2" "Cell type enhanced" "Detected in many" 19 "Cardiomyocytes: 54.3;Muller glia cells: 252.1;Peritubular cells: 141.1" "Cancer enriched" "Detected in all" 7 "prostate cancer: 83.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 2.5;myeloid DC: 1.6" "Group enriched" "Detected in many" 4 "dendritic cells: 1.6;monocytes: 2.5" "Cell line enhanced" "Detected in many" "ASC diff: 75.8;hTERT-RPE1: 144.5;HUVEC TERT2: 75.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007450, HPA026770" Uncertain Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA007450: AB_10603116, HPA026770: " "unprognostic (1.05e-1)" "unprognostic (9.25e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.93e-5)" "unprognostic (5.83e-3)" "prognostic unfavorable (9.08e-4)" "unprognostic (1.00e-2)" "prognostic unfavorable (4.72e-4)" "unprognostic (9.09e-3)" "unprognostic (1.60e-1)" "prognostic unfavorable (3.77e-5)" "prognostic unfavorable (9.40e-4)" "unprognostic (1.26e-1)" "unprognostic (2.21e-1)" "unprognostic (1.90e-2)" 11.3 31.0 20.6 4.0 30.4 1.5 9.3 68.2 92.2 20.5 7.4 36.0 5.1 2.1 20.5 26.1 5.6 6.8 14.3 38.6 29.9 16.6 18.0 1.4 1.9 1.7 35.5 29.0 3.2 3.7 1.4 3.7 7.6 19.6 48.9 3.6 5.2 2.9 20.7 5.6 3.2 2.6 23.2 21.7 6.8 3.7 15.9 36.0 0.1 3.3 0.0 1.6 8.1 11.5 0.0 1.6 0.4 2.5 0.0 0.0 0.6 0.5 0.1 38.2 0.0 75.8 15.5 0.0 12.4 11.5 27.0 15.2 0.0 0.0 0.0 0.0 25.9 6.8 0.5 0.1 8.9 8.4 2.1 0.0 0.0 2.3 0.0 0.5 0.0 0.0 27.0 3.6 16.6 2.9 144.5 75.8 0.0 0.0 0.0 7.7 0.0 0.0 0.0 2.4 0.0 3.5 0.0 0.0 0.0 18.0 1.2 0.4 1.8 6.1 0.1 0.0 4.8 0.0 0.1 12.1 38.5 1.3 13.1 3.5 0.0 0.0 0.0 20.9 0.5 17.4 0.0 2.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 20.6 30.4 68.2 28.5 29.9 16.6 35.5 29.0 19.6 36.0 0.0 0.0 0.0 1.7 1.5 5.0 54.3 0.0 0.0 0.0 21.0 2.0 0.4 1.7 0.7 8.2 2.1 0.0 0.0 1.2 0.4 9.5 48.4 0.0 0.0 0.8 7.9 33.7 1.3 2.4 8.9 16.1 1.1 6.8 1.0 0.0 252.1 1.5 0.0 141.1 1.7 3.2 12.9 12.8 7.5 5.9 1.3 0.1 0.0 0.1 2.1 SPOCK2 "KIAA0275, testican-2" ENSG00000107742 "SPARC/osteonectin, cwcv and kazal like domains proteoglycan 2" Q92563 10 72059035-72089032 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 47.1;brain: 70.7;lung: 52.1" "Group enriched" "Detected in many" 9 "Alveolar cells type 1: 268.0;Bipolar cells: 102.9;T-cells: 96.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 27.5;MAIT T-cell: 47.1;memory CD4 T-cell: 27.7;memory CD8 T-cell: 21.9;naive CD4 T-cell: 21.5;naive CD8 T-cell: 21.2;T-reg: 37.5" "Lineage enriched" "Detected in many" 8 "T-cells: 47.1" "Group enriched" "Detected in some" 7 "Hep G2: 25.4;SCLC-21H: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044605 Enhanced "Secreted to blood" NA NA 42000 "HPA044605: AB_10965991" "prognostic favorable (4.05e-4)" "unprognostic (3.11e-3)" "unprognostic (2.92e-2)" "unprognostic (2.29e-1)" "unprognostic (2.77e-2)" "prognostic favorable (1.95e-5)" "unprognostic (4.18e-2)" "unprognostic (9.04e-2)" "prognostic favorable (4.72e-4)" "prognostic unfavorable (7.19e-4)" "unprognostic (4.53e-3)" "unprognostic (2.29e-1)" "unprognostic (1.46e-3)" "unprognostic (5.59e-2)" "unprognostic (5.49e-2)" "unprognostic (3.19e-3)" "unprognostic (2.24e-2)" 4.2 29.8 31.9 24.9 47.8 27.9 2.0 70.7 63.2 2.5 4.2 9.8 0.0 6.2 2.5 2.7 2.8 4.7 9.9 4.7 27.5 49.5 18.8 2.5 52.1 36.4 36.0 32.1 3.7 1.5 1.7 12.8 2.9 47.9 3.0 4.1 5.4 2.8 4.5 3.6 1.9 9.3 3.4 22.3 16.9 8.3 13.6 9.2 43.4 3.3 0.6 27.0 8.0 1.4 5.6 0.7 2.9 0.2 2.8 47.1 10.3 0.1 0.2 0.2 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 4.4 0.1 0.7 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.4 0.1 0.6 25.4 0.9 0.2 0.6 0.1 0.2 0.0 0.0 0.1 0.0 1.4 0.0 0.4 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 36.2 2.2 0.0 0.8 0.2 0.2 0.0 0.9 0.1 0.0 0.1 0.1 0.0 0.4 0.8 3.8 0.1 0.0 0.1 0.0 0.1 0.0 27.5 0.2 47.1 5.6 27.7 21.9 0.0 4.5 21.5 21.2 2.9 2.8 0.0 0.7 37.5 10.3 31.9 47.8 70.7 42.0 27.5 49.5 36.0 32.1 47.9 9.2 268.0 14.3 16.4 0.2 3.4 102.9 2.5 0.0 2.7 5.7 14.0 5.9 0.1 0.0 0.4 6.3 9.0 0.7 0.0 0.7 0.0 2.4 0.4 3.5 0.0 0.2 3.2 4.7 6.7 2.6 8.2 4.9 2.0 5.0 0.0 0.3 3.8 0.0 0.0 5.6 0.0 12.4 0.0 4.2 3.6 0.6 3.9 0.3 96.9 0.0 0.3 SPP2 SPP24 ENSG00000072080 "Secreted phosphoprotein 2" Q13103 2 234050679-234077134 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 879 "liver: 113.0" "Cell type enriched" "Detected in some" 22 "Hepatocytes: 258.9" "Cancer enriched" "Detected in some" 112 "liver cancer: 65.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.1;RH-30: 3.5;RPTEC TERT1: 1.0;U-698: 1.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Secreted to blood" NA NA 540000000 "prognostic favorable (2.33e-6)" "unprognostic (7.02e-3)" "unprognostic (9.62e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 3.5 0.0 1.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 3.5 0.9 0.0 0.0 0.0 0.3 7.6 2.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 4.7 258.9 0.1 0.0 0.0 5.5 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SVBP "CCDC23, MGC45441" ENSG00000177868 "Small vasohibin binding protein" Q8N300 1 42807052-42817252 "Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 164.4;Spermatogonia: 149.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008507 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" "Secreted to blood" Yes No "Nucleoplasm, Nuclear bodies, Cytosol" "HPA008507: AB_2072066" "prognostic favorable (6.33e-4)" "unprognostic (2.68e-2)" "unprognostic (2.91e-1)" "unprognostic (4.60e-2)" "unprognostic (2.05e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (3.15e-2)" "unprognostic (3.35e-3)" "unprognostic (1.59e-2)" "unprognostic (6.73e-3)" "unprognostic (2.16e-1)" "unprognostic (5.37e-3)" "unprognostic (1.17e-3)" "unprognostic (7.07e-2)" "unprognostic (2.44e-3)" "unprognostic (2.31e-3)" 20.1 14.1 25.6 11.1 18.9 32.3 20.1 24.0 20.4 16.2 15.7 17.6 10.4 9.7 20.5 23.9 13.0 20.1 15.5 19.6 21.8 19.7 16.0 15.9 13.8 17.8 23.5 22.3 34.4 9.1 10.7 20.0 23.5 20.4 16.8 14.5 13.6 11.6 14.5 21.1 10.1 11.8 17.1 26.9 14.3 11.5 38.2 18.7 29.2 15.5 16.1 19.4 16.2 15.1 24.5 16.0 30.2 16.8 14.3 44.8 9.7 10.2 4.9 32.3 11.6 13.1 20.9 15.7 8.8 7.3 12.0 12.4 9.0 8.2 11.1 9.7 11.8 9.4 7.1 5.7 9.4 16.2 19.7 9.8 22.3 4.9 17.9 10.6 16.7 14.6 13.1 15.1 6.7 6.9 13.0 12.1 22.4 17.3 6.0 15.3 4.8 16.7 20.0 17.7 9.8 6.0 12.2 24.6 7.8 12.7 11.2 19.3 17.3 10.5 6.1 12.6 35.9 4.8 47.3 9.2 10.6 12.0 8.5 14.2 5.8 7.1 8.0 6.8 11.4 10.0 20.8 16.6 30.2 11.4 15.9 10.3 22.1 20.4 14.0 16.0 24.5 19.2 16.4 29.3 14.3 16.8 13.4 44.8 9.7 25.6 18.9 24.0 20.4 21.8 19.7 23.5 22.3 20.4 18.7 8.9 4.6 32.1 27.2 0.0 5.5 0.0 28.1 13.4 17.0 19.2 2.0 47.5 46.4 41.3 113.1 20.3 12.5 93.5 21.4 53.4 17.5 19.3 10.5 31.8 64.1 6.4 17.5 31.3 40.5 49.2 39.7 28.7 0.0 64.1 23.7 13.2 34.6 28.5 50.5 34.8 13.5 58.2 0.0 164.4 149.9 0.0 51.5 20.0 30.2 25.4 TFF3 "HITF, ITF" ENSG00000160180 "Trefoil factor 3" 21 42311667-42315651 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 230.9;thyroid gland: 258.3" "Cell type enriched" "Detected in many" 21 "Mucus-secreting cells: 36697.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 30 "eosinophil: 9.5" "Lineage enriched" "Detected in single" 63 "granulocytes: 9.5" "Cell line enhanced" "Detected in some" "MCF7: 28.4;OE19: 44.4;SCLC-21H: 8.7;T-47d: 13.3;TIME: 36.9" "Region enriched" "Detected in single" 20 "cerebellum: 1.7" "Not detected" "Not detected" "CAB020681, HPA035464" Enhanced Approved Nucleoplasm,Nucleoli "Secreted to blood" No NA 151000000 Nucleoplasm Nucleoli "CAB020681: , HPA035464: AB_2674636" "unprognostic (2.84e-2)" "unprognostic (3.61e-3)" "unprognostic (1.07e-1)" "prognostic favorable (5.60e-6)" "unprognostic (1.28e-1)" "unprognostic (2.35e-2)" "unprognostic (2.13e-1)" "unprognostic (5.03e-2)" "unprognostic (1.58e-1)" "unprognostic (1.05e-1)" "unprognostic (3.71e-1)" "unprognostic (6.90e-2)" "unprognostic (4.31e-2)" "unprognostic (1.25e-1)" "unprognostic (2.04e-1)" "unprognostic (2.44e-2)" "unprognostic (3.86e-2)" 2.2 1.2 0.2 16.8 0.2 0.0 4.3 0.2 0.2 45.1 66.3 0.2 0.5 40.8 2.8 1.2 5.1 8.0 230.9 0.7 0.2 0.3 1.0 0.6 12.6 0.6 0.4 0.2 2.0 4.8 0.0 0.5 0.5 0.2 3.6 63.3 0.3 54.8 0.7 0.6 1.6 70.6 1.5 0.5 5.0 1.1 0.4 0.2 0.3 258.3 14.4 72.6 1.1 1.6 0.0 0.0 9.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 28.4 0.0 0.5 0.1 44.4 4.3 0.0 3.2 0.3 0.0 0.0 8.7 0.1 0.0 0.8 0.0 0.0 13.3 0.0 36.9 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.3 0.4 0.2 0.2 0.2 14.9 22.3 0.9 17.0 37.0 0.0 13.4 1110.8 464.4 316.2 21.0 0.0 0.3 0.0 9.0 0.0 51.4 1768.3 0.0 62.1 0.6 20.3 103.0 60.8 0.9 1.9 4.8 740.8 82.9 2.6 0.8 2.3 2.5 91.1 0.0 36697.4 0.0 28.0 1779.2 7.4 0.0 0.0 0.0 6.1 0.3 0.3 33.8 0.7 1.0 1243.2 29.6 VCAN "CSPG2, PG-M" ENSG00000038427 Versican P13611 5 83471465-83582303 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Fibroblasts: 557.1;Kupffer cells: 784.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 55.5;myeloid DC: 21.3" "Group enriched" "Detected in many" 31 "dendritic cells: 21.3;monocytes: 55.5" "Cell line enhanced" "Detected in some" "AF22: 43.6;HSkMC: 29.6;hTERT-RPE1: 140.3;RPTEC TERT1: 55.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004726, CAB008979" Supported Approved Vesicles "Secreted to blood" NA NA 5200000 Vesicles "CAB008979: , HPA004726: AB_1080561" "unprognostic (7.90e-2)" "unprognostic (9.03e-3)" "unprognostic (7.09e-2)" "unprognostic (6.06e-3)" "unprognostic (1.87e-1)" "unprognostic (4.49e-2)" "unprognostic (1.23e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (7.59e-4)" "unprognostic (4.36e-3)" "unprognostic (2.68e-3)" "unprognostic (2.05e-1)" "prognostic unfavorable (5.17e-4)" "prognostic unfavorable (1.41e-4)" "unprognostic (1.15e-1)" "unprognostic (4.44e-2)" "unprognostic (5.30e-3)" 33.3 18.3 14.8 53.2 10.3 20.1 12.3 4.8 16.2 25.2 8.4 17.9 1.7 3.6 14.5 23.5 9.0 7.6 23.2 35.7 19.8 8.9 8.5 3.1 25.8 21.2 13.9 9.8 5.3 3.2 3.7 2.0 52.0 14.4 8.9 8.9 3.3 6.5 4.1 9.0 9.3 4.7 33.9 18.2 18.4 6.2 8.7 19.4 1.1 5.7 6.5 2.3 24.4 9.8 0.0 21.3 1.2 55.5 0.1 0.1 17.7 0.0 0.8 43.6 0.0 17.7 12.2 0.0 0.3 0.8 0.3 0.2 0.4 0.0 0.0 6.7 15.7 0.5 0.0 0.0 0.0 0.2 0.0 1.3 0.3 0.0 0.3 0.8 0.0 0.0 29.6 0.0 18.5 0.1 140.3 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 7.4 0.0 1.4 0.0 9.1 0.0 55.4 0.0 0.5 2.2 0.0 0.0 0.0 5.0 0.0 0.0 16.8 13.3 0.0 24.4 25.0 0.0 0.0 0.0 6.1 0.0 2.3 1.2 55.5 0.1 0.1 7.7 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.9 0.1 0.8 0.4 0.0 17.7 14.8 10.3 4.8 9.8 19.8 8.9 13.9 9.8 14.4 19.4 17.9 29.9 3.0 4.4 34.3 0.0 6.8 30.6 25.4 30.7 24.4 0.0 7.1 0.0 1.6 0.8 12.1 0.0 0.0 0.6 5.1 557.1 1.5 11.6 2.1 24.5 0.0 0.0 23.4 784.4 0.7 17.3 132.2 42.2 5.4 0.0 0.0 19.5 0.0 110.7 1.2 0.0 0.0 33.9 0.3 0.4 25.1 9.6 4.4 0.0 0.8 VMO1 ENSG00000182853 "Vitelline membrane outer layer 1 homolog" Q7Z5L0 17 4785285-4786433 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 37.9" "Cell type enriched" "Detected in many" 14 "monocytes: 1494.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "non-classical monocyte: 37.9" "Lineage enriched" "Detected in many" 9 "monocytes: 37.9" "Cell line enhanced" "Detected in many" "A549: 6.1;MCF7: 7.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA023038 Uncertain "Secreted to blood" NA NA 1200000 "HPA023038: AB_10964632" "unprognostic (1.30e-1)" "unprognostic (5.71e-2)" "unprognostic (1.65e-3)" "unprognostic (9.09e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" "unprognostic (7.77e-2)" "unprognostic (5.58e-3)" "unprognostic (1.20e-1)" "unprognostic (1.65e-1)" "unprognostic (7.41e-2)" "unprognostic (4.23e-1)" "prognostic unfavorable (1.34e-6)" "unprognostic (1.10e-2)" "unprognostic (1.07e-1)" "unprognostic (2.60e-1)" "unprognostic (2.69e-1)" 3.8 1.3 1.6 5.9 1.4 1.5 1.9 1.2 2.8 2.6 1.4 1.7 0.4 4.4 1.1 1.9 1.1 0.5 2.8 7.1 1.8 2.1 2.1 9.2 7.4 4.9 1.9 1.4 1.1 2.3 21.2 19.9 1.9 3.6 1.7 0.5 13.1 2.9 1.4 8.8 1.3 4.6 1.0 3.3 21.1 0.8 0.9 1.9 1.4 0.7 2.8 1.2 3.5 1.8 0.0 4.4 0.0 37.9 0.1 0.0 1.1 0.5 6.1 0.6 3.6 0.8 1.6 0.7 1.1 2.2 0.3 0.7 1.9 2.3 0.2 0.1 0.3 0.5 1.0 0.0 0.9 0.4 4.4 0.9 0.2 1.1 1.5 1.3 0.0 2.8 1.0 0.9 0.2 0.9 1.3 0.0 0.9 0.6 1.0 1.2 7.9 0.0 1.8 1.6 1.3 2.4 1.3 2.8 0.6 0.0 1.4 0.6 0.9 0.5 0.5 0.6 0.6 2.3 0.2 0.6 2.7 0.2 0.7 0.4 0.1 0.5 0.1 1.0 1.3 1.7 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.1 37.9 0.0 0.0 1.1 1.6 1.4 1.2 2.8 1.8 2.1 1.9 1.4 3.6 1.9 3.0 10.6 6.9 8.3 7.6 6.1 0.8 2.5 17.4 42.1 0.0 0.0 0.3 1.7 0.8 3.5 1.6 1.7 0.0 1.3 0.2 1.5 9.1 13.9 3.2 17.0 0.0 1.2 104.3 52.6 25.1 0.3 82.9 5.0 1494.2 1.0 0.8 1.1 0.0 1.1 1.4 2.5 12.9 3.4 0.5 1.0 6.4 0.2 0.7 1.0 9.2 WDR25 "C14orf67, MGC4645" ENSG00000176473 "WD repeat domain 25" Q64LD2 14 100376418-100530303 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Exocrine glandular cells: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003113 Uncertain Approved Nucleoplasm "Secreted to blood" NA NA Nucleoplasm "HPA003113: AB_2215263" "unprognostic (5.31e-2)" "unprognostic (5.76e-3)" "unprognostic (2.28e-2)" "unprognostic (1.24e-1)" "unprognostic (1.11e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (7.36e-4)" "unprognostic (1.79e-2)" "unprognostic (6.62e-2)" "unprognostic (3.94e-3)" "unprognostic (2.44e-2)" "unprognostic (1.37e-2)" "prognostic favorable (3.89e-5)" "unprognostic (1.01e-2)" "unprognostic (1.73e-1)" "unprognostic (7.30e-2)" "unprognostic (7.51e-2)" 6.9 10.9 10.8 5.0 13.5 7.9 9.5 14.4 14.8 15.2 8.3 11.2 5.4 6.8 11.1 9.4 7.6 14.0 7.2 7.6 10.8 9.4 7.6 9.0 7.5 6.8 8.6 13.3 11.0 16.2 7.7 13.4 7.2 9.4 9.2 5.7 10.9 11.9 9.7 11.4 6.1 5.8 7.3 7.5 6.8 8.4 15.0 11.3 6.4 17.3 4.4 6.6 7.4 6.6 9.9 11.9 19.5 13.9 4.2 10.8 10.0 3.3 5.9 4.1 15.2 6.7 6.3 3.4 6.2 9.9 7.2 7.3 2.7 6.3 4.8 7.8 5.1 2.0 6.0 3.9 7.6 3.8 4.7 2.8 3.2 6.7 4.6 12.3 3.7 3.7 9.4 9.0 5.2 7.9 6.3 5.2 5.8 3.9 7.1 4.7 12.7 5.5 4.2 3.2 4.0 10.5 4.0 5.8 3.3 5.5 2.7 9.7 10.2 5.0 1.9 8.3 4.1 7.0 1.3 8.8 2.7 3.2 10.6 3.5 4.8 2.4 2.4 9.6 2.8 5.2 19.5 13.9 19.5 7.5 11.8 7.8 9.9 10.0 8.0 11.9 7.2 10.8 7.9 7.3 4.2 12.4 9.2 9.7 10.0 10.8 13.5 14.4 14.8 10.8 9.4 8.6 13.3 9.4 11.3 0.0 5.4 3.4 3.8 2.9 8.0 2.0 0.0 9.4 3.4 3.5 9.8 7.2 8.3 9.6 8.2 6.7 5.9 0.0 29.6 4.1 6.6 2.6 3.5 7.2 5.9 4.8 5.2 5.5 4.4 4.2 6.4 3.5 5.0 5.4 6.1 12.1 13.6 3.5 10.6 13.5 15.2 12.9 8.0 10.9 15.2 2.6 5.8 5.3 6.8 1.8